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Abstract 
This thesis is focused on the development and evaluation of different hybrid 
scaffolds for the treatment of injuries in cartilage or bone. These hybrid materials 
were three-dimensional polycaprolactone macroporous scaffolds obtained through 
freeze extraction and particle leaching combined method and modified with 
hyaluronic acid or mineral particles. In order to facilitate the description of the 
obtained results, the thesis is divided in two sections dedicated to bone and cartilage 
tissue engineering respectively. 
In the case of bone tissue engineering we addressed the treatment of disorders 
associated with the spine that require spinal immobilization. This Thesis proposes 
the development of a synthetic macroporous support for intervertebral fusion as an 
alternative to commercial bone substitutes. Macroporous scaffolds were developed 
with bare polycaprolactone or its blends with polylactic acid in order to increase its 
mechanical properties and degradation rate. Furthermore, the scaffolds obtained 
were reinforced with hydroxyapatite or Bioglass®45S5 to improve their mechanical 
properties and turn them in bioactive scaffolds. The supports were characterized 
physicochemically and biologically to determine if they met the requirements of the 
project. Finally, materials were tested in vivo in a bone critical size defect preformed 
in a rabbit model against a commercial support. 
Cartilage engineering has been extensively studied in the last years due to the 
inherent limited self repair ability of this tissue. The second part of the thesis was 
focused in developing a construct composed by in vitro differentiated chondrocyte 
like cells in a hybrid scaffold for cartilage tissue engineering. Polycaprolactone 
hybrid substrates coated with hyaluronic acid scaffold were developed obtaining a 
substrate with positive influence over the development of chondrocyte phenotype in 
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culture and able to protect the cells from excessive mechanical loading in the joint. 
Cell-scaffolds constructs were obtained combining hybrid scaffolds with 
mesenchymal stem cells and differentiating them to chondrocytes using 
chondrogenic culture medium combined with hypoxia, mechanical stimulus or co-
culture. Finally the cellularized scaffolds were mechanically, biochemically and 
histologically characterized to determine the production of extracellular matrix and 
expression of chondrogenic markers.  
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Resumen 
La presente tesis se centró en el desarrollo y evaluación de diversos soportes 
tridimensionales híbridos para el tratamiento de las lesiones de cartílago o hueso. 
Dichos materiales híbridos eran soportes tridimensionales macroporosos de 
prolicaprolactona obtenidos por el método combinado de freeze extraction y particle 
leeaching posteriormente modificados con ácido hialurónico o partículas minerales. 
Para facilitar la compresión de los resultados obtenidos la tesis se estructura en dos 
secciones dedicadas a ingeniería tisular de hueso y de cartílago respectivamente.  
La ingeniería tisular ósea abarca distintas patologías, tales como determinados 
desordenes asociados con la columna vertebral que requieren de la inmovilización 
de esta mediante la fusión de vertebras. En esta tesis proponemos el desarrollo de un 
soporte macroporoso sintético para fusión intervertebral como alternativa a los 
sustitutos óseos comerciales. Se diseñaron soportes macroporosos de 
policaprolactona pura o mezclada con ácido poliláctico para incrementar las 
propiedades mecánicas del constructo y su velocidad de degradación. Por otro lado 
los andamios obtenidos fueron reforzados adicionalmente con hydroxyapatita o 
Bioglass®45S5 a fin de mejorar sus propiedades mecánicas y dotarlos de 
bioactividad. Los soportes fueron caracterizados fisicoquímicamente y 
biológicamente para determinar si cumplían los requisitos del proyecto. Finalmente 
los materiales fueron testados in vivo en un modelo de defecto óseo de tamaño 
crítico realizado en conejo frente a un soporte comercial. 
El cartílago ha sido ampliamente estudiado debido a la escasa capacidad del 
cartílago para autorrepararse. El segundo bloque de la tesis se centró en el desarrollo 
de un constructo formado por células diferenciadas in vitro a condrocito en un 
soporte híbrido para ingeniería tisular. Se desarrollaron soportes híbridos de 
policaprolactona recubiertos con ácido hialurónico obteniendo así un andamio 
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celular con una influencia positiva sobre el fenotipo celular y capaz de proteger las 
células de cargas mecánicas excesivas de la articulación. Se prepararon constructos 
de células mesenquimales en scaffolds y diferenciaron a condrocitos mediante el uso 
de medio de cultivo condrogénico combinado con el uso de hipoxia, estímulo 
mecánico o cocultivo. Finalmente los constructos fueron caracterizados 
mecánicamente, bioquímicamente e histológicamente a fin de estudiar la producción 
de matriz extracelular y la expresión de marcadores fenotípicos correctos. 
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Resum 
La present tesi es centrà en el desenvolupament i avaluació de diversos suports 
tridimensionals híbrids per al tractament de les lesions de cartílag i ós. Aquestos 
materials híbrids són suports tridimensionals macroporosos de prolicaprolactona 
obtinguts pel mètode combinat de freeze extraction i particle leeaching 
posteriorment modificats amb àcid hialurònic o partícules minerals. Per facilitar la 
comprensió dels resultats obtinguts la tesi s'estructura en dues seccions dedicades a 
l’enginyeria tissular d'ós i cartílag respectivament.  
L'enginyeria tissular òssia abasta diferents patologies tal com determinats desordres 
associats amb la columna vertebral que requereixen de la immobilització d'aquesta 
mitjançant la fusió de vertebres. En aquesta tesi proposem el desenvolupament d'un 
suport macroporós sintètic per fusió intervertebral en lloc dels substituts ossis 
comercials. Amb aquesta finalitat es van dissenyar suports macroporosos de 
policaprolactona pura o barrejada amb àcid polilàctic per incrementar les propietats 
mecàniques del constructe i la seva velocitat de degradació. D'altra banda suports 
macroporosos obtinguts addicionalment es varen reforçar amb hydroxyapatita o 
Bioglass® per tal de millorar les seves propietats mecàniques i dotar-los de 
bioactivitat. Els suports van ser caracteritzats fisicoquímicament i biològicament per 
determinar si acomplien amb els requisits del projecte. Finalment els materials van 
ser testats in vivo en un model de defecte ossi de mida crítica en conill comparant-lo 
amb un suport comercial.  
El cartílag a sigut àmpliament estudiat a causa de l'escassa capacitat del cartílag per 
regenerar-se. El segon bloc de la tesi es va centrar en el desenvolupament d'un 
constructe format per cèl·lules diferenciades in vitro a condròcit en un suport híbrid 
per enginyeria tissular. Es van desenvolupar suports híbrids de policaprolactona 
recoberts amb àcid hialurònic obtenint així un scaffold amb una influència positiva 
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sobre el fenotip cel·lular i que protegeix les cèl·lules de les càrregues mecàniques 
excessives de l'articulació. Es varen preparar constructes de cèl·lules mesenquimals 
en scaffolds i es van diferenciar a condròcits mitjançant l'ús de medi de cultiu 
condrogènic combinat amb l'ús d'hipòxia, estímul mecànic i cocultiu. Finalment els 
constructes formats per un scaffold amb cèl·lules van ser caracteritzats 
mecànicament, bioquímicament e histològicament a fi d’estudiar la producció de 
matriu extracel·lular y la expressió dels marcadors fenotípics correctes. 
.  
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General objective and specific purposes 
General objective 
The aim of this thesis is the development of three-dimensional scaffolding systems 
for bone and cartilage regeneration. Bone regeneration supports were developed 
having in mind their application as bioactive spinal fusion strips (although they can 
find application in other bone diseases) while cell/scaffold constructs were 
developed for articular cartilage tissue engineering.  
Specific purposes 
 To produce polycaprolactone and polycaprolactone/polylactic acid blend 
macroporous scaffolds by freeze extraction and particle leaching in order to 
obtain a bimodal porosity composed by interconnected macropores whose 
pore walls are in turn microporous. 
 For the synthetic spinal fusion strips these scaffolds were combined with 
mineral coating or containing particles to favour bone anchorage. 
Morphologic and physical properties will be characterized while biological 
response will be assessed by in vitro culture. Samples of optimized 
composition were produced for an in vivo study performed at the Instituto of 
Biomecánica de Valencia 
 Supports for cartilage engineering will be based on PCL scaffolds whose 
pore walls were coated with hyaluronic acid. Different approaches to 
produce this coating will be tested. Cell-scaffold constructs will be produced 
by seeding the scaffolds with mature chondrocytes or mesenchymal stem 
cells and culturing them in chondrogenic conditions. The effect of hypoxia, 
mechanical stimulation and co-culture of chondrocytes and MSCs will be 
assessed.
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1. Introduction 
1.1. Connective tissue: Bone and cartilage 
Connective tissue is derived from embryonic mesoderm and is commonly formed by 
few cells immersed in a huge amount of extracellular matrix (ECM), composed 
principally by fibrillar proteins and the ground substance (adhesion proteins, 
proteoglycans and interstitial fluid). Connective tissues are widely distributed along 
the body and consist of a huge variety of specialized structures and cell types that 
provide binding, support, protection and insulation to other tissues.[1] Connective 
tissue types are embryonic connective tissue, adult connective tissue and special 
connective tissue. Embryonic connective tissue is developed during early embryonic 
stages and found mainly in the umbilical cord. Adult connective tissue is comprised 
of both loose and dense connective tissue; which are differentiated on the cell/ECM 
ratio.[2] Loose connective tissue shows a high cell/collagen ratio and provides 
support and insulation while dense connective tissue shows a low cell/collagen ratio 
and provides flexible and strong connections between tissues.[2,3] On the other 
hand, the so-called special connective tissues are tissues with a unique extracellular 
matrix structure, cell type and functions which are not found in the other connective 
tissues.[2,3] Special connective tissues includes four types, which are hematopoietic 
tissue, adipose tissue, bone and cartilage.[2] The present thesis is focused on bone 
and cartilage connective tissues.  
 
1.1.1.  Bone 
Bone is a highly vascularized and mineralized tissue with a dual structure: cortical 
and cancellous bone. Bone is a natural composite consisting of mineral crystals 
Introduction                                                                                                       . 
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(70% of dry weight) and an organic phase (30% of dry weight)[4]. The combination 
of mineral crystals and collagen results in a tissue with outstanding mechanical 
properties.[5] The mechanical properties of the composite are adapted to their load-
bearing function much better than the separated components since collagen provides 
toughness that compensates hydroxyapatite brittle fracture while mineral phase 
provides the hardness and the rigidity which bare collagen is lacking.  
Cortical bone shows the highest mechanical properties and is a dense and slightly 
porous tissue composed by osteons that are concentric extracellular matrix lamellae 
surrounding the Haversian canal which is, itself, crossed by a blood vessel[4,6,7] as 
shown in figure 1-1. On the other hand cancellous bone is a highly porous structure 
(75-95%) localized between the diaphysis and the bone end in long bones as shown 
in figure 1-2 and filling short and flat bones.[4,6-8] Cancellous bone is organized in 
trabeculae or spicules showing lower mechanical properties than cortical 
bone.[4,6,8,9]  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-1. Cortical bone osteon structure diagram [6]. [Ross MH and Pawlina W: 
Histology: A Text and Atlas 6th edition. Lippincott WIlliams & Wilkins, 2011] 
                                                                                                        Introduction 
13 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-2. Long bone structural organization.[6] [Ross MH and Pawlina W: Histology: 
A Text and Atlas 6th edition. Lippincott WIlliams & Wilkins, 2011] 
 
Bone cells are called osteoblasts (osteocytes) and osteoclasts, they regulate bone 
homeostasis, which is a highly dynamic process of tissue remodelling. [10] 
Osteoblasts are non-migratory cells derived from mesenchymal stem cells (MSC), 
which show different behaviours and characteristics along their maturation steps. 
Active osteoblast is a mononucleated cell found in the osteoid (non-mineralized 
extracellular matrix region) that shows a high alkaline phosphatase expression. 
Osteoblast secretes collagen type I and non-collagenous proteins to form the 
extracellular matrix, cytokines and growth factors which regulate the osteoid and 
mineralization as final step. Once osteoid is mineralized and the osteoblast is 
surrounded with mineralized extracellular matrix, it is called osteocyte and remains 
quiescent, although still playing a role in the regulation of bone homeostasis.[10] On 
the other hand osteoclast is a cell type derived from hematopoietic stem cells that 
Introduction                                                                                                       . 
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regulates bone resorption through the acidification of mineralized extracellular 
matrix and the enzymatic degradation of ECM proteins. Osteoclast attaches to the 
mineralized matrix and acidify the zone using a carbonic anhydrase that dissolves 
the bone mineral.[10] 
As shown in figure 1-1, cells are distributed among the extracellular matrix, a 
complex macromolecular network composed of highly mineralized collagen fibres 
which allows cell anchorage and structural support. 
Protean extracellular matrix is composed by collagen type I and non-collagenous 
proteins. Collagen type I is formed by three polypeptide, composed by glycine, 
proline and hydroxyproline, associated in helix conformation. Collagen is assembled 
staggered in parallel with the unit ends separated by gaps of 40nm with an overlap 
of 27nm constituting a 67nm zone called “hole zone”. Hydroxyapatite crystals 
nucleate in this space, but its growth is limited due to the gap size.[4] On the other 
hand non collagenous proteins are a diverse pool of proteins, like bone sialoprotein, 
osteopontin, osteonectin and osteocalcin, which represent just a 10% of bone ECM 
proteins. Non-collagenous protein functions are not entirely understood, but it is 
known that they affect hydroxyapatite crystal nucleation and growth, cell 
signalization and ion homeostasis.[4] 
Mineral phase is composed by hydroxyapatite crystals that nucleate and grow inside 
the hole zone, a gap between collagen fibres. Hydroxyapatite formation is regulated 
by proteins that generate a dynamic equilibrium between the bone remodelling and 
the mineral needs of the organism.[4] Hydroxyapatite found in bones is similar to 
geological hydroxyapatite (Ca5(PO4)3(OH)) but with a lower Ca/P molar ratio than 
1.67 for stoichiometric hydroxyapatite. Comparing with geological apatite crystal, 
biological apatite is smaller and show differences in chemical composition such as 
                                                                                                        Introduction 
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several ionic substitutions (presence of carbonate, magnesium, etc) associated with 
calcium or hydroxyl deficiencies that disrupt the crystalline network.[4,11]  
 
1.1.2.  Cartilage 
Cartilage is an avascular and aneural connective tissue composed by chondrocytes 
dispersed in an extracellular matrix composed by proteoglycans and collagen.[12] 
Three types of cartilage tissues can be distinguished: fibrocartilage, elastic and 
hyaline cartilage that are classified by its appearance, mechanical properties and 
extracellular matrix characteristics.[6] Fibrocartilage is present on intervertebral 
discs and insertion points of bone with ligament or tendons. This cartilage is 
structured in chondrocytes surrounded by a small amount of cartilaginous matrix 
composed by collagen type I parallel fibre groups with lack amorphous matrix rich 
in chondroitin sulphate and dermatan sulphate surrounding the chondrocytes. Elastic 
cartilage is present on ear canal, epiglottis and larynx and compared to hyaline 
cartilage shows less extracellular matrix. The ground substance is composed mainly 
by elastic fibres highly ramified.[12] 
On the other hand hyaline cartilage is a tissue with a highly complex and specialized 
structure, localized mainly on bone surface joints. It is a tissue with a low cellularity 
(3-5% of wet weight) with a highly hydrated extracellular matrix composed by 
collagen (mainly collagen type II) and proteoglycans.[6] As shown in figure 1-3, 
four different zones compose hyaline cartilage structure with differences in the 
distribution and composition of their extracellular matrix. From cartilage surface to 
bone they are: Superficial, intermediate, deep zone and calcified zone. Superficial 
zone is the thinnest zone of hyaline cartilage, it is composed by two layers rich in 
collagen, fibronectin and water. This structure adds resistance to shear stress at the 
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articular joint but it is important as well sustaining compressive strength. The upper 
layer of this zone is a collagen acellular sheet that covers the joint while the bottom 
one is composed by flattened chondrocytes immersed in a collagen matrix with 
fibres oriented parallel to the articular joint surface. The intermediate zone is 
composed by spherical chondrocytes that show synthetic organelles surrounded by 
an ECM with fibrils obliquely or randomly oriented with respect to superficial zone. 
Extracellular matrix shows a higher content of proteoglycans but lesser collagen and 
water content. The deep zone is the thickest part of the cartilage, and it is composed 
by highly biosynthetic round chondrocytes aligned in columns. Finally the calcified 
zone is the closest zone to subchondral bone and is composed by small round 
chondrocytes with low metabolic activity and surrounded by calcified extracellular 
matrix. [6,13] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-3. Hyaline cartilage structure diagram (a) and histology (b)[6] [Ross MH and 
Pawlina W: Histology: A Text and Atlas 6th edition. Lippincott WIlliams & Wilkins, 
2011] 
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Cartilage cellular population is composed exclusively by chondrocytes that derive 
from mesenchymal stem cells and are isolated in ECM structures called lacunae. 
These structures vary in shape and orientation along with cartilage deepness, but 
cells adapt to the lacunae shape independently of this.[12,13] Furthermore, cellular 
membrane presents cilia that penetrate the extracellular matrix in some chondrocytes 
and are suspected to act as mechanical signal sensors.[13] Finally chondrocytes 
shows two different subpopulations inside the hyaline cartilage tissue: mature 
chondrocytes and hypertrophic chondrocytes.[13] Mature chondrocytes are not able 
to proliferate and occupy the main part of the tissue, where they secrete collagen and 
other macromolecules to maintain hyaline cartilage homeostasis. On the other hand 
hypertrophic chondrocytes are the final chondrocyte development stage and occupy 
the calcified zone near to bone. [12,13] 
Cartilage ECM is composed by collagen and glycosaminoglycans distributed so as 
to resist mechanical loading. Collagen fibril network provides tensile and shear 
strength while glycosaminoglycans fill the interstices, as a water-retaining gel, 
absorbing shock compression forces and providing the joint with non adherent 
surface.[12,13] Collagen is the most abundant protein in hyaline cartilage ECM and 
collagen type II is the most representative collagenous protein (80% of total 
collagen).[6] Cartilage type II forms fibres of 15 to 45 nm of diameter that, in 
association with other collagen types, form a mesh that entraps other 
molecules.[12,13] The remaining amount of collagen is composed by collagen types 
VI, IX, X and XI. Collagen type IX and XI are associated to collagen type II and 
stabilize it. Collagen type IX participates in the interaction between proteoglycans 
and collagen type II mesh. Collagen type XI regulates collagen type II fibril 
size.[6,12,13] Collagen type X is present only in calcified zones and organizes 
collagen fibrils in hexagonal lattices that contribute to bone mineralization.[6] The 
other principal component of hyaline cartilage extracellular matrix are the 
Introduction                                                                                                       . 
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proteoglycans. Proteoglycans composition is a 5% of protein and a 95% of 
unbranched polysaccharides.[13] Proteoglycans are one of largest molecules 
produced by cells with molecular weights that can reach 3.5 x 10
6
 Dalton; they are 
composed by a core protein of 200 to 300 nm length with glycosaminoglycans 
attached to it.[12] Glycosaminoglycans attached to core protein are linear 
polysaccharides composed by disaccharide monomers (an amino sugar and another 
monosaccharide) with a carboxylate or sulfate groups. The main 
glycosaminoglycans present in hyaline cartilage are hyaluronic acid, chondroitin 
sulfate, dermatan sulfate, keratan sulfate and heparan sulfate.[13] Proteoglycans in 
vivo are commonly bound to a hyaluronic acid molecule constituting a huge 
molecule that is trapped by the collagen fibre network filling the intrafibrillary space 
and retaining water as a hydrogel.[12] 
 
1.2. Regenerative capacity of bone and cartilage. 
1.2.1. Bone healing 
Bone shows a high regeneration capacity that generally grants a complete bone 
fracture healing without external intervention. Fracture healing is a complex process 
regulated by cells and the huge amount of biological molecules that they secrete.[14] 
Fracture healing is divided in two types: direct and indirect fracture healing. Direct 
fracture healing requires that bone ends do not show any gap and a stable fixation. 
This process is characterized by presenting only intramembranous bone healing. On 
the other hand, the most typical process is indirect fracture healing that show 
intramembranous and endochondral bone healing.[15] Indirect fracture healing start 
after trauma when bone fracture is covered with a hematoma produced by blood 
flowing from bone marrow and peripheral blood vessels. Cells start secreting tumor 
necrosis factor-α and diverse interleukins which regulate the inflammatory response 
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by recruiting inflammatory cells and promoting angiogenesis.[15] After hematoma 
formation the callus formation between the fracture ends helps to stabilize the 
structure.[14,15] Mesenchymal stem cells recruitment is fundamental in this 
step.[15] Mesenchymal stem cells are a population of stromal cells with low 
presence in bone marrow (less than 0.01%) that show a high self-renewal capacity 
and are able to differentiate into different cell types, including osteocyte and 
chondrocyte lineage.[16,17] MSCs are recruited from bone marrow, surrounding 
soft tissues and peripheral blood and attracted to the hematoma due to chemotactic 
signals like cell-derived factor-1 and bone morphogenetic proteins such as        
BMP-7.[15] Once MSCs migrate towards the hematoma they start secreting 
signalling molecules and an extracellular matrix containing collagen type I and II, 
that start forming the callus tissue.[15] Blood supply is essential for bone 
regeneration,[14,15] thus angiogenesis promotion during endochondral fracture 
healing is combined with chondrocyte apoptosis and matrix degradation to allow 
enough space to the growth of new blood vessels. Callus tissue becomes mineralized 
and cartilage callus tissue is substituted by bone tissue[15] while mesenchymal stem 
cells differentiate to osteoblasts. Cell differentiation is regulated by biologic signals 
like bone morphogenetic proteins[14,18,19] and physical signals such as mechanical 
stimulus[20]. Finally bone remodelling starts as a lamellar bone deposition and 
mineralized callus resorption to rebuild the functional bone structure.[15] On the 
other hand in some clinical cases like those which imply bone filling, pathological 
bone loss, fracture nonunion or in spinal fusion need be improved[21,22] and bone 
grafting is a well-recognised strategy[21]. Bone autograft have a important role in 
orthopaedic surgery because is biocompatible, osteogenic, osteoinductive and 
osteoconductive.[21] Nevertheless, autologous tissue availability is limited and bone 
graft surgery shows postoperative pain and morbidity.[21] Allogenic bone graft is an 
alternative when extensive grafting is required.[21] Bone allografts are used frozen 
or freeze-dried but rarely fresh due to the risk of disease transmission and host 
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rejection.[21] On the other hand tissue preparation and sterilization minimize the 
immune response and disease risk transmission but also affect the graft 
properties.[21] 
 
1.2.2. Cartilage healing 
Cartilage shows very little self-repair ability.[13] Cartilage injuries are catalogued in 
three types: matrix disruption, partial thickness defect and full thickness defect. [13] 
Matrix disruption occurs when extracellular matrix damage is not excessive. 
Traumatized tissue is restored through the surrounding chondrocytes which increase 
their biosynthetic activity to repair the matrix.[13] Partial thickness defects are 
fissures or some other kind of visible tissue disruption that do not reach the 
subchondral bone. Cells adjacent to the injury start proliferating and increasing the 
ECM production, but for unknown reasons this process usually stops before the 
injure is repaired.[13,23] In full thickness defect the injury reaches the subchondral 
bone and induces bleeding, thereby filling the injury with a fibrin clot. Due to this 
characteristic, full-thickness defect is able to recruit mesenchymal stem cells in 
contrast to previous cartilage injury types and fill the defect with a tissue 
intermediate between hyaline cartilage and fibrocartilage.[13,23,24] The lack of self 
repair ability compared to bone tissue can be explained by three features: 1) 
chondrocytes do not proliferate and have a low metabolic activity; 2) Cartilage 
extracellular matrix may impede chondrocyte migration and cell adhesion; 
3)mesenchymal stem cells are only recruited when subchondral bone is 
damaged.[13] Classical therapeutic solutions for repairing damaged cartilage are 
two: tissue transplantation and induction of spontaneous regeneration.[13,23,25] The 
tissue transplantation intends to fill the cartilage defect with a tissue graft that can be 
osteochondral plugs, periosteal and perichondrial grafts.[13,24,25] Osteochondral 
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plugs transplantation (autologous or allogenic) allows filling the cartilage defect to 
substitute damaged cartilage but does not induce tissue regeneration.[13,24,25] 
Autologous grafts are extracted from non-load bearing cartilage areas and are used 
to fill small cartilage defects. On the other hand allogenic grafts are used in large 
defects[24] but this procedure showed the typical drawbacks associated to allografts, 
such as host reject immunoreaction and disease risk transmission. [13,25] 
Immunogenic response can be reduced by freezing the graft, thereby increasing the 
graft shelf-life and allowing a disease screening prior to implantation, but at the 
same time, it comes with a reduction of tissue viability.[13] The other tissue grafts 
options are periosteal and perichondrial grafts, that have been used in humans to 
repair cartilage defects. This technique solves the problem of donor morbidity site of 
autologous osteochondral plugs but 70% of perichondrial grafts fails after five years 
due to graft ossification.[13] On the other hand, induction of spontaneous 
regeneration consists in stimulating the regeneration, giving access to bone marrow 
MSCs to invade the defect and regenerate it like in natural full-thickness defect 
healing.[13,25] Subchondral bone penetration is performed by abrasion, drilling or 
microfracture that induces fibrin clot formation thus serving as scaffold for 
mesenchymal stem cell migration and differentiation.[13,25] Microfracture is many 
times the preferred option since it can be performed arthroscopically and only 
generates a minimal iatrogenic tissue damage.[25] On the other hand regenerated 
tissue varies from fibrocartilage to hyaline cartilage, but even regenerated hyaline 
cartilage formed by this technique shows worse mechanical properties and durability 
compared to healthy tissue.[13] 
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1.3.   Cell free and cell based approaches in cartilage and bone tissue 
engineering 
Tissue engineering is a promising alternative based on the use of engineering and 
biological sciences to understand the relationship between structure and function of 
mammalian tissues to design substitutes that restore and support the tissue 
functions.[26] Tissue engineering tries to mimic the tissues using scaffolds as 
extracellular matrix, expanded cells obtained from a donor and adding growth 
factors.[26, 27] Main tissue engineering approaches are two: (1) using acellular 
scaffolds that should be invaded by surrounding host tissue or (2) implanting cell-
scaffold constructs. One of the key factors in both approaches is the scaffold that is a 
three-dimensional porous structure fabricated with synthetic or natural based 
biomaterials. It plays the role of a synthetic extracellular matrix allowing cell 
colonization, migration, proliferation and differentiation.[26] Cell free scaffold 
implantation has the objective to induce cell invasion by providing migration paths, 
but also to guide the organization of new-formed extracellular matrix. On the other 
hand cell-scaffold construct are based on cell seeded scaffolds that have been 
cultured in vitro to induce cell proliferation (even cell differentiation) and ECM 
deposition prior to implantation. 
Both approaches have also been proposed in bone tissue engineering [28].Viability 
of transplanted cells in bone defects depends of local blood supply, as 150-200µm is 
the maximum distance from blood vessel where optimally effective nutrient 
diffusion takes places;[29] cell death is observed when cells are too far away from 
blood supply. This points to that seeded scaffold implantation as not the best choice 
if the construct is not pre-vascularized in vitro through co-culture with endothelial 
cells[30]. Acellular osteoconductive scaffold implantation may induce mesenchymal 
stem cell migration from bone marrow and posterior differentiation working as a 
guide to bone fracture healing process.[31,32] Thereby the scaffold properties such 
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as biocompatibility, biodegradation rate, pore size, pore interconnectivity, volume 
porosity, mechanical behaviour and surface topography and chemistry are essential 
to achieve a successful tissue regeneration.[33] Among other factors, those 
properties determine not only MSCs adhesion and osteoblastic differentiation inside 
the scaffold, but also angiogenesis inducing the growth of a network of blood 
vessels inside the pore structure simultaneously to the formation of new bone tissue. 
Scaffold must have a pore size between to 200-400 µm, enough to leave space to 
osteon formation (223µm of size in humans)[28] that defines the Haversian canal 
(50-70µm of diameter) that contains the capillary.[34] On the other hand 
angiogenesis promotion can be improved using scaffolds that release angiogenic 
factors such as vascular endothelial growth factor or grafting the scaffold surface 
with proangiogenic peptide like Ser-Val-Val-Tyr-Gly-Leu-Arg derived from 
osteopontin or promote selectively human endothelial cell adhesion with Arg-Glu-
Asp-Val sequence from fibronectin.[30] Other important feature in bone tissue 
engineering is bioactivity, the ability of the material to bond to bone tissue[35] that 
can be predicted in vitro through the formation of an apatite layer over the scaffold 
when it is immersed in simulated body fluid.[36,37] Bioactivity can be improved 
with the addition of bioactive particles in the scaffold materials or by surface 
modifications[36,38]. 
In cartilage tissue engineering, cell-free scaffold implantation[39-44] and cell-
scaffold construct[45-49] approaches have been proposed. Acellular scaffold 
implantation serves as an improvement of cartilage regeneration induction therapies 
based on subchondral bleeding[50]. The scaffold fills the defect overcoming the 
critical-size limit for spontaneous healing because the pores are filled with blood and 
bone marrow derivates that form a fibrin clot and allow the MSC attachment[50] 
guiding spontaneous cartilage healing; the scaffold also provides a mechanical 
support to the regenerating tissue. On the other hand, scaffolds can be seeded with 
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chondrogenic cells and cultured in vitro to induce cell proliferation, ECM deposition 
and differentiation prior to the implantation. Present option allows the graft 
manipulation at three levels: scaffolds, cells and construct assembly procedure.[51] 
To develop a cell/scaffold construct, the first step is the cell population isolation and 
in vitro expansion to reach the required cell numbers to seed the scaffold.[51] In 
cartilage tissue engineering research adult autologous chondrocytes or mesenchymal 
stem cells are currently used[52] previously expanded ex vivo in monolayer. Mature 
chondrocytes isolated from hyaline cartilage have been considered a logical 
option.[53] However, chondrocytes expanded in monolayer cultures 
dedifferentiate[13,53-56] losing the typical chondrocyte phenotype.[13,52] The huge 
number of cells required for this approach is limited because an extensive number of 
passages induces cell dedifferentiation[55,57] and chondrocyte isolation is limited 
by tissue rareness and donor zone morbidity[52,53,58]. On the other hand MSCs are 
considered an interesting option due to the availability, high expansion capacity in 
vitro and their ability to differentiate to chondrocytes.[53] These characteristics 
allow two different tissue engineering approaches based on mesenchymal stem cells: 
to differentiate them to chondrocytes in vitro inside the scaffold and implant the 
construct when cells show the correct phenotype markers or seeding the scaffold 
with MSCs and implant it in the host body to allow the neighbour tissues inducing 
cell differentiation in vivo.[59] Drawbacks of MSCs imply phenotypic 
instability[60,61] and it has been pointed that in vivo environment is not enough to 
drive a correct chondrogenic differentiation of implanted uncommitted MSC[62]. 
Scaffolds are fabricated with biomaterials, which are materials able to interact with 
the biologic systems and replace the tissue.[63] Biomaterials commonly used in 
bone and cartilage tissue engineering are biodegradable polymers that can be 
synthetic or of natural origin.[9,35] Natural polymers are proteins or polysaccharides  
that present adhesion motives and are biocompatible. Natural-based polymers 
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present problems of purification, they can transmit diseases [63] and their processing 
to produce scaffolds with predesigned pore architectures is quite limited. On the 
other hand, synthetic polymers resolve most of natural polymer drawbacks but do 
not present biological cues as natural origin polymers[35,64]. Synthetic polymers 
are produced from simple monomers with known structure, with a high impurities 
control showing reproducible and predictable properties[9,22,35] and are compatible 
with a variety of processing technologies that have been developed to produce 
sponges with a variety of pore architectures.[35,65] 
 
1.3.1. Bone tissue engineering cell-free approach: Biomaterials and mineral 
composite scaffolds. 
Biodegradable synthetic polymers are a huge group of biomaterials with different 
properties. This work is focused on saturated aliphatic polyesters. Polyesters are 
polymers widely used in tissue engineering research and approved by the Food and 
Drug Administration of United States for many medical applications.[9] The most 
important polyesters are polylactic acid, polyglycolic acid and 
polycaprolactone.[9,22] Aliphatic polyesters have a common basic chemical 
structure that show a similar degradation mechanism, the hydrolysis of ester bonds 
and weight loss through oligomers diffusion. Finally the short chains are degraded to 
monomeric subunits that are metabolized or excreted.[9,22]  
Polycaprolactone (PCL) is a semicrystalline polyester with a low melting point 
(58ºC)[9,22] synthesized by the ε-caprolactone monomer ring aperture and 
polymerization[22] (Chemical structure showed on figure 1-4). Polycaprolactone is 
a non-toxic polymer approved for medical applications by the Food and Drugs 
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Administration [35] and a widely used polymer in bone[66-71] and cartilage[39,48] 
tissue engineering. 
 
Figure 1-4. Chemical structure of cyclic caprolactone and polycaprolactone[63] 
[Reprinted from Progress in Polymer Science, 32, Nair LS, Laurencin CT. 
Biodegradable polymers as biomaterials, 762-798, ©2007, with permission from 
Elsevier] 
Polycaprolactone is a flexible polymer as its glass transition point is at -60ºC[63] 
thus at body temperature the amorphous phase is in rubbery state. Young modulus 
(0.4 GPa) are in range with the modulus for cancellous bone.[22] On the other hand 
the ester bonds make it degradable in presence of water by hydrolysis but its 
degradation speed is lower than polylactic acid.[9,22] Finally polycaprolactone is a 
polymer soluble in a huge variety of organic solvents[22]. All these characteristics 
allow producing polycaprolactone scaffolds with a wide range of fabrication 
protocols.[22]  
Polylactic acid is a polymer widely used in tissue engineering composed by a 
monomeric unit that is a chiral compound that shows two optical isomers D and L-
lactic.[22,63] The polymer synthesis happens through ring opening polymerization 
of cyclic lactic acid dimer[22], chemical structure of Polylactic acid is shown in 
figure 1-5.  
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Figure 1-5. Chemical structure of cyclic lactide and polylactide[63] [Reprinted from 
Progress in Polymer Science, 32, Nair LS, Laurencin CT. Biodegradable polymers as 
biomaterials, 762-798, ©2007, with permission from Elsevier] 
The poly-L-lactic acid (PLLA) is a semicrystalline polymer with high mechanical 
properties (young modulus of 2.7 GPa) quite similar to cortical bone.[22] The 
mechanical properties of polylactic acid are higher than those of polycaprolactone 
due to the higher glass transition temperature of the amorphous phase, 60-65ºC, that 
makes it to be in the glassy state at body temperature.[9] The degradation is 
consequence of ester bond hydrolysis and its degradation is faster than that of 
polycaprolactone due to a higher density of ester groups in the main polymer chain. 
It is worth noting that hydrolysis of polylactic acid release lactic acid that is a cell 
metabolizable non toxic chemical[9,22]. On the other hand, lactic acid reduces the 
pH acting as a catalyser of the degradation reaction.[9,22] Finally polylactic acid 
like polycaprolactone is soluble in various organic solvents[22] and compatible with 
diverse scaffold fabrication protocols. 
Synthetic polymer scaffolds for bone tissue engineering have downsides. Saturated 
aliphatic polyesters are hydrophobic thus impairing cell invasion[35], they show a 
lack of bioactivity that inhibits bone tissue integration due to a deficient surface 
mineralization[9] and they do not show biological cues[35].To solve these 
limitations hybrid or composite scaffolds are developed to try to mimic the bone 
tissue composite nature that is composed by collagen type I mineralized with 
nanometric hydroxyapatite crystals. Composite material is a mixture of two (or 
more) different materials that show the better properties of both components.[9] 
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Polymer/ceramic composites showed improvement of mechanical properties[72-74], 
protein adsorption [75,76] and subsequently the cell adhesion on polymer scaffolds 
with respect to any of its components. Polymer phase provides the formability while 
the ceramic provides the composite with higher mechanical properties, as well as 
bioactivity[9] and hydrophilicity[77]. Finally composites show particular surface 
properties compared to naked polymer scaffold that can affect cell behaviour. Since 
polymeric scaffolds do not show biological motives, cell-material interaction is 
mediated by proteins adsorbed from serum or biologic fluid (blood, synovial fluid, 
etc). The amount and conformation of adsorbed proteins is determined in large 
extent by surface chemistry or surface energy.[78] In this way changes on substrate 
stiffness, or chemistry can affect the fate of mesenchymal stem cells cultured on 
it.[79,80] The two main strategies to develop a polymeric composite scaffold are the 
biomineralization to coat the pore walls with a mineral layer and mixing the polymer 
with mineral particles before the sample fabrication[9,81]. 
Biomineralization is a surface modification to coat the implant with a 
hydroxyapatite layer.[81] Diverse methods are used to mineralize polymer scaffolds 
but the easiest and most common is the immersion in simulated body fluid to 
precipitate calcium phosphate over the polymeric scaffold (natural or synthetic) in 
aqueous solution.[81] This technique has two important advantages over the other 
techniques. Simulated body fluid allows a complete and uniform surface coating 
with a mineral layer almost identical in composition and structure to the mineral 
bone phase.[81] On the other hand coating conditions are not toxic and do not need 
to expose the scaffold to high temperature or pressure.[81] The technique consists in 
the immersion of the sample in simulated body fluid that is an aqueous solution with 
ions concentration similar to that of human plasma.[81] Anionic chemical groups 
like carboxyl or hydroxyl present on sample surface attract and lead to the 
adsorption of calcium ions at the surface when it is immersed in simulated body 
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fluid.[81,82] Later calcium cations abundance leads in turn to attraction and 
adsorption of phosphate anions and the cycle repeats itself leading to the growth of a 
phosphate calcium coating. On the other hand the success of this method depends of 
surface scaffold properties that could not promote enough hydroxyapatite 
deposition.[81] To resolve this drawback, scaffold surfaces are modified to improve 
hydroxyapatite deposition.[81] An easy option is to increase the number of anionic 
functional groups such as carboxyl or hydroxyl moieties on the scaffold surface; this 
can be easily done by plasma treatment or chemical degradation. [38,81,82] Plasma 
treatment is based on plasma reaction with polymer surface.[83] Plasma contains 
ions, electrons and free radicals which react with polymer,[82] affecting only the 
surface (10nm or less) without modifying the bulk properties.[82,83] Oxygen and air 
plasma increase the presence of oxygen containing chemical groups.[82,83] 
Hydrophilicity and mineral layer deposition have been increased after polymer 
substrate exposure to plasma.[36,38,82] On the other hand, in the case of polyesters, 
a chemical degradation can increase the presence of carboxyl groups that are related 
with apatite nucleation initiation.[81,82] Hydrolysis is usually performed with 
sodium hydroxide that cleaves the ester bonds thereby eroding the polymer, which 
increases the roughness and the presence of carboxyl group that has been related to 
an increased mineralization.[81,82] 
Composite scaffold fabrication by mineral particle addition is achieved by 
fabricating scaffolds with a mixture of mineral particles with polymer solution[9] or 
polymer melt[84]. The addition of particles to the polymer matrix can reinforce 
mechanically the scaffold and improve scaffold hydrophilicity.[9,77] The 
degradation kinetics of the polymer phase is altered too, due to the changes in 
equilibrium water content and water transport properties in the composites; besides, 
mineral phase may buffer the polymer acidic degradation residues thus limiting 
autocatalysis.[9] Finally the presence of bioactive particles improves the 
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biomineralization (described above)[38] and the obtained hydroxyapatite layer is 
chemically and structurally equivalent to bone mineral phase and works as a 
bonding interface with tissues.[9,81] Not only the presence of particles is important, 
the different bioactive particles have different properties and can affect the 
composite final properties. Among all the possible reinforcements, (hydroxyapatites, 
bioactive glasses, tricalcium phosphate, bicalcium phosphate, calcium sulphate, 
calcium silicide, etc.) in this work hydroxyapatite and Bioglass
®
45S5 particles, 
widely described in the literature [66-68,70,85-88], have been studied.  
Hydroxyapatite (HAp) is widely used in bone tissue engineering as it promotes a 
faster bone regeneration and bonding to the neighbouring tissue without 
intermediary tissue[89]. Polycaprolactone composites reinforced with 
hydroxyapatite [67,68] for bone tissue engineering have been described in literature. 
Biological response of these composites was improved, compared to naked polymer 
scaffold [68].   
Bioglass® 45S5 (BG) (45% SiO2, 24.54% Na2O, 24.4% CaO y 6% P2O5) is a 
bioactive glass that shows good biocompatibility and osseous integration[9] and do 
not show cytotoxicity[90]. Bone bonding is achieved through the development of a 
calcium deficient carbonate phosphate layer over the surface in presence of 
biological fluid that allows the chemical bonding to the bone.[9] Another important 
feature of bioactive glasses is the release of soluble ionics compounds that alter the 
osteoblast gene expression profile of genes related with bone homeostasis and cell 
metabolism (extracellular matrix remodelling, cell-cell adhesion and cell-matrix 
adhesion).[91] Composite scaffolds that use bioactive glasses like Bioglass
®
45S5 as 
ceramic reinforcement showed an increase in mechanical properties [88].  
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1.3.2. Cartilage tissue engineering cell-scaffold construct approach: 
Polymer/hydrogel scaffolds and cells. 
Scaffolds for cell-scaffold construct must define the space for the engineered tissue 
to guide the restructuring and allow oxygen and nutrients diffusion.[51] On the other 
hand, scaffolds should show structural integrity and transmit the mechanical 
forces[51]to create the adequate biomechanical environment for the cells lodged in 
the pores. Scaffolds and hydrogels are used for cell transplantation in cartilage tissue 
engineering.[46-49] Hydrogel research for cartilage tissue engineering has increased 
in the last years[92] due to hydrogels seem the most logical option in order to mimic 
the natural environment of hyaline cartilage matrix[92,93] to allow the chondrogenic 
differentiation. Hydrogels are three-dimensional networks of crosslinked hydrophilic 
polymers (natural or synthetic) able to retain huge amount of water.[53,92-94] Many 
hydrogels present adequate biocompatibility, biodegradability and proper nutrients 
and waste residues diffusion due to the pores and the water retained.[92-94] 
Hydrogels based on natural polymers are the most suitable option since they offer 
biological cues for adherent cells[82,92] and mimic clue aspects of extracellular 
matrix and can direct cell migration, proliferation and cell organization.[93] Natural 
hydrogels are natural highly hydrophilic polymers (proteins or polysaccharides) like 
collagen, chondroitin sulphate, alginate or agarose that can be crosslinked through 
physical, ionic or covalent bonding[92,93]. 
Hyaluronic acid (also called hyaluronan) is an interesting natural hydrogel for 
cartilage tissue engineering. It is a non-sulphated glycosaminoglycan component of 
hyaline cartilage. Hyaluronic acid is a linear polysaccharide composed by N-acetyl-
D-glucosamine and glucuronic acid disaccharide units, [22] as shown in figure 1-6.  
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Figure 1-6. Chemical structure of hyaluronic acid[63] [Reprinted from Progress in 
Polymer Science, 32, Nair LS, Laurencin CT. Biodegradable polymers as biomaterials, 
762-798, ©2007, with permission from Elsevier] 
Hyaluronan promotes mesenchymal stem cell migration, differentiation and collagen 
deposition.[22] This polymer show a hydrophilic surface that impedes non-specific 
protein adsorption obstructing cell attachment[95], avoiding cell spreading; instead 
it provides a specific cue that promotes adhesion specifically through the CD44 
receptor[96], furthermore hyaluronic acid may increase proliferation and 
chondrogenesis.[97-101] 
Nevertheless, due to their low rigidity, hydrogels could not be the best support for 
chondrocytes from the point of view of stress transmission and generation of the 
right biomechanical environment, since they are too compliant. When cartilage cells 
are exposed to compressive loading, they change their secretion profile[102,191] 
and when the loading is excessive, the extracellular matrix loses 
proteoglycans[103,191] leading to a degeneration of the extracellular matrix. On the 
other hand, increasing hydrogel modulus to match cartilage modulus is not the best 
option as it implies a crosslink degree increase that can compromise cell 
viability[104,191]. Hydrogels like agarose and alginate, which show better 
mechanical properties than other hydrogels, are not tough enough to resist wear and 
tear due to joint friction in large animal model.[105] On the other hand, scaffolds 
made with synthetic polymers like polyesters showed better mechanical properties 
than polymers of natural origin and are more resistant to joint friction[105] and can 
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be fabricated as foams, woven and non-woven fibre meshes[105] with a defined size 
and adjusted to fit in the injured tissue. Finally saturated aliphatic polyesters do not 
offer biological signals (like biological adhesion sites) that may enhance 
chondrocyte phenotype and ECM secretion[64]. Cell material interaction is 
mediated by the interaction of membrane integrins with the proteins adsorbed over 
the material surface[95] such as fibronectin, laminin or vitronectin. Polyesters are 
adhesive substrates that induce cell spreading, which is related to a decrease in 
chondrogenic marker expression; furthermore cell-matrix interactions mediated by 
integrin have been shown to inhibit MSC chondrogenesis[106,107]. On the other 
hand, hydrophilicity promotes cell rounding and expression of chondrocyte-like 
phenotype[108]due to the lower protein absorption over the hydrogel[95] that 
reduces cell adhesion and spreading; it is for this reason that synthetic polymer 
drawbacks may be resolved modifying the surface, increasing the hydrophilicity or 
adding biological macromolecules.[95]  
Scaffold embedding approach is an interesting option to develop hybrid 
polymer/hydrogel for cartilage tissue engineering since composite scaffold combines 
the load bearing capacity of polymeric macroporous scaffold with the biologic 
properties of a natural hydrogel as a cell carrier to increase the cell seeding[109]. 
This approach is not a cell-free approach as cells must be placed inside the hydrogel 
phase before the hydrogel infiltration, which must be crosslinkable in situ by photo-
crosslinking, chemical crosslinking, enzymatic crosslinking or temperature and pH 
inducible gelation.[93] Natural biopolymers present these properties or can be 
modified to acquire them. The chemical crosslink is the crosslink (reversible or not) 
between polymer chains by adding a crosslinker, a molecule with at least two 
reactive groups able to bond two polymer chains or two points of same 
molecule[93,110]. On the other hand gelling time depends of concentrations of 
polymer and crosslinker.[93] Photo-crosslink is based on grafting polimerizable 
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vinyl groups graft on hydrogel chain and crosslinking by polymerization in presence 
of ultraviolet light;[93] concentrations and exposure time must be controlled to 
avoid cell damages or death.[93] It may not be the best option for our purpose to 
produce hybrids since scaffolds may absorb ultraviolet light. Enzymatic crosslink 
can be performed by the reaction between phenol derivatives groups present on 
polymer chains catalyzed by peroxidases.[93] This approach is applicable to 
polymers without phenol groups such as hyaluronic acid provided that they are 
modified substituting the carboxyl group of glucuronic acid with tyramine.[111] 
Enzymatic crosslink procedure shows a good biocompatibility and provide a good 
control over the reaction, but the presence of reactive oxygen species can have 
cytotoxic effects.[93] Finally certain polymers are able to gel through physical 
crosslink in response to temperature or pH variations.[93] In thermosensitive 
hydrogels changes in temperature can affect the molecular interaction with water 
and at a certain critical temperature, their polymer have more affinity to polymer 
chains that to water, inducing a phase separation between water and polymer 
phase.[93] On the other hand it has been reported that chitosan in water solution can 
jellify when the pH of the solution increases[93]. 
 
1.3.2.1   Cells and cell culture protocols for cartilage tissue engineering. Cell-
scaffold construct. 
Cell-scaffold construct to repair damaged cartilage tissue requires in vitro culture of 
cells seeded in a scaffold to induce cell proliferation, extracellular matrix deposition 
and differentiation prior to implantation. Apart from scaffold type, important factors 
which influence the quality of the engineered tissue are the type of cells selected and 
the chondrogenic culture conditions used. 
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As we said above, both mature chondrocytes and MSCs are used in cartilage tissue 
engineering.[52] Chondrocytes from hyaline cartilage are the current gold 
standard[53]. Chondrocyte harvesting is limited by tissue availability[52,53], and 
chondrocytes start dedifferentiating when expanded in monolayer[13,53] losing the 
spherical shape, showing a fibroblastic shape, a reduced expression of collagen type 
II and a higher expression of collagen type I.[13,52] On the other hand, culture in 
three-dimensional substrate allow cell redifferentiation,[52,54] via the use of 
external stimulus such as growth factors, mechanical stimulus or oxygen level 
tension that can induce cell redifferentiation[52] and raise the number of passages up 
to which cells can be efficiently redifferentiated.[54]. Mesenchymal stem cells are 
an alternative to mature chondrocytes as they are able to differentiate towards 
chondrocytes.[53] Mesenchymal cells can be isolated easily from diverse tissues 
from which the most common are bone marrow and adipose tissue[53,112]. 
Mesenchymal stem cells in vitro can be differentiated to chondrocyte in presence of 
growth factors, hypoxia or mechanical stimulus.[52] Nevertheless, a current 
drawback to this technology is that mesenchymal stem cells usually fail to develop 
good quality, long lasting mature hyaline cartilage[113] because they show a 
transient chondrocyte phenotype showing hypertrophy markers[60,61]; moreover, 
there is still no consensus about the optimal combination of culture conditions that 
may lead to a stable phenotype.[54] 
Chondrocytes and mesenchymal stem cells require of extrinsic factors to obtain a 
functional phenotype[52,53] through regulation of cell differentiation pathways 
(figure 1-7). Chondrogenesis is a complex process regulated by key transcription 
factors[114], the first stage of which is the pre-cartilage condensation that is the 
chondroprogenitor mesenchymal cell aggregation.[115] This stage is regulated 
through Sox9, which is member of the Sox proteins family, a group of transcription 
factors.[114,116] Sox9 probably regulates the expression of membrane proteins that 
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are necessary for mesenchymal condensation.[114] Next step is the chondrocyte 
differentiation, which is regulated by Sox5, Sox6 and Sox9[114,115] when cells 
start to secrete of collagen type II, IX, XI and aggrecan, components of cartilage 
extracellular matrix.[115] Sox5 and Sox6 are co-expressed with Sox9 in this step 
(but not at mesenchymal condensation)[115]but unlike Sox9 they do not show 
transcriptional activation domain[114]. On the other hand, Sox9 establishes a 
complex with Sox5 and Sox6 to work cooperatively, where they (Sox5 and Sox6) 
act as architectural proteins that organize the DNA to facilitate the access of other 
transcription factors (as Sox9) to chondrocyte target genes enhancing the 
expression.[114,116] Finally chondrocytes can differentiate to hypertrophic 
chondrocyte, characterized by the expression of collagen type X and alkaline 
phosphatase[115] and extracellular matrix mineralization. Chondrocyte hypertrophy 
is regulated through Runx2 (a transcription factor of the runt family) expressed in 
prehypertrophic chondrocytes due to in deficient Runx2 mice hypertrophy is 
blocked.[115,117] On the other hand Sox9 negatively regulates this stage because it 
suppresses the earlier chondrocyte conversion to hypertrophic chondrocyte. 
[117,118] 
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Figure 1-7. Sequence of mesenchymal stem cell chondrogenesis stages.[53] [Reprinted 
from Trends in biotechnology, 27, Vinatier C, Mrugala D, Jorgensen C, Guicheux J, 
Noël D. Cartilage engineering: a crucial combination of cells, biomaterials and 
biofactors, 307-314, ©2009, with permission from Elsevier] 
Current cell culture protocols prescribe the use of growth factors such as 
transforming growth factor-β or fibroblast growth factor which are necessary to 
induce and maintain the correct chondrocyte phenotype[53]. Transforming growth 
factor-β family are the most commonly used factors in cartilage tissue engineering, 
as they are able to improve biochemical and mechanical properties of tissue 
construct through their effect as stimulator of extracellular matrix production in 
chondrocytes and inductor of MSC differentiation.[52,53] Fibroblast growth   factor-
2 is usually used during cell expansion due to its mitogenic effect over adult 
chondrocytes while in mesenchymal stem cells it induces proliferation and increases 
chondrogenic differentiation potential.[53] Chondrocytes expanded in presence of 
fibroblast growth factor-2 and transforming growth factor-β1 and subsequently 
redifferentiated with transforming growth factor-β1 and dexamethasone under 
serum-free conditions were reported to show an increment of chondrogenic 
markers.[52,119] In addition to growth factors, biophysical stimulus such as 
hypoxia, mechanical stimulus and recently coculture conditions can act as extrinsic 
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chondrogenic factors and are increasingly studied as factors to drive chondrogenic 
differentiation or redifferentiation. [52,53] 
 
1.3.2.1.1.    Oxygen level tension 
Low oxygen tension is a key factor in the proliferation and differentiation of 
chondrocytes and mesenchymal stem cells.[53] Hyaline cartilage is an avascular 
tissue where the oxygen and nutrient supply occurs via diffusion from the synovial 
fluid.[53] This hypoxic environment varies from 7% of oxygen to 1% depending on 
tissue depth.[53,120] Cell survival to hypoxia is given by the hypoxia inducible 
factor activity. The hypoxia inducible factor is an heterodimeric transcription factor 
that binds to hypoxic inducible genes initiating the transcription.[121] This 
transcription factor is composed by hypoxia inducible factor-1α (HIF-1α), 2α or 3α 
that heterodimerize with the aryl hydrogen receptor nuclear translocator (also called 
hypoxia inducible factor-1β [53,121] under hypoxic conditions and bind to hypoxia 
responsive element initiating the transcription (figure 1-8).[53,121] On the other 
hand hypoxia inducible factor-1α under normoxia conditions have residues that 
show a oxygen-dependent hydroxylation through the prolyl-4 hydroxylase that 
allows recognition by the E3 ubiquitin ligase Von Hippel-Lindau that mark HIF-1α 
for proteasomal degradation.[122] 
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Figure 1-8. Sketch of hypoxia inducible factor pathways. Prolyl-4 hydroxylase (PHD), 
E3 ubiquitin ligase Von Hippel-Lindau(VHL), hypoxia inducible factor-1α (HIF-1α) 
and aryl hydrogen receptor nuclear translocator (ARNT) [122] [Reprinted from Bone, 
47, Araldi E, Schipani E, Hypoxia, HIFs and bone development., biomaterials and 
biofactors, 190-196, ©2010, with permission from Elsevier] 
 
Hypoxia (oxygen levels of 1.5-5%) application on in vitro cultured three-
dimensional substrates showed an increment of cell redifferentiation and phenotype 
stability in chondrocytes that showed an induction of Sox9 and biosynthetic activity. 
[52] Literature suggests that HIF-1α is responsible of chondrocyte survival while 
hypoxia inducible factor-2α is essential for the induction of chondrocyte phenotype 
maybe through Sox9 induction. [52,53] On the other hand hypoxia has been shown 
to induce mesenchymal stem chondrogenesis and inhibits hypertrophy and 
apoptosis. [52,53] HIF-1α is considered responsible of promoting chondrogenesis in 
monolayer culture[52] and inhibiting hypertrophy through the downregulation of 
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Cbfa/Runx2 promoter expression and affinity for DNA.[123] On the other hand 
hypoxic conditions have been shown to enhance the quality of in vitro engineered 
tissue through secreted enzymes that stabilize the extracellular matrix.[124] 
 
1.3.2.1.2. Mechanical loading stimulation 
Hyaline cartilage in vivo supports mechanical forces like shear strain, compression 
or hydrostatic pressure that are key factors in chondrogenesis.[20,53] Mesenchymal 
stem cell differentiation and chondrocyte redifferentiation can be induced in vitro by 
mimicking these mechanical stimuli through different kinds of bioreactors that 
reproduce shear strain, uniaxial compression or hydrostatic pressure.[20,52,125,126] 
On the other hand cell-scaffold constructs show differences in secretion and 
organization of extracellular matrix depending on the mechanical stimulus type, 
duration and magnitude applied[52,53] but the response to the culture conditions has 
also been shown to depend on the substrate used.[107] Transmission of mechanical 
signals through surface cell receptors interaction with the substrate has been 
proposed as one possible way for cells to sense mechanical cues[127]. Cells show 
differences in integrin expression and cell differentiation in response to substrate 
stiffness,[79] chemistry[80] or presence of biologic adhesion motives[128] that can 
explain the substrate-dependent response.  
The current strategies to apply mechanical stimulus in vitro are the use of 
bioreactors to generate fluid flow, compression or hydrostatic pressure. Fluid flow is 
based on continuous or discontinuous shear stress application on culture medium. 
Fluid flow induces MSC proliferation and upregulates both Sox9 and Runx2 
expression, suggesting that expression of transcription factors implied in different 
differentiation fate can be affected by fluid flow.[20] Compression stimulus aims to 
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mimic the compressive load that happens in articular joint. Dynamic compression 
stimulus induce chondrogenesis of mesenchymal stem cells showing an induction of 
Sox9 and transforming growth factor β1[20] but this effect seems dependant on the 
time of application showing a detrimental effect on cells at earlier time points when 
the pericellular matrix is not yet developed.[20,129] Finally, hydrostatic 
compression is the application of physiological levels of cyclic hydrostatic pressure 
that mimics the “strain-free” stress experienced by cells in the nearly incompressible 
fluid inside the cartilage matrix during joint loading.[130] Cyclic hydrostatic 
pressure loading applied at physiological levels (1-10MPa)[130-132] induces the 
expression of chondrogenic markers such as sulphated glycosaminoglycan or 
collagen type II in mesenchymal stem cells and chondrocytes[132-134] and reduces 
the expression of hypertrophic markers such as collagen type I, MMP-13 and 
calcification of engineered grafts[107,135,136].  
 
1.3.2.1.3.    Co-culture 
Cells in tissues in vivo communicate with each other through membrane proteins or 
soluble signals. Mature hyaline chondrocytes in vivo are isolated from other cells by 
an ECM that prevents cell-to-cell contact allowing only paracrine signalling. On the 
other hand, surface chondrocytes of articular cartilage and mesenchymal stem cells 
during the cartilage development show cell-to-cell contacts. [137] Co-culture intends 
to restore direct or indirect interaction between two cell populations in the same 
culture in order to mimic their natural, physiological interplay. In cartilage tissue 
engineering, this interaction appears usually between a cell type that induces the 
chondrogenesis and a second type that presumably will repair the objective 
lesion.[137] Chondrocyte coculture with mesenchymal stem cells showed increase 
chondrocyte proliferation, increased extracellular matrix synthesis and construct 
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functional properties.[137] The mechanisms by which cells interact with each other 
is not clear but literature reports point towards a combination of cell-to-cell and 
soluble mediators signalization. Cell-to-cell contact formation mechanisms remain 
unknown but different membrane proteins such as gap junction proteins connexins 
can affect chondrocyte differentiation.[137] On the other hand, another co-culture 
signal way are the soluble paracrine mediators, given that chondrocyte culture 
medium supernatant can induce chondrocyte redifferentiation and promote 
mesenchymal stem cell chondrogenesis and hypertrophy prevention.[52,137,138] 
Parathyroid hormone related peptide secreted by chondrocytes in co-culture[138] 
has been reported to inhibit hypertrophic markers expression[125,138], probably 
through Runx2 blocking and Sox9 phosphorylation[139]. Parathyroid hormone 
related peptide in combination with other soluble paracrine molecules may hold the 
key for efficient mesenchymal stem cell differentiation and phenotype stabilization 
in co-culture.[138] 
Co-culture experimental designs have two main variables: cell types used and co-
culture design. Cell type selection is really important. Most common choices are 
chondrocyte-chondrocyte and chondrocyte-mesenchymal stem cell, but other cell 
types such as dermal fibroblast, osteoblast or synovial fibroblast have been 
studied.[137] Chondrocyte-chondrocyte co-culture showed that a small number of 
primary chondrocytes are able to rescue phenotype of dedifferentiated chondrocytes 
even if one cell type in co-culture is from a xenogenic source.[52] The importance 
of chondrocyte-chondrocyte strategy is its capacity to upregulate gene expression of 
aggrecan, collagen type II and SOX9 while downregulating collagen type I.[52] On 
the other hand chondrocyte-mesenchymal stem cells show a more interesting 
interaction. Mesenchymal stem cells in pellet co-culture with chondrocytes can 
promote chondrocyte redifferentiation. While this does not happen when MSC are 
substituted with other cells, such as dermal fibroblasts, this reduces the need of high 
                                                                                                        Introduction 
43 
numbers of chondrocytes substituting part of them by MSC.[140] On the other hand, 
co-culture with chondrocytes induces MSC chondrogenesis and inhibits hypertrophy 
in direct and indirect coculture.[138,140,141] 
Cell co-culture strategies can be divided as direct and indirect co-culture as shown 
on figure 1-9. Direct co-culture experiments uses two cell types seeded together, 
allowing to establish both cell-to-cell contacts and paracrine signal 
communication.[137] Many direct co-culture designs have been proposed, but the 
most common involved a mixed monolayer cell culture, pellet or mixed seeding on 
scaffold or hydrogel[137,138,140,142-146]. Direct co-culture has been proposed as 
a preferential method for mesenchymal stem cell chondrogenesis and hypertrophy 
inhibition.[140] On the other hand indirect co-culture is based on the physical 
separation of both cell types using monocultures (in monolayer or three-
dimensional) separated by a porous membrane that impedes cell migration, using 
chondrocyte conditioned culture medium or retaining cells separated in two gels or 
scaffolds.[137,138,140-142,146,147] In indirect co-culture, only the effect of 
paracrine signalling is thus relevant, as direct cell-to-cell contact between different 
cell types is not allowed. Indirect co-culture has showed contradictory 
findings[137]; while some works point towards a positive effect of indirect co-
culture[138,141,147] other works suggest that only direct co-culture have a 
chondrogenic effect[140,145]. Described differences between works probably are 
due to differences in cell types selected and co-culture systems used.[137] 
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Figure 1-9. Overview of different direct and indritect co-culture systems in two and 
three dimensional cultures[137] 
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2. Materials and methods 
2.1. Materials: 
2.1.1. Polymers and chemicals 
2.1.1.1. Polycaprolactone 
Polycaprolactone, is a semicrystalline aliphatic polyester obtained through ring 
opening polymerization of ε-caprolactone and has been approved by the Food and 
Drugs Administration.[22,35,63] The polymer is formed by ester bonds which 
degrade by hydrolysis with a small degradation rate.[22,35,63] The PCL used in 
these experiments was supplied by Polyscience. (MW 43,000–50,000 Da, 
Polysciences) 
 
2.1.1.2. Polylactic acid  
Poly(L-lactic acid) is also a Food and Drugs Administration approved polyester 
which degradation kinetic is higher than PCL and its degradation end product is 
lactic acid, a normal by-product of cell metabolism.[9,22,63] The polylactic acid 
was supplied by Cargill Dow. 
 
2.1.1.3. Elvacite 2043 
Elvacite 2043 is an acrylic resin soluble in ethanol and with a low molecular weight 
composed by polyethylmethacrylate (PEMA). Elvacite 2043 beads with a mean 
diameter of 200µm were supplied by Lucite International. 
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2.1.1.4. Hydroxyapatite 
Hydroxyapatite is a biocompatible crystalline ceramic that shows osteoinductive 
properties.[89] The synthetic hydroxyapatite [Ca5 (OH)(PO4)3]X used in this work is 
similar but more crystalline than the hydroxyapatite from biologic source. 
Hydroxyapatite with a 200nm particle size was supplied by Sigma-
Aldrich(Hydroxyapatite, 677418). 
 
2.1.1.5. Bioglass
®
45S5 
Bioactive glasses are biocompatible and bioactive materials which in dissolution 
release ions able to modify the gene expression[9]. The chosen bioactive glass is 
Bioglass
®
 45S5 (45% SiO2, 24.5% Na2O, 24.5% CaO y 6% P2O5). The Bioglass® 
with a 20µm particle size was supplied by MO-Sci Corporation(GL-0160). 
 
2.1.1.6. Hyaluronic acid 
Hyaluronic acid (HA) is a linear and non-sulphated glycosaminoglycan, component 
of hyaline cartilage.[22,63] Furthermore hyaluronic acid promotes mesenchymal 
stem cell migration and differentiation.[22]The bacterial obtained HA, from 
Streptococcus Equi, was supplied by Sigma-Aldrich (Hyaluronic acid sodium salt 
from Streptococcus equi, 53747). 
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2.1.1.7. Divinyl sulfone 
Divinyl sulfone (DVS) is a non colored chemical able to react and crosslink with 
HA hydroxyl groups establishing ether bonds under alkaline pH[148] without 
affecting the biologically active groups[149]. The divinyl sulfone was supplied by 
Sigma-Aldrich (Divinyl sulfone, V3700). 
 
2.1.1.8. Tyramine 
Tyramine is a chemical compound derived from the amino acid tyrosine. Tyramine 
is able to react and substitute the carboxyl group of glucuronic sub-unit and form a 
biodegradable chain crosslink when exposed to active oxygen radicals; this allows 
for in situ crosslinking using peroxidase and peroxide in presence of cells.[111] 
Tyramine was supplied by Sigma-Aldrich(Tyramine hydrochloride, T2879).  
 
2.1.1.9. Alginate 
Alginic acid (also called alginate), is a linear polysaccharide obtained from brown 
algae able to gel in presence of calcium.[35,63] Alginate sodium salt was supplied 
by Sigma-Aldrich (Alginic acid sodium salt from brown algae, 71238).  
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2.1.1.10. Fibronectin 
Fibronectin (FN) is an extracellular matrix glycoprotein that allows integrin-
mediated cell adhesion.[6] Interaction of cells with fibronectin influences a wide 
range of biological aspects such as cell adhesion and differentiation.[95] The 
fibronectin was supplied by Sigma-Aldrich (Fibronectin from human plasma, 
F2006) 
 
2.1.2. Cells and culture medium 
2.1.2.1. Cells:  
2.1.2.1.1. Cell lines: 
2.1.2.1.1.1. MC3T3-E1 
MC3T3-E1 cell line was used for the biological characterization of composite 
scaffolds for bone tissue engineering. This cell line is derived from mouse calvaria 
and is often used in bone tissue engineering and the study of osteoblastic 
differentiation, as it shows robust proliferation and a physiologically relevant 
coupling between proliferation and differentiation[150]. Cells were purchased from 
the Riken Cell Bank (Japan). 
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2.1.2.1.2. Primary cell culture 
2.1.2.1.2.1. Human chondrocytes 
Human chondrocytes were harvested from knees of patients undergoing arthroplasty 
after their informed consent following the guidelines of the ethical committees of 
Universitat Politècnica and Clínica de la Salud of Valencia. The cartilage was 
dissected from subchondral bone, finely diced and then washed with supplemented 
100 U penicillin, 100 µg streptomycin Dulbecco’s modified Eagle’s medium 
(DMEM) (Gibco). For chondrocyte isolation, finely diced cartilage was incubated 
for 30 min with 0.5 mg/ml hyaluronidase (Sigma– Aldrich) while shaking at 37C, 
and then with 1 mg/ml pronase (Merck, VWR International SL) during 60 min in the 
same conditions. Subsequently the cartilage pieces were washed with supplemented 
Culture medium and digested with 0.5 mg/ml of collagenase-I (Sigma–Aldrich) in a 
shaking water bath at 37ºC overnight. The resulting cell suspension was filtered 
through a 70 µm pore nylon filter (BD Biosciences) to remove tissue debris. Cells 
were centrifuged and washed with culture medium supplemented with 10% foetal 
bovine serum(FBS) (Invitrogen SA).  
 
2.1.2.1.2.2. Bovine chondrocytes 
Bovine chondrocytes were harvested from the metacarpophalangeal joints of an 
animal obtained from a local slaughterhouse. The cartilage was dissected from 
subchondral bone following the same protocol than for human chondrocytes. 
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2.1.2.1.2.3. Mesenchymal stem cells 
Porcine mesenchymal stem cells were harvested from the femoral bone marrow. The 
femur bone was cut in the upper part in aseptic conditions and the gelatinous bone 
marrow was removed. Bone marrow was grinded and centrifuged to remove the 
non-desired hematopoietic cells. The cells were seeded at 4x10
5
 cells/cm in a 
T75cm
2
 culture flask and non adherent cells were removed when the medium was 
changed. Cells were harvested and isolated at the Trinity Centre of Bioengineering 
(TCBE) of Trinity College Dublin (Ireland). 
 
2.1.2.2. Cell culture medium 
Cell culture mediums are classified in the present thesis as expansion cell culture 
medium and cell culture medium of cells seeded in scaffolds. Expansion medium is 
used to expand cells in monolayer in order to obtain the cell number necessary to 
seed the scaffolds. On the other hand culture medium contains different supplements 
in order to induce cell differentiation or maintain the correct phenotype. The 
different culture mediums used on present work for each cell type are listed in table 
2-1.  
  
 
 
Table 2-1. Table with culture medium composition for cell expansion and culture in scaffolds of each cell type.  
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2.2. Methods 
2.2.1. Scaffold manufacture 
2.2.1.1. Polymeric scaffolds obtained through freeze-extraction and particle leaching 
combined technique. 
The scaffolds fabrication protocol is a combination of two methods, one being 
freeze extraction (a modification of freeze drying proposed by Wang et al.[151]) and 
the other, the particle leaching method using polymer beads as porogen. This 
protocol generates both micropores -when the polymer solvent crystallizes as 
consequence of thermal induced phase separation between polymer and solvent on 
the other hand removing porogen leads to an interconnected macroporosity (figure 
2-1). 
To fabricate the different scaffolds of polycaprolactone and 
polycaprolactone/polylactic acid blend at (80/20) or (20/80) the polymer (or 
combination of both) is dissolved at 20% (polycaprolactone) or 15% (polymer 
blend) calculated in weight/volume in dioxane. As porogen Elvacite 2043 beads 
with a mean diameter of 200 µm were used. The polymer solution was mixed with 
PEMA beads at a weight ratio 1:1 and immediately frozen in liquid nitrogen. 
Solvent extraction was performed in cold ethanol at -20ºC in a freezer; ethanol was 
changed three times. Subsequently particle leaching to extract the porogen was 
performed at 37ºC in ethanol that was changed over 14 times. When no more PEMA 
is detected in the extraction solvent the samples are removed, ethanol is evaporated 
and the samples packed. [158, 191] 
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Figure 2-1. Mixed process of freeze extraction with particle leaching. 
 
2.2.1.2. Polymer-ceramic composite scaffolds fabrication 
With the aim of improving the mechanical properties and the osteoactivity of 
polycaprolactone scaffolds, polymer-ceramic composite scaffolds were prepared.  
To do so, polymer solutions were mixed with different amounts of mineral particles 
(5, 10 or 20 % by weight with respect to polymer). The ceramic reinforcements used 
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were synthetic hydroxyapatite and Bioglass® 45S5. Particles were homogenezed by 
ultrasonic dispersion in dioxane (Ultrasonic homogenizer, Sonopuls HD 3200) and 
subsequently the polymer was dissolved by continuous stirring. The scaffold 
fabrication protocol used was the same as for non-reinforced scaffolds. [158] 
 
2.2.1.3. Polycaprolactone scaffold composites obtained by biomimetic apatite 
coating 
Seeking to increase the polycaprolactone scaffold bioactivity and to improve 
wettability they were coated with a calcium phosphate layer. The mineral coating 
protocol is divided in three steps (figure 2-2): to enhance the surface capacity to 
nucleate crystals, to nucleate calcium phosphate crystals over scaffold surfaces and 
to coat the scaffold surface with a biomimetic hydroxyapatite layer.  
Surface modification to improve the presence of functional chemical groups to 
enhance crystal deposition was performed with two methods: Air plasma treatment 
and chemical degradation. Air plasma treatment attacks the polymer surface with 
ions, electrons, radicals and neutral molecules that react with polymer and increase 
the presence of oxygen containing chemical groups[82,83]. Samples were placed in 
plasma chamber (Plasma Electronic GmbH) at 40% of potency and at 20% of gas 
flow. Chemical degradation was performed with sodium hydroxide to degrade 
polymer ester bonds to increase the number of carboxyl groups present on the 
scaffold surface. Samples were immersed in ethanol to fill the pores and the solvent 
was substituted with ethanol/water 50/50 and finally substituted with water using a 
vacuum pump to ensure the filling of the sample. Then samples were filled with 
sodium hydroxide solution using a vacuum pump and incubated at 37ºC. Finally 
samples were washed with water. 
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Nucleation treatment consists in nucleating phosphate calcium crystals over scaffold 
surface. Samples were filled with ethanol/water 50/50 using a vacuum pump and 
drying the water excess. The procedure was the following: sample immersion in 
calcium chloride, blot over tissue paper and washing in ethanol/water 50/50. The 
second step consisted in drying the water excess and immersing in phosphate 
potassium. Finally samples were washed in water.  
Biomimetic hydroxyapatite coating was performed immersing the samples in 
simulated body fluid allowing crystal growth. Samples were infiltrated with water 
and immersed in simulated body fluid and incubated at 37ºC. Finally samples were 
washed with water and dried. 
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Figure 2-2. Polymer surface biomineralization process. 
 
2.2.1.4. Polycaprolactone scaffold coating with hyaluronic acid 
With the aim to increase the wettability and biological response of naked scaffolds 
the PCL scaffolds were coated with HA. To do so, a hyaluronic acid solution was 
infiltrated and crosslinked under alkaline conditions to allow the reaction between 
DVS, and hyaluronic acid hydroxyl groups. This obtained hydrogel is crosslinked 
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through ether bonds[148] yielding a stable link between the hyaluronic acid chains 
without affecting the biologically active groups.[149]  
The effect of hyaluronic acid coating conformation was studied for three coating 
methods(figure 2-3): 1step, 1 step modified and 2 step crosslinking.  
The 1 step crosslinking’s purpose was to fill the scaffold’s pores with swollen 
hyaluronic acid hydrogel. In the first step, a 2% hyaluronic acid solution in 0.2M 
sodium hydroxide (Scharlau) aqueous solution was mixed with a 2:1 molar ratio of 
DVS. The scaffolds were placed in the solution and then connected to a vacuum 
pump for 2 min to infiltrate de hyaluronic acid and fill the pores. Excess hyaluronic 
acid was removed and the samples were incubated for 2 hours at room temperature 
(RT) to carry out the crosslink reaction. Subsequently samples were washed with 
acetone/water mixture 50/50 and dried.[191] 
In the 1 step crosslinking modified protocol, the purpose was to leave a thin and low 
swelling hyaluronic acid coating on the scaffold pore walls. To obtain the thin 
coating, after infiltration with the HA mixed with DVS as in the precedent 
paragraph, samples were left for 1 hour at room temperature to allow the crosslink 
reaction and dried at 37ºC for 48 hours. Then scaffolds were washed repeatedly with 
water to wash out unreacted DVS.  
The 2 step crosslinking also aims to coat the scaffold pore walls with a thin 
hyaluronic acid layer. In the first step a 1% hyaluronic acid (w/v) is dissolved in 
distilled water. The scaffolds were placed in the hyaluronic acid solution and 
connected to a vacuum pump for two minutes. After eliminating excess hyaluronic 
acid the samples were placed in an oven at 37ºC for one day and finally dried with 
vacuum. HA coating step was repeated three times. Subsequently the samples were 
immersed in acetone/water mix (80/20) at pH 12 with a 2:1 molar ratio of DVS with 
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respect to HA reactive moieties calculated from hyaluronic acid coating dry weight. 
The acetone/water solution avoids hyaluronic acid dissolution but permits HA 
swelling and the de-protonation of hydroxyl groups of hyaluronic acid[148] 
necessary for the crosslink reaction to take place. The samples were incubated for 24 
hours and after incubation the samples were washed with 80/20 (v/v) acetone/water 
mixture and dried. [191] 
 
Figure 2-3. Scaffold coating with hyaluronic acid. 
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2.2.1.5. Tyramine substituted hyaluronic acid tyramine substituted hyaluronic acid 
To obtain a hyaluronic acid crosslinkable in situ the carboxyl acid group of 
glucuronic acid was substituted with tyramine. The protocol for peroxidase crosslink 
of hyaluronic acid was inspired by Dr Calabro[111]. 
To substitute the hyaluronic acid, 500 mg of hyaluronic acid were dissolved slowly 
in a reaction buffer (4-Morpholineethanesulfonic acid at 5.4%w/w in 100 ml of 
NaCl 150mM equilibrated at pH 5.75 using 1.5 ml of NaOH 5M diluted ). Once the 
hyaluronic acid was homogenously dissolved, 434 mg of tyramine HCl ( molar 2:1 
to hyaluronic acid) were added and after its complete dissolution, 480 mg of N-(3-
Dimethylaminopropyl)-Nomethylcarbodiimide (molar 1:1 to tyramine HCl) and 
57.6 mg N-Hydroxysuccinimide (molar 1:10 to N-(3-Dimethylaminopropyl)-N′-
ethylcarbodiimide) were added, too. The reaction was carried out at 37ºC with 
agitation for 24 hours. When the reaction was stopped the tyramine substituted 
hyaluronic acid was dialyzed against 150 mM NaCl solution for 48 hours changing 
the buffer each 8 hours, and subsequently against miliQ water. Finally the tyramine 
substituted hyaluronic acid was lyophilized for 24 hours at-80ºC and 0.001mbar in a 
Telstar Lyoquest lyophilizer. 
 
2.2.1.5.1. Tyramine substituted hyaluronic acid crosslink 
Tyramine substituted hyaluronic acid allows in situ crosslinking which permits to 
encapsulate the cells inside the scaffold. The crosslink is catalyzed by horseradish 
peroxidase that generates two free radicals between tyramine hydroxyl groups. 
The tyramine substituted hyaluronic acid was dissolved at 20mg/ml in Dulbecco’s 
phosphate buffered saline (DPBS) with 2g/l glucose (DPBSG), and mixed with 2 
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U/ml horseradish peroxidase (HRP) (final concentration: 1U/ml). Then, if it was to 
be used for cell seeding, the solution was mixed with cell suspension (1:1) and 
injected in the scaffold at 10 µl/sample and incubated with 30µl H2O2 at 0.01% for 
30 min. Finally, the sample was washed with culture medium supplemented with 
FBS; the medium was further changed after 1, 2 and 4 hours to remove any free 
radicals or peroxide residues. 
 
2.2.2. Physico-chemical characterization 
2.2.2.1. Scanning electron microscopy and cryo scanning electron microscopy 
Observation of the scaffold morphology was carried out using scanning electron 
microscopy (SEM) in secondary mode. To do so, samples were cryofractured (to 
preserve the microstructure of the scaffolds), mounted on copper stubs with a 
graphite conductive tape and gold sputtered. For CryoSEM, wet samples were 
carefully wiped with filter paper, mounted in a clamp, ultrafrozen, and then 
cryofractured. Samples were sublimated at -50ºC and gold sputtered inside the 
microscopy vacuum chamber. The microscope used was JEOL JSM6300 scanning 
electron microscope at an acceleration voltage of 15 kV. [158, 191] 
 
2.2.2.2. Energy dispersion X-ray analysis 
The scaffold’s surface composition was analysed using energy dispersive X-ray 
(EDX) analysis to confirm the presence of ceramic particles. 
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Samples were cryofractured, mounted on copper stubs with a graphite conductive 
tape and carbon sputtered. The microscope used was JEOL JSM6300 scanning 
electron microscope at an acceleration voltage of 15 kV. [158] 
 
2.2.2.3. Differential scanning calorimetry 
Differential scanning calorimetry (DSC) measurements were carried out in a Mettler 
Toledo 823e DSC on samples with a weight between 5-10mg. A first heating scan at 
10ºC/min from 0ºC to 220ºC enabled to characterize the structure of the sample after 
degradation. After annealing at 220ºC for three minutes, and cooling down at 
10ºC/min to 0ºC, a second heating scan at 10ºC/min was recorded to analyze the 
behaviour after having erased thermal history. 
The degree of crystallinity and melting enthalpy of the scaffolds, was determined 
using the DSC software, and crystallinity was calculated for each phase of the blend 
assuming that melting heat for pure crystals of polylactic acid and polycaprolactone 
are ΔHºPLLA=90.95 J/g [152] and ΔHºPCL=136.1 J/g[153]respectively. 
 
2.2.2.4. Ceramic content in composite samples 
Ceramic content in composite scaffolds was assessed using a calcination technique; 
the samples were submitted to a temperature scan up to 800ºC so that the polymer 
was thermally degraded, and mineral residue was measured. [158] 
The thermogravimetric analysis (TGA) was performed using a SDT Q600 analyser 
from TA Instruments or a tubular oven to determine the residue produced by the 
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calcination of the sample as an indicator of the actual amount of reinforcement 
present in the scaffolds.  
When using the SDT Q600, the sample was placed in a platinum pan and subjected 
to a heating scan from 50 to 800ºC at 20ºC/min under nitrogen atmosphere. The 
mass was monitored as a function of the temperature and results were analysed 
using software TA Analyzer from the device.  
When the thermo gravimetric analyser was not available, samples were tested in a 
tubular oven (Gallur; HC300 CONATEC, version 10-1-2000) .Samples were 
weighed before and after calcination of the polymer at 600ºC to calculate the 
percentage of mineral phase. [158] 
 
2.2.2.5. Polymer content in blend and hybrid samples 
Thermogravimetric analysis was performed in a SDT Q6000 from TA Instruments 
to determine the amount of polymer (polylactic acid, polycaprolactone or 
crosslinked hyaluronic acid) present in hyaluronic acid coated scaffolds or blend 
scaffolds. Weight loss of each polymer component was determined applying a linear 
relationship between the scaffold and the pure polymer weight loss between the 
temperatures in the range of the weight derivate peak of pure polymers. The samples 
were placed in the platinum pan and the temperature was raised from 50 to 1000ºC 
at a heating rate of 10ºC/min (for blend scaffolds) or 20ºC/min (HA coated 
scaffolds) under nitrogen atmosphere. The mass was monitored as a function of the 
temperature; results were analyzed using the software TA Analyzer from the 
instrument.[191] 
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2.2.2.6. Porosity measurement by gravimetry 
The porosity of the scaffolds was determined by gravimetry: samples were weighted 
dry and wet to determine the weight increase and relate it to the pore volume. 
The porous samples were cut in pieces with a defined size, weighed dry and filled 
with ethanol (introduced under vacuum). Porosity was calculated as the quotient of 
the volume of pores to the total volume of the sample according to the following 
equation  
  
 pores
 polymer  pores
 
where the volume of pores (Vpores) was deduced from the quotient of the mass 
difference between dry (mdry) and wet (mwet) scaffold and the ethanol density 
(dethanol). For this experiment we assumed that the amount of ethanol absorbed by the 
polymer phase is negligible. 
     pores  
mwet-mdry
dethanol
 
Volume of polycaprolactone (Vpolymer) was calculated from the quotient of dry 
weight (mdry) of the scaffold and the density of the polymer (dpolymer).  
     polymer  
mdry
dpolymer
 
[158, 191] 
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2.2.2.7. Water absorption behaviour 
For water absorption analysis five samples were immersed in distilled water and 
allowed to take up water until equilibrium was reached (48 h). Samples were 
weighed dry (Wd) and wet (Ws) and a ratio describing water uptake was calculated 
according to equation. 
 welling ratio  
 s
 d
 
[191] 
2.2.2.8. Mechanical analysis: Compression assays 
 caffold’s mechanical properties were determined following the American Society 
for Testing and Mmaterials D1621-04a ‘‘Compressive properties of rigid cellular 
plastics’’ guidelines. 
Uniaxial compression tests were performed using a Microtest Universal Testing 
Machine with a 15 N load cell. The sample was compressed at room temperature 
using a crosshead speed of 1mm/min. The load ramp up to -15 N was performed and 
a stress–strain curve was traced. The standard stress-strain curve obtained in the 
compression assay in porous scaffolds can be divided in 4 sections (figure 2-4). The 
first section is the adaptation zone (a). This zone represents the approximation of 
load cell to the sample. Linear elasticity zone (b) represents the non plastic 
deformation of trabeculae where the stress shows a linear dependence of the strain. 
The plateau zone (c) is the sample plastic deformation as a consequence of 
trabeculae buckling. When the stress overpasses the yield strength, the trabeculae 
buckle and the pores collapse, showing the plateau zone due to the sample strain 
increase at nearly no stress. When the trabeculae are collapsed the densification zone 
                                                                                        Materials and methods 
67 
starts (d). Elastic modulus was determined as the slope of initial segment of the 
curve, Yield strength was determined as the stress at the inflexion point between 
elastic zone and plateau zone and densification modulus was determined as the 
tangent of the maximum modulus reached during densification zone. [158, 191] 
 
Figure 2-4. Scaffold’s stress-strain curve for compression assay divided in 4 
sections. Adaptation (a), linear elasticity zone (b), plateau zone (c) and 
densification zone (d). 
 
2.2.2.9. Dynamic mechanical analysis: Equilibrium and dynamic modulus 
Void scaffolds were incubated in sterile culture medium (supplemented with acid 
ascorbic, bovine serum albumin, dexamethasone and sodium azide) at 37ºC during 
up to 35 days to determine the mechanical contribution of hydrolytic degradation in 
the construct properties. This effect was assessed through the measurement of 
Materials and methods                                                                                    . 
68 
equilibrium and dynamic modulus using a thermal mechanical analyser, and the 
determination of elastic modulus using the Microtest Universal testing machine at 
different time points. 
Samples were removed at 1, 17 and 35 days, washed with Dulbecco’s phosphate 
buffered saline and placed in DPBS at 4ºC until analysis was performed. The 
samples were compressed at room temperature in immersion on DPBS. Stress 
relaxation test was performed using a thermal mechanical analyser. Compressive 
equilibrium modulus was determined from the equilibrium values reached by the 
samples after applying 10% strain and holding it for 30 min. Dynamic modulus was 
determined overlaying a cyclic strain of 1% of amplitude at 0.1 Hz to the 10% 
equilibrium strain for 10 cycles.[134] 
 
2.2.2.10. Stability in physiological medium 
In the case of composite samples, the dissolution of the mineral phase can affect the 
pH of the culture medium and thus cell fate. Thus, evolution of the pH of phosphate 
buffer in contact with the composite samples was studied for up to 48 h. ( phosphate 
buffer was chosen over more physiological carbonate buffer due to the high 
instability of carbonate buffer pH in normal atmosphere). 
For each material, three samples were cut and incubated with 1 ml phosphate buffer 
1 M at 37 ºC after vacuum infiltration. pH was measured at 0, 0.5, 1, 3, 8 and 
24hours. [158] 
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2.2.2.11. Degradation study 
Degradation study was performed to determine the effect of hydrolytic degradation 
in different polycaprolcatone/polylactic acid blends. Assay was performed with a 
low saline buffer to avoid salt precipitates that can interfere with the weight 
measures. 
Samples were incubated with phosphate buffer (NaH2PO4 3,12g/l, Na2HPO4 
28.66g/l and 0.02% NaN3 pH=7.4) in a ratio of 0.5% sample weight in buffer 
volume, samples were incubated at 37ºC for 78 weeks and medium was changed 
every two weeks. Samples were removed and stored at 0, 30, 44, 60 and 78 weeks. 
 
2.2.3. Cell Culture 
2.2.3.1. Disinfection protocol, sample preconditioning and cell seeding protocol 
Scaffold seeding protocols were adapted to each type of scaffold developed. 
Polymeric scaffolds are hydrophobic and do not show biologic adhesion motives, 
and for this reason they were preconditioned. First step of sample preconditioning 
was the sample disinfection. Absolute ethanol was infiltrated inside the samples and 
incubated and after one hour was changed with sterile ethanol 70% at 4ºC during 72 
hours. The preconditioning step consists in washing the samples with DPBS three 
times to remove ethanol and incubating the samples overnight at 37ºC in culture 
medium supplemented with FBS, and penicillin/streptomycin. This protocol allows 
filling the scaffold with culture medium and coating the surface with adhesive 
proteins. MC3T3-E1 were seeded on polycaprolactone and composite scaffolds by 
depositing a small drop of concentrated cell solution on the scaffold surface. 
Samples were incubated for 30 minutes at 37ºC and then cell culture medium was 
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added. On the other hand, human chondrocytes were injected in PCL and hyaluronic 
acid coated samples using a Hamilton syringe (figure 2-5). [158, 191] 
 
Figure 2-5. Chondrocyte and MC3T3-E1 seeding in polymeric scaffolds. 
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Figure 2-6. Mesenchymal stem cells seeding in polymeric scaffolds using 
agarose molds. 
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Finally polycaprolactone, Bioglass composite and hyaluronic acid seeded with 
MSCs were previously deposited on agarose moulds that surrounded all the samples 
sides except for the top side to improve the cell seeding. Mesenchymal stem cells 
were concentrated and injected (hyaluronic acid samples) or deposited in a drop on 
the scaffold top and incubated at 37ºC. Fifteen minutes after 1 ml of culture medium 
was added and they were incubated for 2 hours prior to cover the sample with cell 
culture (figure 2-6). MC3T3-E1 were seeded at 2.5X10
5
 cells/scaffold (12.5X10
6
 
cells/ml), chondrocytes at 4X10
5
 cells/scaffold (10X10
6
 cells/ml) and mesenchymal 
stem cells at 5X10
5
 cells/scaffold (10X10
6
 cells/ml).  
On the other hand polycaprolcatone scaffolds used in co-culture experiments were 
sterilized with gamma ray radiation (25kGy performed by Aragogamma) and 
preconditioned with phosphate saline buffer. PCL scaffolds were coated with 
20µg/ml of fibronectin for 1 hour. Fibronectin coated scaffolds were washed with 
phosphate saline buffer and seeded with the same protocol than mesenchymal stem 
cells. On the other hand tyramine substituted hyaluronic acid was sterilised by 
filtration and cells-hyaluronic acid mixture was injected on PCL scaffolds (figure 2-
7) and crosslinked in situ as is described on section 2.2.1.5.1. Mesenchymal stem 
cells were seeded at 3X10
5
 cells/scaffold (10X10
6
 cells/ml). 
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Figure 2-7. Cell seeding with tyramine substituted hyaluronic acid 
crosslinkable in situ. 
 
2.2.3.2. Normoxia and hypoxia 
Cell cultures were performed at 37ºC in normoxia conditions with a 20% of oxygen 
and 5% of carbon dioxide. On the other hand for cell culture in hypoxic conditions 
an incubator connected to a nitrogen flow was used to reduce the oxygen 
concentration to 5% and 5% of carbon dioxide. 
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2.2.3.3. Hydrostatic pressure 
Cell culture stimulated with hydrostatic pressure was performed using a custom 
made bioreactor developed in the Trinity College Dublin. The bioreactor (sketch 
showed on picture 2-8) is a metallic cylinder filled with water in which the samples 
are immersed. The pressure cylinder is then sealed and connected to a compression 
machine that compresses water generating an intermittent hydrostatic pressure 
increment inside the vessel.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2-8. Sketch of the bioreactor system used to stimulate samples with 
hydrostatic pressure. (1-Water deposit valve, 2-Main system valve, 3-Pressure 
cylinder in-valve, 4-Pressure cylinder out-valve) To open the pressure cylinder 
to put or remove sealed plastic bags with samples valve 3 is closed and 4 open 
to remove cylinder cap. To fill the bioreactor valves 1, 2, 3 and 4 are opened. 
When the bioreactor is working only valves 2 and 3 are opened to transmit the 
hydrostatic pressure generated by fatigue testing machine through pneumatic 
piston. 
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To stimulate cells with hydrostatic pressure samples of each material, at day 14 they 
were divided in two groups and sealed inside sterile plastic bags with 2.5 ml/sample 
of chondrogenic culture medium during the loading period (3 weeks). The 
hydrostatic pressure group samples were placed inside the bioreactor and the free 
swelling control samples were placed into an open water bath, both inside a 37ºC 
incubator. The hydrostatic pressure loading protocol consisted in a dynamic pressure 
(max pressure 10MPa) at a frequency of 1 Hz for a period of 2hours/day five times 
each week.[134] 
2.2.3.4. Co-culture 
A co-culture study was designed to develop an indirect coculture system between 
chondrocytes and mesenchymal stem cells (figure 2-8). Chondrocytes were mixed 
with alginate to obtain 7X10
6
 cells/ml dissolved in 0.5% solution of alginate. Cell-
alginate suspension was placed in negative teflon-agarose mould composed by a 
teflon part at the bottom part and an agarose mould over teflon. The bottom part was 
a rectangular teflon piece with vertical cylindrical inserts 3 mm in diameter and 3 
mm height. Top part was a 3% agarose with 0.1M of calcium piece with 4mm height 
and holes of 8mm of diameter where the cell suspension is deposited that matched 
with the teflon inserts. The agarose mould part is made pouring molten agarose in a 
sterile plastic plate and putting a negative teflon mould to generate the holes. 
Chondrocytes-alginate construct is a cylinder of 8 mm in diameter and 4 mm height 
with a hole in the middle of 3 mm in diameter and 3 mm height (figure 2-9).  
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Figure 2-9. Alginate mold fabrication protocol. 
 
Scaffolds seeded with mesenchymal stem cells were inserted in that hole. As a result 
the two types of cell were expected to grow separately and only can interact through 
soluble signals. Porcine mesenchymal stem cells were seeded at 3X10
5
 cells/scaffold 
and chondrocytes at 1.2X10
6
 cells/alginate gel and cultured with chondrogenic 
media under normoxia conditions for 35 days. 
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Figure 2-10. Co-culture sketch. Monocultures are defined as only one material 
with cells the alginate mold or scaffold and co-culture defined as scaffold and 
alginate mold seeded with cells. 
 
2.2.4. Biological characterization 
2.2.4.1.  Cytotoxicity determined by MTS 
Cytotoxicity was evaluated using a contact-free assay. Basal DMEM without phenol 
red with 1 % P/S was incubated with 5 % w/v of the samples to be tested and with 
latex (positive cytotoxic control) during 48 h at 37ºC. MC3T3-E1 cells were seeded 
in a P24 multiwell plate in standard growth medium without phenol red. At 24 
hours, when reaching subconfluence, the medium was replaced with the medium 
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incubated with the materials (n = 3). The culture medium was removed after 24 h 
and medium with MTS reagent (dilution 1:5) was added. Cultures were incubated 
for 3 h in the incubator at 37º C protected from light and absorbance at 490 nm was 
read in a Perkin-Elmer VICTOR microplate reader. Metabolic activity was 
determined using a standard curve provided in the kit. [158] 
 
2.2.4.2. Sample enzymatic digestion for biochemical assays 
Biochemical analyses were performed on digested samples. Enzymatical digestion 
allows to solubilize the biomolecules to test and protect them from endogenous 
enzymes released from lysed cells. Samples were washed with DPBS and stored at   
-80ºC in a microtube until the analyses were performed. After thawing, cells were 
digested adding papain (Sigma-Aldrich) or proteinase K (Roche) and finally the 
sample was analysed or stored at -80º. 
Papain digestion was performed incubating the samples during 18 h at 60°C adding 
3.875 U/ml of enzyme in Activated Papain Enzyme Digestion Solution (100mM 
Sodium Phosphate Buffer, 5mM Na2EDTA, 10mM L-cysteine, pH 6.5). On the 
other hand proteinase K digestion was done at 60ºC during 16 hours followed by 
enzyme inactivation at 90ºC for 10 min with 50 µg/ml of enzyme dissolved in DPBS 
at pH 8.1. Samples were assayed immediately or stored at -80ºC. [158, 191] 
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2.2.4.3. DNA content 
Total DNA content present in the samples was measured using P7589 Quant-iT 
PicoGreen dsDNA assay kit (Invitrogen) or DNA Quantitation Kit, Fluorescence 
Assay. Quantitation of DNA using PicoGreen reagent (invitrogen) and bisBenzimide 
H 33258 dye (Hoechst 33258) ( igma) was performed following the manufacturer’s 
instructions. Previous to the DNA quantification assay the samples were tested to 
determine the optimal dilution.  
Samples and standards were put in a black P96 multiwell plate in triplicate and 
added 200 µl of working solution and then incubated 5 min at room temperature 
protected from light. The fluorescence for PicoGreen was read at 520 nm using a 
multiwell plate reader (VICTOR3 from Perkin-Elmer) and for Hoechst at 460 nm in 
a microplate reader (SynergyTM HT from BioTek). The DNA content was 
determined using the DNA standard calibration curve and the cell seeding efficiency 
as the sample’s total DNA divided by the amount of DNA present in a cell and then 
divided by the theoretical number of seeded cells. [158,191] 
 
2.2.4.4.   Sulfated glycosaminoglycans content 
The total glycosaminoglycans (GAGs) content present in the samples was measured 
using Blyscan assay kit (Biocolor), a modified version of 1,9-dimethylmethylene 
blue assay following the manufacturer’s instructions. Previous to the 
glycosaminoglycans quantification assay the samples were tested to determine the 
optimal dilution.  
Samples and standards were spun and the optimal volume of supernatant was diluted 
with papain buffer extract up to a total of 200ul and mixed with 1 ml of Blyscan in a 
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centrifuge microtube. Samples were incubated for 30min in an orbital shaker and 
then were centrifuged at 15000g for 10 min and supernatant was discarded. The 
resulting precipitate was dissolved in 1 ml dissociation reagent and placed at 
200μl/well in P96 multiwell plate and absorbance was read at 656nm in a microplate 
reader (SynergyTM HT from BioTek or VICTOR3 from Perkin-Elmer). Quantities 
of sulphated glycosaminoglycan were determined from a calibration curve 
performed using chondroitin sulphate standard provided in the kit.[191] 
 
2.2.4.5. Hydroxyproline content 
Collagen content present in the samples was measured determining the 
hydroxyproline content using the protocol described by Kafienah.[154] Previous to 
the hydroxyproline quantification assay the samples were tested to determine the 
optimal dilution.  
Samples were spun and the optimal volume of supernatant was mixed with papain 
buffer extract up to a total sample volume of 200μl, then 200μl of 38% HCl was 
added and incubated 18h at 110ºC. Samples were dried by evaporation at 45ºC and 
then samples dissolved in 200 μl of MiliQ water. Finally, 60 μl/well were put in P96 
multiwell plate and was mixed Chloramine T reagent to allow for hydroxyproline 
oxidation. Finally 4-(Dimethylamino)benzaldehyde reagent was added. The amount 
of hydroxyproline was measured by reading the absorbance at 570nm in a 
microplate reader (SynergyTM HT from BioTek or VICTOR3 from Perkin-Elmer). 
Quantities of hydroxyproline were determined from a calibration curve realized 
using hydroxyproline standard and the amount of collagen was calculated using a 
value of hydroxyproline-to-collagen ratio of 1:7.69.[155] 
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2.2.4.6. Collagen type II and X ELISA 
Collagen type II and X presence in the sample was measured through a colorimetric 
immunoassay. The Enzyme-linked immunosorbent assay for collagen type II 
(Collagen type II ELISA, mdbioproducts) was performed using a heterogeneous 
sandwich ELISA and collagen type X (Porcine collagen type 10 (CoL-10) Elisa kit, 
BlueGene) was quantified with a competitive enzyme immunoassay technique. The 
assays were performed following the kit’s user manual 
Samples were washed with DPBS and stored at -80ºC. Samples were homogenized 
in 200 µl of cold NaCl 0.9% solution. Samples were sonicated 5 min and 
centrifuged at 1500 g for 15 min. Then 100 µl of supernatant was stored at -80ºC for 
Collagen type X assay. Remaining sample with construct debris was mixed with 450 
µl of pepsin at 1.1 mg/ml (pepsin from porcine gastric mucosa, Sigma) in 62.5mM 
of acetic acid (pH=3.00) and incubated for 72 h at 4ºC with gentle mixing. After the 
incubation period 50 ul of TBS 10X (1M Trizma® base, 2M NaCl, 50mM CaCl2 in 
water) were added and samples adjusted to pH 8.00. Then 50 ul of elastase (Elastase 
from porcine pancreas; Sigma) were added and incubated for 24 h at 4ºC with gentle 
mixing. Samples were removed and centrifuged at 10000 rpm for 5 minutes. The 
supernatant was collected and stored at -80ºC. 
Collagen type II ELI A was performed following the kit’s user manual.  amples 
and standards were pipetted at 100 µl on coated multiwell plate and incubated for 2 
hours. Microplate was washed 6 times with 200 µl of wash buffer. 100 µl of 
conjugated antibody were added and incubated for 2 hours. After washing the plate, 
100 µl of streptavidin-HRP were added and incubated for 30 min. Wells were 
washed and 100 µl of substrate were added and incubated for 20 minutes. Finally the 
reaction was stopped with 100 µl of stop solution. The absorbance was read at 450 
nm with the Perkin-Elmer VICTOR3 multiplate reader. 
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Collagen type X ELISA protocol. Samples and standards were pipetted at 100 µl 
and 50 ul of conjugate on coated multiwell. The multiwell plate was incubated for 1 
hour at 37ºC. Samples were washed 5 times with 400 µl of wash buffer. Then 50 µl 
of substrate  A and substrate B were incubated for 15 minutes at 37ºC and stopped 
with 50 µl of stop solution. The absorbance was read at 450 nm with the Perkin-
Elmer VICTOR3 multiplate reader.  
 
2.2.4.7. Alkaline phosphatase analysis 
The alkaline phosphatase (ALP) presence in the sample was measured both in 
released form from the culture medium as well as in intracellular form by measuring 
the activity of lysed cells extract.  
Activity of alkaline phosphatase as the conversion of P-nitrophenyl phosphate to p-
nitrophenol was measured as the result number of product millimol obtained by the 
activity of a cellular extract. Samples were washed with DPBS and then fragmented 
using a scalpel and dispersed in lysis buffer (0.2 % Triton X-100, 10 mM Tris–HCl 
pH 7.2) on ice for 7 min, and further sonicated for 2 min. The samples were 
centrifuged at 13000 rpm at 4ºC for 7 min to precipitate cellular and scaffold debris. 
Supernatant was mixed (1:1) with p-nitrophenylphosphate (p-nitrophenyl phosphate, 
Sigma) at 1 mg/ml and incubated for 2 h at 37ºC. Reaction then was stopped adding 
1 M NaOH. Finally aliquots of 100 µl were put in a P96 in duplicate and were read 
at 405 nm with the Perkin-Elmer VICTOR3 multiplate reader. The p-nitrophenyl 
phosphate conversion was determined using a nitrophenol standard curve. [158] 
The amount of ALP released to the media was determined measuring the substrate 
conversion using SensoLyte® pNPP Alkaline Phosphatase Assay kit *Colorimetric* 
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(Ana pec) following the manufacturer’s instructions.  amples were collected from 
the culture media 2 days after the media change. The samples were centrifuged at 
1500 rpm for one minute to precipitate cellular and scaffold debris. Supernatant was 
placed at 50µl/well in triplicate in P96 well plate, and then 50 µl of colorimetric 
alkaline phosphatase substrate was added and incubated for 40 min at room 
temperature protected from light. The absorbance was read at 405 nm with the 
Perkin-Elmer  ICTOR3 multiplate reader.  ample’s ALP content was determined 
using the enzyme standard calibration curve. 
 
2.2.4.8. Scanning electron microscopy and CryoSEM 
The cell distribution and morphology was analyzed using scanning electron 
microscopy. Samples were fixed with 2.5% glutaraldehyde 1 hour at 4ºC. The 
samples were washed and stored in DPBS at 4ºC. The samples were dehydrated 
through a series of increasing percentages of alcohol and finally dried at air. 
Samples were mounted on copper stubs with a graphite conductive tape and gold 
sputtered. The microscope used for both methodologies was a JEOL JSM6300 
scanning electron microscope at an acceleration voltage of 15 kV. [158, 191] 
 
2.2.4.9. Sample inclusion 
Samples were fixed, included in a inclusion media and cut to obtain the tissue 
sections used to staining protocols. Samples for microscopy were washed in DPBS 
and fixed with 10% neutral buffered formalin (1 hour at 4ºC) for optimum cutting 
temperature compound embedding and 4% paraformaldehyde (16 hour at 4ºC) for 
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polyester wax embedding. Samples were washed twice with DPBS to remove the 
fixing agent and stored in DPBS 4ºC. 
Optimum cutting temperature compound (Tissue Tek) embedded samples were 
incubated in 30 % of sucrose solution overnight. Samples were wiped in order to 
remove excess solution, included in a mould with optimum cutting temperature 
compound and frozen rapidly at -80ºC. The embedded scaffolds were cut 
longitudinally using the cryotome Microm HM 500 at -30 ºC in 200 µm thick 
sections. Sections were washed gently with DPBS two times to eliminate optimum 
cutting temperature compound. On the other hand polyester wax (Electron 
Microscopy Sciences) embedded samples were first dehydrated through a series of 
increasing percentage alcohol substituting the water with ethanol, after this was 
immersed in absolute ethanol/ polyester wax 50:50 overnight and finally included in 
a mould with polyester wax and cured 48 hours at room temperature. The embedded 
scaffolds were cut longitudinally using the microtome Leica RM2025 in 10 μm thick 
sections. [158, 191] 
 
2.2.4.10. Immunostaining 
Presence of cell proteins used as differentiation markers was determined through 
immunostaining, performed as immunofluorescence or immunohistochemistry. 
Immunofluorescence samples were washed to remove the mounting media and 
permeabilized to allow the antibody diffusion. Samples were incubated in presence 
DPBS with bovine serum albumin (BSA) at 1% to avoid the antibodies non specific 
binding points. The primary antibody diluted to the optimum concentration in DPBS 
with BSA at 1% was incubated with the sample and washed with DPBS/TWEEN 
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0.5% to remove non specific bindings. The antibodies chosen were divided in 
osteogenic markers, chondrogenic markers and adhesion proteins. Osteogenic 
markers selected were osteocalcin (Abcam) and Runx2 (Abcam). Positive 
chondrogenic markers used were collagen type II (Chemicon International), 
aggrecan (Invitrogen) and CD-44(Abcam) while collagen type I (Chemicon 
International) was used as negative marker. Adhesion protein markers were integrin 
α5 ( anta Cruz Biotechnology), αV (Millipore), β1 (Millipore) and CD-44 
(Invitrogen). To reveal staining the samples were incubated in presence of 
immunofluorescence conjugated antibody Alexa 488 (Invitrogen) or Alexa 647 
(Invitrogen) and FICT conjugated phalloidin (Invitrogen) diluted both in DPBS with 
BSA at 1%. Finally samples were mounted with Fluorsave Vectashield mounting 
medium with DAPI (Atom). Pictures were taken using an immunofluorescence or a 
confocal microscope. 
Immunohistochemical staining of collagen type I (Abcam) and Collagen type II 
(Chemicon International)was carried out following a modified Dako kit staining 
protocol (EnVision®+dual Link System-HRP, DakoCytomation), adding an antigen 
retrieval step after endogenous peroxidase activity inactivation. After endogenous 
peroxidase inactivation, samples were incubated with pepsin (5mg/ml in 5mM HCl) 
45 minutes at 37ºC. The samples were blocked with DPBS with BSA at 1% and 
incubated in presence of primary antibody. After antibody incubation the samples 
were washed and incubated in presence of HRP-labelled polymer. Finally the 
sample was revealed adding the substrate-chromogen, dehydrated and mounted with 
Entellan mounting media (Electron Microscopy Sciences). Pictures were taken using 
a stereoscopic microscope (Leica MZ APO). 
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2.2.4.11. Histochemistry 
Presence and distribution of cells and ECM components was determined through 
different histochemistry staining. 
Histological staining for mineralization of fresh tissue samples was the Von Kossa 
staining. Samples were cut at 1 mm thick with a scalpel, washed with distilled water 
and incubated in 5 % AgNO3 (Sigma) for 20 min under ultraviolet light. Samples 
were washed with distilled water and revealed incubating in 2% Na2S2O3 (Sigma) 
for 2 min. Then samples were washed in distilled water and counterstained with 
neutral red solution (Fluka) for 2 min. Finally the samples were dehydrated through 
washes in solutions of increasing grade ethanol and after air drying for later viewing 
using a stereoscopic microscope (Leica MZ APO).[158] 
Collagen, glycosaminoglycans and calcium staining was performed on polyester 
wax tissue sections. Samples were deparaffined with ethanol 100% and rehydrated 
with deionised water. Samples were stained for GAGs with 1% Alcian Blue for 30 
min, washed with water and counterstaining for nuclei with 0.1% nuclear fast red for 
5 minutes. Collagen staining was performed with 0.1% Picro-Sirius for 30 min, 
washed with acetic acid 0.5% and water. Cells were counterstained with Harris 
hematoxylin 5 min. ECM calcium deposits were detected with alizarin red. Samples 
were immersed tin 2% alizarin red solution for 2 minutes to remove the dye excess. 
Finally the samples were washed with water, dehydrated and mounted with Entellan 
mounting media (Electron Microscopy Sciences) for later viewing using a 
stereoscopic microscope (Leica MZ APO). 
 
 
                                                                                        Materials and methods 
87 
2.2.4.12. Dynamic mechanical analysis of cell-scaffolds constructs 
To determine the effect of ECM grown inside the pores over the mechanical 
properties, the equilibrium and dynamic modulus were determined using a Zwick 
Z005 (Roell) with 5N load cell for samples of 5 mm diameter and a thermal 
mechanical analyser for samples with a diameter of 3mm. Elastic modulus was 
determined using the Microtest Universal testing machine at different time points. 
Eventually the elastic modulus was determined using the Microtest Universal 
Testing Machine with a 15 N load cell. In order to preserve the samples for future 
biochemical assays a non-destructive test was performed. Five cycles of 
compression were applied until 15% of deformation was reached. First curve was 
discarded to study the elastic modulus after the plastic deformation that would be 
present in a physiological load. Elastic modulus was determined as the slope of 
initial segment of the second cycle curve. On the other hand analysis for equilibrium 
and dynamic modulus was performed as is described on section 2.2.2.9.  
 
2.3. Statistical analysis 
Samples homogeneity was analyzed doing a Levene’s test to choose the correct 
statistical analysis. If Levene’s test was positive a  tudent t-test or one factor 
ANOVA was chosen; but if it was negative a non-parametric test was used; 
differences were considered significant for p<0.05. In all figures, error bars 
represent standard deviation. 
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3. Macroporous PCL composite scaffolds for bone tissue engineering: Results 
and discussion.  
3.1. Abstract 
The present chapter contains the results obtained in the development of a polymer-
ceramic composite scaffold for bone tissue engineering as part of a project focused 
in obtaining a prototype for spinal fusion applications. Spinal diseases usually 
require intervertebral joint immobilization that can be performed with pedicle screw 
devices or bone graft implantation, but for long term stability, bone formation 
between vertebrae is required.[17,156] For spinal fusion, the preferred type of graft 
is the bone autograft but it is limited by availability and donor site 
morbidity.[17,156] This is why other graft types as allografts and synthetic materials 
are proposed, in spite of the known drawbacks associated to allogeneic transplants 
or synthetic biopolymers. [156] The objective of this study was to develop and 
characterize a composite scaffold from the beginning up to in vivo evaluation for its 
application as spinal fusion strip prototype. Composite scaffolds are a great 
approach for designing bone substitutes because they combine the advantages of two 
biomaterials classes[9], bioactive inorganic materials and polymers. Composite 
scaffolds used in this work were based on synthetic biodegradable polymers such as 
PCL or PLLA[63] scaffold. For this work hydroxyapatite nanoparticles or 45S5 
Bioglass® microparticles were selected as bioactive inorganic material for 
reinforcement as they are similar in composition to bone mineral phase (HAp)[89] 
and promote cell differentiation (BG)[157]. 
Spinal fusion strip prototype development was divided in four steps. (I) 
Characterization and validation of ceramic-polymer composite scaffolds. (II) 
Development of several composite scaffolds series with different compositions. (III) 
PCL/PLLA composite scaffolds degradation study and (IV) in vitro selection and in 
Macroporous PCL composite scaffolds for bone tissue engineering:               . 
Results and discussion                                                                                       . 
94 
vivo evaluation. Physical properties were measured (mechanical behaviour, 
morphology, composition, stability in physiological medium) and biological 
response was characterized using osteoblast-like cells and animal model. The in vivo 
study was beyond the scope of the present thesis although it was part of the global 
project. The results obtained in the experiments performed at Inasmet Tecnalia (in 
vitro evaluation) and at Instituto de Biomecanica de Valencia (in vivo evaluation) 
are presented for the sake of global comprehension of the general design process. 
  
 95 
3.2. Characterization and validation of ceramic-polymer composite scaffolds. 
The objective was developing PCL composite scaffolds containing ceramic 
reinforcement to test the viability of the fabrication process and characterizing them 
as candidates for a spinal fusion strip. Composite scaffolds were prepared using PCL 
solutions with different amounts of mineral particles (5, 10 and 20 % by weight with 
respect to PCL). Morphological, mechanical and other physical properties were 
measured as a function of scaffold composition and biological characterization was 
performed using MC3T3-E1 cell line under normoxia conditions. Cells were seeded 
at 250000 cells/scaffold with culture medium for osteoblast differentiation and 
cultured for 28 days. This work has been published in the Journal of Materials 
 cience: Materials in Medicine entitled “Comparative study of PCL-HAp and PCL-
BG composite scaffolds for bone tissue engineering.”[158].  
 
Table 3-1. Table with tested samples composition. 
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The influence of mineral reinforcement over the scaffold features was performed 
with mechanical tests in compression, TGA analysis and EDX analysis. 
The influence of different composite scaffolds over MC3T3-E1 differentiation was 
assessed using biochemical quantitative analysis of DNA and ALP as well using 
immunofluorescent staining of Runx2 and osteocalcin. 
 
“Present section was removed due to copyright statements. Section content is available in 
Ródenas-Rochina J, Ribelles JL, Lebourg M. Comparative study of PCL-HAp and PCL-
bioglass composite scaffolds for bone tissue engineering. Journal of Materials Science: 
Materials in Medicine 2013; 24:1293-308” 
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3.3. Development and evaluation of polymer based composite scaffolds: 
Development of composite scaffolds series and characterization. 
This subchapter was developed as part of Cenit Intelimplant project coordinated by 
Tequir I+D+i and funded by Spanish Ministry of Industry, Tourism and Commerce 
through INGENIO 2010 program. The objective was developing a spinal fusion strip 
prototype and proceeding to its in vivo evaluation. The objective of this section was 
the development of particular materials in the line of those described in the 
preceding section but addressed to the intended application in the framework of 
Cenit Intelimplant project.  
In this project, scaffolds as described in the former section were used with different 
surface modifications. Here, a different polymer (polymer 2) was added to the 
formulation still looking for a less compliant matrix and higher degradation rate. 
Polymer 1used in this work is a quite compliant material even if the objective is the 
development of a vertebral fusion strip that must sustain low loading after 
implantation during bone invasion. Moreover, degradation of polymer 1 is very slow 
and may not be adapted to the rate of bone remodelling, which is relatively fast. 
Composite scaffolds were prepared using polymer 1 and polymer blends solutions 
with mineral particles. Samples were cut to 2 different sizes. Samples for 
mechanical test were 4x4x7 mm
3
 and samples for remaining physico-chemical tests 
were 4x4x4 mm
3. Finally sample’s surface was modified with plasma treatment, 
nucleation or hydroxyapatite coating.  
The effect of polymer blends and mineral reinforcement was determined using SEM, 
compression mechanical test and DSC analysis. 
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Samples compositions were omitted due to a confidentiality agreement between the 
center and the company owner of the results. 
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3.3.1. Morphology and microstructure 
Figure 3-1 shows the developed samples. All samples showed the same 
interconnected porous structure with a high porosity with a bimodal pore structure 
divided in macropores and micropores. Macropores were obtained after porogen 
removal along the particle leaching and micropores as consequence of dioxane 
crystallisation along the phase separation induced by the freeze extraction as 
described in the previous section. Mineral particles addition did not show any 
important effect over the scaffold architecture or pore structure but surface 
roughness was increased. On the other hand EDX spectroscopy analysis, was 
performed to confirm if mineral particles are present on the pore wall surface. The 
EDX spectrum (figure 3-2) of both mineral particles composite samples surface 
showed the peaks corresponding with the expected respective mineral particles 
formula. Composition 13 and composition 17 showed calcium and phosphate peaks 
that corresponds to expected spectrum for mineral particles 1 introduced. On the 
other hand composition 9 showed specific element peaks that matched with mineral 
particles 2 composition.   
  
 
Figure 3-1. Micrographs of developed scaffolds (A). Micrographs of developed scaffolds (B). (magnification/scale 
bar = X100/500 μm; X200/300 μm and X1000/60 μm).  
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Figure 3-2. Micrographs and energy-dispersive X-ray spectroscopy spectra of 
scaffolds. (magnification/scale bar = X1000/50μm). 
 
Nucleation and coating treatment were performed to increase scaffold bioactivity. 
Samples with nucleation and coating treatment at low magnifications did not show 
any differences over scaffold structure. On the other hand at high magnifications a 
mineral layer was observed coating part of the scaffold surface hiding the 
micropores. In order to determine if layer composition was calcium phosphate 
crystals, it was analyzed with EDX spectroscopy. EDX results show that surface 
treatments allow the growth of phosphate-calcium crystals. Plasma treatment 
combined with nucleation allows calcium phosphate crystal nucleation on the 
sample surface confirmed by the EDX spectroscopy spectrum that showed calcium 
and phosphate presence. On the other hand, samples that were subjected to the 
complete coating protocol (plasma, nucleation and coating) exhibited the presence 
of typical “cauliflower-like" structure of biomimetic hydroxyapatite. 
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Polymer blend scaffolds (composition 5 and composition 17 scaffolds) showed a 
particular microstructure characterized by dispersed spherical aggregates (figure 3-
1) on the pore walls. Polymer blend seems not to compromise the correct scaffold 
structure where macropores are still well interconnected, although trabeculae are 
thinner and with a more irregular shape. On the other hand composition 5 and 
composition 17 showed a statistically significant porosity increment compared to 
composition 1 scaffold. 
  
  
 
Figure 3-3. Micrographs of different scaffolds. Beside micrographs the corresponding EDX spectra for the sample 
surfaces are shown. (magnification/scale bar= X1000/50 μm).   
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3.3.2. Crystallinity and ceramic content. 
Heating thermograms obtained with DSC are shown in figure 3-4. Thermograms 
showed that polymer blend samples have two melting points corresponding to 
polymer 1 and polymer 2. Melting temperature of polymer 1 phase is very close to 
that of pure homopolymer scaffold. Mineral particle inclusion produced a slight 
reduction of melting temperature. Crystallinity was calculated from the DSC heating 
thermograms (table 3-2). For composition 1 scaffolds crystallinity changes from 
67.9% for bare samples to 66.4% for composition 13. In composition 5 crystallinity 
of polymer 1 was a 10% lower compared to composition 1 scaffold. On the other 
hand introduction of mineral particles in the compostition 17 decreased more 
dramatically the crystallinity than in composition 13. In composition 17, polymer 1 
crystallinity was reduced around a 8% compared to composition 5 wich polymer 2 
phase crystallinity decreased around 17% whereas in composition 13 crystallinity 
only dropped about 2% with respect to composition 1.  
 
 
Figure 3-4. Differential scanning calorimetry graphs of developed scaffolds.  
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Percentage of ceramic phase shown in table 3-2 was determined through the residue 
obtained after pyrolysis of composite samples. Tested samples showed a mineral 
content smaller than expected. Reinforcement content was around 6% lower than the 
theoretical one in mineral particles containing samples (composition 13 and 
composition 17) the difference was still higher in the case of composition 9 that had 
a 16% mineral content less than theoretical.  
 
3.3.3. Mechanical properties 
Table 3-4 presents the values of the mechanical properties (elastic modulus and 
yield strength) for the fabricated scaffolds. Introduction of mineral particles 1 
reduced the elastic modulus whereas mineral particles 2 increased it, differences in 
both cases are small but statistically significant. Composition 5 showed higher 
mechanical properties with an elastic modulus 7 times higher than composition 1 
samples. On the other hand, mineral particles 1 introduction in composition 17 
scaffolds decreased dramatically the mechanical properties although the modulus of 
composition 17 is still higher than that of composition 1 and composition 13 
scaffolds.  
  
 
 
 
 
 
 
 
Table 3-2. Total porosity, solid residue analysis, crystallinity and mechanical analysis of the different scaffolds. 
The Diff. (%) means the difference in the amount of microparticles detected in the composites and the nominal 
value. Samples that show significant differences (p<0.05) with composition 1 sample are pointed with (*) and (**) 
for samples compared to composition 9.  
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3.3.4. Discussion 
Polymer 1 is a semicrystalline polymer with a viscoelastic behaviour that is very 
interesting for different tissues, but quite compliant for bone substitutes even to 
sustain the low loading to which the vertebral fusion strip is subjected after 
implantation during bone invasion. In the previous section the particulate mineral 
filler plays the role of increasing the stiffness of polymer matrix, in addition to 
provide the scaffold with bioactive properties. To further increase stiffness of the 
polymeric component of the hybrid scaffold polymer blends of with other 
biodegradable polymers were used in present part of the work. 
The pore architecture described above was considered adequate for invasion of bone 
tissue and vascularization. It was shown that the different modification of the 
material blending polymer 1 with polymer 2 or increasing the mineral content did 
not alter the general characteristics of the pore size and interconnectivity. As in the 
previous section, mineral particles 1 or mineral particles 2 reinforcement did not 
have any effect over scaffold structure but increased surface roughness as a 
consequence of mineral particle presence on the polymer surface. Polymer blending 
only showed a slight effect over scaffold structure and showed heterogeneous 
polymer structures on scaffold’s pore walls compared to composition 1 scaffold. In 
our blends the polymer that was present in lower proportion was isolated in small 
spherical domains included in a continuous matrix of the other polymer. These 
structures were a consequence of phase separation between polymer 1 and polymer 
2. Phase separation takes place when the solution in solvent is frozen as a first step 
of freeze extraction. At room temperature the solution of polymer 1 and polymer 2 
in solvent is homogeneous but on cooling, not only solvent crystallizes, but also the 
two polymers crystallize or vitrify. In addition porosity in blends was statistically 
higher than composition 1 reference control. Porosity increment was related with 
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microporosity because the polymer concentration in the initial solution in blends 
was at 15% compared to 20% in other samples. Micropores are dependent of 
polymer/solvent proportion because freeze extraction technique generated the 
micropores when the solvent (solvent A in the present work) starts to crystallize 
after thermally induced phase separation between solvent and polymer. When the 
solvent proportion increased the number of micropores increased too increasing 
global porosity. The difference in the solution concentration was forced by the high 
viscosity of blend; moreover, homogeneous solutions of polymer 1 and polymer 2 in 
solvent could not be obtained at concentrations higher than 15%.  
Ceramic content determined by the residues of pyrolysis was smaller than expected 
by the amount of mineral mixed in the initial solution, as happened in the previous 
section. Mineral loss can happen during freeze extraction if mineral particles get 
trapped inside the solvent phase; there may also be some release of poorly bound 
particles at the surface of the samples during the process of particle leaching. In 
composition 9 samples, the highest particle loss could be consequence of mineral 
particles dissolution in ethanol along particle leaching. On the other hand SEM 
showed that mineral particles were quite apparent on pore walls surfaces (figure 3-
2) not only as deduced by the increase of roughness with respect with pure polymer 
scaffolds but its presence is also confirmed by EDX spectroscopy. Their presence on 
pore surfaces may not only allow to interact with the environment directly, but it 
may also increase protein adsorption[75] and mineral precipitation from body 
fluids[177]. On the other hand, the exhibition of mineral components on the pore 
walls was further improved using surface treatments. Synthetic polymer scaffolds 
have a low intrinsic bioactivity[9]. The first step of surface modification consisted in 
plasma treatment intending to increase the density of carboxyl groups on the 
polymer surface that can improve wettability and higher negative charge may favour 
both mineral deposition and cell adhesion.[82,83] The second step in order to 
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modify the surface of the implant was a nucleation treatment, in order to form 
crystallization nuclei on which calcium phosphate coating can later develop. The 
third and last step used for increasing bioactivity was a coating protocol using 
simulated body fluid. Coating follows previous treatments and consists in incubating 
the samples in simulated body fluid to allow the mineral deposition and 
hydroxyapatite crystal growth. As a result of this treatment, a layer of cauliflower 
shaped biomimetic hydroxyapatite is expected to be deposited, as described 
extensively in the literature[36,38]. This was observed in our work, where the 
coating formed over the scaffold surface as a result of the used protocol occluded 
part of micropores as shown in figure 3-3 but did not cover the whole scaffold 
surface. Finally it seems that mineral particles affect the apatite coating on 
composition 13 samples. Composition 13 samples showed a higher number of 
cauliflower crystals than other tested scaffolds pointing that mineral particles 
introduction improves bioactivity in good agreement with other works[36,177]. 
As expected, mechanical properties were affected by particle inclusion and blending. 
Blend scaffolds showed the highest elastic modulus and yield strength of all tested 
scaffolds due the blend nature of polymer scaffold. On the other hand mineral 
particles introduction on composition 17 cause a downfall of mechanical properties. 
One possible explanation like in the previous section was the inhomogeneous 
dispersion of mineral particles that weakened the structure. Blend solution was a 
more viscous solution than non blend composition hampering particle dispersion in 
the solution and probably forms particle agglomerates that cause structure defects. 
Finally polymer degradation is interesting in bone tissue engineering because bone 
has a fast regeneration rate compared with other tissues. Polymer 2 degradation is 
faster than polymer 1 and its presence in the polymer blend probably accelerates 
scaffold degradation. On other hand mineral particles could improve the degradation 
rate of developed scaffolds since degradation depends, among other factors, on the 
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polymer crystallinity and sample wettability.[9] The addition of mineral particles 
could improve degradation increasing sample hydrophilicity[9] and reducing 
polymer crystallinity. These properties configure a complex system that could be 
used to modulate the degradation properties of our developed samples. 
 
3.3.5. Conclusion 
Composite and bare polymer blend scaffolds were obtained with a porosity and 
morphology suitable for bone tissue engineering. Composite scaffolds showed 
similar features than composites obtained in the first section of this chapter. Polymer 
phase separation did not seem to compromise the correct scaffold structure, only a 
higher porosity was observed in blend samples due the lower proportion of 
polymer/solvent used. On the other hand mechanical properties were highly 
improved in polymer blend scaffold. 
Macroporous PCL composite scaffolds for bone tissue engineering:  
                                                                                        Results and discussion 
111 
3.4. Development and evaluation of polymer based composite scaffolds: 
PCL/PLLA composite scaffolds degradation study. 
Polycaprolactone is a semicrystalline polymer too compliant for bone substitutes. To 
resolve these drawbacks in the current thesis we add poly(lactic acid) in the form of 
polymer blend and use a mineral filler to increase the stiffness of PCL. In the present 
section we analyze the degradation rate of PCL/PLLA blends. Degradation is an 
important aspect of scaffold design: the material should be resorbed by the organism 
at the same time that new formed tissue grow in order to guide tissue regeneration. 
PCL/PLLA blend materials probably will show different degradation rates due to the 
huge difference between both components. The presence of PLLA in the blend can 
accelerate the bioresorption of the scaffold because it degrades faster than PCL and 
lactic acid subproduct decrease pH in the surrounding of the polymer increasing the 
chain cleavage[22].  
In a previous work of our group hydrolytic degradation behaviour of microporous 
PCL/PLLA membranes was studied by Gaona et al.[179] In that work it was 
observed that PLLA phase suffer a more prominent degradation than PCL phase. On 
the other hand PLLA/PCL blends showed an intermediate behaviour between pure 
polymers. Present work introduces the presence of macropores and mineral 
microparticles. These changes probably increase the hydrolysis of the blend 
membrane since it will improve sample hydrophilicity and facilitate water diffusion 
inside the sample.  
This work has been recently submitted for publication entitled “Effects of 
hydroxyapatite filler on long-term hydrolytic degradation of PLLA/PCL porous 
scaffolds”[180]. 
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Scaffolds were prepared using PCL/PLLA (20/80) and PCL/PLLA (80/20) solutions 
at 15% in dioxane with (or not) 20% of HAp. Samples were cut to 6 mm diameter 
and 3.5 mm of height. Samples degradation was performed in phosphate-buffered 
solution (with sodium azide as biocide) at 37 
0
C in a water bath with orbital shaking, 
for up to 78 weeks. 
Table 3-3. Table with tested samples composition. 
 
The influence of degradation performed in immersion in phosphate buffer at 78 
weeks was evaluated by weight loss of each component using TGA analysis and 
morphologic and mechanical changes using SEM and mechanical test in 
compression. 
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3.4.1. Morphology and physico-chemical properties. 
Figure 3-5 shows the double pore structure described along this chapter of 
developed PCL/PLLA blend scaffolds that showed a porosity around 90%. PCL and 
PLLA phase separation was also observed as shown by the inclusion of spherical 
domains of the minority phase inside the main phase. Phase separation features were 
more exacerbated for PCL rich blends, but inclusion of inorganic phase did not 
modify the morphology of the scaffolds as described previously. PCL/PLLA(20/80) 
based scaffolds showed thinner struts and more heterogeneity between the pores. 
Mineral nanoparticle content, crystallinity and mechanical properties were 
determined and are showed in table 3-4. Nanoparticle content was lower than 
expected with a 30% less in PCL/PLLA(20/80)-20HAp and 4% in 
PCL/PLLA(80/20)-20HAp. Crystallinity of PCL and PLLA phases was independent 
of blend composition. On bare blend scaffolds crystallinity of PCL phase was 
around 70% whereas PLLA phase it was around 40%. On the other hand, 
hydroxyapatite addition produces a crystallinity decrement in both polymer 
components. Crystallinity in PCL phase decreased around a 20% in both composite 
polymer blends and a 10% in PLLA phase. Composites showed decreasing 
mechanical modulus with hydroxyapatite addition or with the increase of PCL 
content. PCL/PLLA(20/80) showed the highest modulus followed by 
PCL/PLLA(20/80)-20HAp. PCL/PLLA(80/20) showed a modulus 2.6 times lower 
than PCL/PLLA(20/80). Finally PCL/PLLA(80/20)-20HAp showed the lowest 
modulus that was 30 times lower than non composite blend and 82 times lower than 
PCL/PLLA(20/80). On the other hand, the yield strength was not detectable on 
PCL/PLLA(80/20)-20HAp. 
  
  
 
 
 
 
 
 
Table 3-4. Total porosity of composite scaffolds series, solid residue analysis of composite scaffolds series, 
mechanical analysis of scaffolds, crystallinity analysis of scaffolds series and relative weight loss at 78 weeks. The 
Diff. (%) means the difference in the amount of microparticles detected and the nominal value. Samples that show 
significant differences (p<0.05) with PCL/PLLA(20/80) sample are pointed with (*), (**) for PCL/PLLA(80/20) 
and (***) for samples compared to PCL/PLLA(20/80)-20HAP.  
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3.4.2. Morphology and microstructure evolution. 
After 78-week degradation the overall gross morphology of the PCL/PLLA(80/20) 
scaffolds showed some visual differences compared to the day the experiment 
started and microstructure was generally preserved (Figure 3-6). On the other hand, 
PLLA rich blends showed some loss of integrity, with a progressive structure 
collapse and broken struts, likely due to the fragile nature of PLLA (Tg above 
ambient temperature). In PCL rich blends, the size of polylactic acid inclusions 
decreased with time. 
  
  
 
 
 
Figure 3-5. Microstructure of polyester scaffolds at week 0 and 78. Detail views of blend scaffolds in the upper 
right corner of each micrograph. (magnification/scale bar = 200X/300 μm and 1000X/60 μm). 
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3.4.3. Weight loss evolution 
The structure changes as result of polymer chain degradation and structure erosion. 
Evolution of sample weight and sample composition with time is presented in figure 
3-7. This kind of visualization allows simultaneous envisioning of the total weight 
loss and of the weight loss that can be attributed to each phase: PCL (Blue), PLLA 
(green) and inorganic content (red). Content of each polymer phase was determined 
from gravimetry measurements; PLLA degrades thermically around 320ºC while 
PCL degrades around 400ºC, and thus weight loss of each phase can be 
differentiated from each other by the temperature range where it occurs. During all 
the degradation period, PCL phase and PLLA phase were seen to be thermally 
degraded at easily distinguishable temperatures as seen in the defined and separated 
peaks seen in the derivate signal of the weight loss (although theses temperatures 
varied along the degradation time due to the changes in chain length). Weight loss of 
a particular phase was determined as the weight loss between the temperatures 
limited by the onset and offset of weight loss derivate peaks (see figure 3-7). 
Weight loss is most noticeable for PLLA rich blend sample, PCL/PLLA(20/80), and 
least noticeable for PCL rich composite sample, PCL/PLLA(80/20)-20HAp. In the 
case of the PCL rich blends (PCL/PLLA(80/20) and (PCL/PLLA(80/20)-20HAp), 
inclusion of HAp seems to limit the weight loss of the polymeric phase, while in the 
case of PLLA rich blends, (PCL/PLLA(20/80) and PCL/PLLA(20/80)-20HAp), 
HAp introduction leads to a retarded but increased loss of polymeric phase. In PCL 
rich blends, both phases lose weight in a similar proportion, whereas in PLLA rich 
blends, most of the weight loss can be ascribed to PLLA phase.  
  
  
 
Figure 3-6. Representative TGA curve at day one for bare PCL/PLLA blends and composite. Weight loss of a 
particular phase was determined as the weight (blue curve) loss between the temperatures limited by the onset 
and offset of weight loss derivate peaks(red curve).  
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Figure 3-7. Evolution of sample weight and composition with time as 
determined by weighing and thermogravimetry. PCL (Blue), PLLA (green) and 
inorganic content (red). Error bars represent standard deviation. Significance 
(p<0.05) compared to same material phase at day 0 is signalled as: (A) PLLA, 
(B) PCL and (C) mineral particles. 
 
3.4.4. Mechanical properties 
Evolution of mechanical properties is shown in figure 3-8. Elastic modulus and 
yield strength of as-synthesized scaffolds were higher for PCL/PLLA(20/80) and 
PCL/PLLA(20/80)-20HAp than respective PCL/PLLA(80/20) blend, as can be seen 
in figure 3-8 A and figure 3-8 B. Inclusion of inorganic phase does not lead to a 
mechanical strengthening in the case of these materials: PCL/PLLA(80/20)-20HAp 
shows the lowest modulus and yield strength was undetectable for these samples. 
Nevertheless, after 30 weeks of degradation, PLLA rich scaffolds lost more than half 
of their strength and rigidity and there was no significant difference between 
PCL/PLLA(20/80) and PCL/PLLA(20/80)-20HAp on one side and 
PCL/PLLA(80/20) on the other side. On the contrary, densification modulus 
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increased with degradation time for PCL/PLLA(20/80) blends but in 
PCL/PLLA(80/20) did not show important differences with time.  
 
Figure 3-8. Mechanical compressive properties of the scaffolds. Evolution of the 
elastic modulus with time (A) evolution of the yield strength with time (B) and 
evolution of the densification modulus with time (C). Error bars represent 
standard deviation. Significance (p<0.05) compared to same scaffold at day 0 is 
signalled as: (a) PCL/PLLA(80/20), (b) PCL/PLLA(20/80), (A) 
PCL/PLLA(80/20)-20HAP and (B) PCL/PLLA(20/80)-20HAP.  
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3.4.5. Discussion 
This work was focused on the study of degradation in PCL/PLLA blends eventually 
reinforced with HAp. We fabricated highly porous PCL/PLLA blend scaffolds 
reinforced with hydroxyapatite. Samples showed a phase separation between 
polycaprolactone and polylactic acid and an interconnected double pore structure as 
result of the fabrication process. Modulus of the scaffolds was in the same order of 
magnitude as samples developed in previous sections of this chapter but still they 
remain below the mechanical values of bone[22]; such supports should thus be used 
with external support for load bearing application. The ratio of PCL and PLLA 
content of the blend highly influenced the properties of the scaffold due to the large 
differences in mechanical and degradation properties of the two components. On the 
other hand hydroxyapatite addition have a negative effect over mechanical 
properties and crystallinity that decreased in presence of mineral reinforcement as 
already reported in previous sections. 
Degradation of PCL/PLLA blends has been studied extensively and it has generally 
been shown that polylactic acid, was less degraded in polycaprolactone rich blends 
than in polylactic acid rich blends.[181] This is generally explained in terms of 
impaired water diffusion through the polycaprocatone matrix limiting the hydrolysis 
rate of polylactic acid inclusions. On present work weight loss associated to 
polylactic acid phase was higher in PCL/PLLA(20/80) blend than in 
PCL/PLLA(80/20) blend. On the other hand in the present work polycaprolactone 
phase weight loss cannot be explained by water diffusion as it was higher in 
PCL/PLLA(80/20) than in PCL/PLLA(20/80) in contradiction with the findings of 
Fukushima et al.[182] that found that PCL was degraded more rapidly in 
Poly(DL)lactic acid rich blends. On the other hand hydroxyapatite nanoparticles 
addition increased significantly the degradation of polymer phase in 
PCL/PLLA(20/80)-20HAp samples after an induction period of around 30 weeks. 
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Polylactic acid degradation increment as consequence of hydroxyapatite 
reinforcement is described in literature for in in vitro studies[183] and PLLA 
composites are reabsorbed in vivo faster than pure polylactic acid devices.[184] It is 
noteworthy that the main part of degraded polymer was the polylactic acid phase, 
but no differences were found in polylactic acid phase weight loss between 
reinforced samples and not. On the other hand, in polycaprolactone rich blends a 
reduction of polylactic acid phase weight was observed when hydroxyapatite was 
present. The present work showed that PCL, when reinforced with hydroxyapatite, 
was more resistant to hydrolysis, as shown by the reduced weight loss of these 
samples. The increase in degradation for polylactic acid samples could be explained 
with the lower crystallinity obtained in hydroxyapatite containing samples as 
degradation affects mainly the amorphous phase. Another explication is that 
hydroxyapatite increases sample hydrophilicity improving water diffusion through 
the sample, thus increasing polymer hydrolysis; nevertheless none of these 
explanations is able to explain polycaprolactone phase behaviour. 
Weight loss of polymer samples was as consequence of polymer hydrolysis that 
caused sample erosion. After 78-week the polymer degradation affects substantially 
the scaffold structure. On PCL/PLLA(80/20) polymeric and composite scaffolds the 
most visible effect is the size reduction of PLLA spherical inclusions. On the other 
hand in PCL/PLLA(20/80) and PCL/PLLA(20/80)-20HAp the large weight lost 
affected substantially the scaffold structure. Scaffold was collapsed in polylactic 
acid rich blends due the weakening of the structure. 
Finally scaffold’s mechanical properties decreased with degradation time as 
expected. Although glassy PLLA is initially much more rigid than PCL (which is 
rubbery at ambient temperature), soon after 30 weeks there is no significant 
difference between the yield strength or elastic modulus of PLLA rich or PCL rich 
samples. Densification modulus of the PLLA based blends increased with 
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degradation time, whereas PCL based blends had relatively constant densification 
modulus.  
 
3.4.6. Conclusion 
The effect of hydroxyapatite filler on long-term (78 weeks) hydrolytic degradation 
of PCL/PLLA blend scaffolds was studied. Introduction of HAp shielded the PCL 
from degradation and decreasing the weight loss (more pronounced when PCL was 
the main phase). On the other hand, the presence of HAp had no significant effect on 
PLLA weight loss. Mechanical properties of the scaffolds decreased with 
degradation time as was expected. PCL/PLLA(20/80) was initially much more rigid 
than PCL/PLLA(80/20), but after 30 weeks hydrolysis there was no significant 
difference between the yield strength or elastic modulus of both bare blend polymer 
scaffolds.
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3.5. Annex: In vitro and in vivo scaffold evaluation as potential spinal fusion 
strip. 
This subchapter was developed as part of Cenit Intelimplant project coordinated by 
Tequir I+D+i and funded by Spanish Ministry of Industry, Tourism and Commerce 
through INGENIO 2010 program. The objective was developing a spinal fusion strip 
prototype and proceeding to its in vivo evaluation. 
Samples compositions and results were omitted due to a confidentiality agreement 
between the center and the company owner of the results. 
Previous to in vivo study an in vitro material selection was carried out by the group 
of Nerea Garagorri Ganchegui at Inasmet Tecnalia. The in vitro culture was 
performed with hFOB1.19 (human foetal osteoblast) cell line at 26 days. 
Experimental results will not be shown here. In summary it can be said that cell 
adhesion and cell viability were determined through WST-1 assay and osteogenic 
differentiation through ALP assay. WTS-1 assay is based on substrate 
transformation in a coloured product done by live cells and measured by absorbance. 
After the in vitro study were selected 3 biomaterials to perform the in vivo 
evaluation. In vivo evaluation to characterize the material properties to guide the 
bone regeneration was performed by Víctor Javier Primo Capella and Irene Lara 
Saez at the Instituto de Biomecanica de Valencia. Animal model selected was a 
critical resection in radius bone (25 mm) of New Zealand white rabbits and 
substitution with the selected material. Samples were implanted in five animals for 
each material and each time point and were sacrificed to evaluate the regenerated 
bone. In vivo study showed that developed biomaterials were able to regenerate the 
bone at same level than reference material. The Results were published in Revista de 
biomecánica, (56), 67-69 with the tittle of Biomateriales poliméricos flexibles para 
fusiones vertebrales.  
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3.5.1. Discussion 
Final step of present work was select and validate the prototypes in a complex 
biological system. In vitro culture screening was performed by Inasmet-Tecnalia on 
all developed materials. In vitro tests allow reducing animal experiments and are a 
standardizable methodology to test cytotoxicity, cell proliferation and 
differentiation. Nevertheless, cell line, culture medium or physical factors can 
modify cell response in vitro, and ex-vivo experiments cannot reproduce tissue-
material interaction.[185] For this reason animal models are necessary to test 
materials as a more accurately approximation to human. Rabbit as animal model for 
musculoskeletal studies is typically used (35% of studies are performed in rabbit) 
because has advantages over other models, such as a fast bone maturation (6 
months), ease to house and handle.[185] On the other hand, bone histology, anatomy 
and bone remodelling is completely different to human, and for this reason it is 
commonly used as a previous stage to other animal models.[185] Implantation in 
rabbits performed in the Instituto de Biomecanica de Valencia had the objective of 
evaluate developed materials and compare them against commercial reference bone 
filler. Polymeric scaffolds did not show significant differences compared to 
reference material, with values near to healthy bone. Polymeric scaffolds developed 
on present work have advantages over bone substitutes actually available for human 
use as demineralised bone matrix, ceramics or collagen with calcium 
phosphate[186]. Advantages over cited substitutes are dismiss disease risk 
transmission of substitutes from animal or human source, are stiffer than collagen 
substitutes and are more manufacturable and flexible than ceramics. 
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3.6. Chapter discussion 
The initial concept of bone substitute that we proposed evolved from PCL scaffolds 
with ceramic reinforcement until the final prototype. The initial hypothesis was 
tested and modified to obtain a prototype to test in vivo. In the first step of the 
research we tested different concentrations of Bioglass
® 
and hydroxyapatite to obtain 
PCL composites. Samples obtained were homogeneous despite the variability of 
ceramic content. Particles addition improved surface roughness, sample 
hydrophilicity and mechanical properties that are important features in the 
development of a bone substitute. The mineral presence on the scaffold surface 
improves the adsorption of proteins and mineral precipitation[75,76,177] and makes 
more hydrophilic the material allowing cell invasion inside the scaffold[77]. 
Unexpectedly, mechanical improvement of composite scaffolds with high mineral 
reinforcement concentration was not found and samples with 20% of reinforcement 
showed modulus similar to naked PCL scaffold[158] remaining below the typical 
values measured for bone[22]. Experiments were performed with MC3T3-E1 and 
showed that 5% of mineral reinforcement improved cell adhesion but did not affect 
cell differentiation.[158] As consequence of this, materials formulation was 
reconsidered and were introduced new formulations. Effect of blending and 
hydroxyapatite reinforcement over degradation behaviour was tested on 
PCL/PLLA(20/80) and PCL/PLLA(80/20) blends (and composites) with an in vitro 
degradation study at 78 weeks. PCL/PLLA(20/80) samples degraded faster than 
PCL/PLLA(80/20) samples as expected. On the other hand hydroxyapatite 
reinforcement increased degradation only on PLLA phase but protected PCL phase. 
Finally biological analysis in vitro of all developed formulations and all surface 
treatments was performed. Materials that supported better cell proliferation and 
differentiation were selected for further research steps. Finally biomaterial 1, 
biomaterial 2 and biomaterial 3 were selected to be implanted in rabbits and showed 
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to be able to regenerate a critical bone lesion similarly than commercialized 
reference material. We can conclude as our developed materials are a promising 
candidate for spinal fusion applications. 
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4. Macroporous PCL constructs for cartilage tissue engineering: Results and 
discussion. 
4.1. Abstract  
This section presents the results obtained in the development of a hybrid scaffold as 
3D support for articular cartilage regeneration. The objective of this study was to 
find a combination of a polymeric scaffold and cell seeding (bone marrow MSCs or 
mature chondrocytes) and culture protocol to develop an in vitro construct (scaffold 
and differentiated cells) to be implanted in a cartilage defect to induce new 
functional tissue formation. The supporting material will be based in a 
polycaprolactone, PCL, macroporous scaffold in which our research group have 
previous experience both in vitro[187-190] and in animal models[39,48]. PCL 
scaffold should provide the desired mechanical properties to the construct while its 
pore walls will be coated with hyaluronic acid that is meant to provide the surface to 
which cells adhere with the biological cues required for a correct cell differentiation 
and tissue integration. 
In vitro construct development was divided in four steps: (I) The first step is the 
production of PCL+HA scaffolds series, their characterization and validation, then 
the study of culture conditions of mesenchymal stem cells inside the scaffold to 
enhance chondrogenic differentiation, including (II) the characterization of hypoxia 
as culture condition, (III) the characterization of mechanical stimulation to improve 
hypoxic effect and (IV) the characterization of co-culture of mesenchymal stem cells 
with mature chondrocytes. Physical properties of the cell-material construct after in 
vitro culture were measured (mechanical behaviour, morphology, composition).  
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4.2. Development of PCL+HA hybrid scaffolds: characterization and 
validation.  
The main objective was to obtain PCL scaffolds with a double micro and macro 
porosity as described above and an homogeneous hyaluronic acid coating of the pore 
walls. Morphology, physical and mechanical properties of these supports were 
characterized and biological response of the in vitro construct (cells and scaffold) for 
cartilage reparation was evaluated.  
PCL macroporous scaffolds were obtained by the combination of freeze extraction 
and porogen techniques as explained in materials and methods section 2.2.1.1. They 
are similar to those used in bone regeneration, with well connected macroporosity, 
macropores with spherical form and microporous pore walls.  
Composite PCL+HA scaffolds were prepared by coating the pore walls with a 
solution of hyaluronic acid which was cross-linked with different protocols (in one 
or two steps). Biologic characterization was performed using mature human 
chondrocytes under normoxia conditions. This work has been published in the 
Journal of Biomedical Materials Research: Part A entitled “Different hyaluronic acid 
morphology modulates primary articular chondrocyte behaviour in hyaluronic acid-
coated polycaprolactone scaffolds”[191].  
The effect of hyaluronic acid coating over human chondrocytes was studied 
measuring the cell proliferation and ECM deposition using immunofluorescent 
staining of collagen and aggrecan as well as biochemical quantitative determination 
of DNA and GAGs.  
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Table 4-1. Table with tested samples composition.  
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4.2.1. Scaffold and coating structure. 
As a result of the preparation process, scaffolds with high porosity (86.6% as 
determined by the weight increase when the pore structure is filled with 
ethanol[177]) and the desired double pore size distribution were obtained (figure 4-
1). The coating techniques described on section 2.2.1.4. succeeded in producing two 
different coating morphology. Hybrid scaffolds produced by one step coating 
PCL+HA1s were prepared by filling the pore structure of PCL scaffold with a 
hyaluronic acid 2% solution in NaOH 0.2 M mixed with DVS (molar ratio of 2:1) to 
fill the macropores with hyaluronic acid hydrogel. One step filling and crosslinking 
of the scaffold pores produces a hyaluronic acid gel phase that fills the macropores. 
When the swollen hydrogel is frozen and water sublimated in the Cryo-SEM a 
micropore structure is shown by this gel which is quite similar to that of the pore 
walls of PCL scaffold. The arrows in figure 4-1 B indicate the hyaluronic acid 
structure filling one of the macropores. Coating in two steps consisted in infiltrating 
1% hyaluronic acid solution and allowing it to dry. Dry coating was partially 
swollen in acetone/water (80/20) mixture at pH 12 and crosslinked with DVS to coat 
the scaffold surface with a hyaluronic acid film. In PCL+HA2s, hyaluronic acid only 
covers the pore walls, sometimes hiding the microporosity (white arrows in figure 
4-1 B) while leaving the macropore space empty. 
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Figure 4-1. Scanning electron microscopy picture of PCL scaffold (A) and 
Cryo-scanning electron microscopy (swollen samples) micrographs of 
PCL+HA1s and PCL+HA2s (B). Detail views of hyaluronic acid coated 
scaffolds in the upper right corner of each micrograph.   
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HA content was determined performing a TGA. Analysis showed that PCL+HA1s 
contained 4.6±2.3% and PCL+HA2s 5.8±2.8% hyaluronic acid by weight. The 
amount of hyaluronan is not significantly different depending on the coating 
procedures, and there is some variability in both groups due to the preparation 
process. As can be seen in table 4-2, hyaluronic acid coating leads to an increased 
equilibrium water content, with a water uptake (measured on a dry basis) of nearly 
3.5 (3.5 grams of absorbed water per gram of dry polymer) for both samples 
regardless of the coating type (3.57±0.36 for PCL+HA1s and 3.38±0.14 for 
PCL+HA2s, but the difference is not statistically significant).  
 
4.2.2. Compression properties  
As seen on table 4-2, compressive elastic modulus of the samples is not 
significantly influenced by the modification with hyaluronic acid, although 
PCL+HA1s have higher mean stiffness, probably due to the filling of the pores. The 
only significant difference appears between wet PCL+HA1s and wet PCL+HA2s. In 
general all wet samples have lower mean modulus. 
 
Table 4-2. Total porosity of hybrid scaffolds series, Hyaluronic acid content 
analysis of hybrid scaffolds series and mechanical analysis of scaffolds. 
Significance (p<0.05) between samples is signalled as (*). 
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4.2.3. Cell morphology and behaviour 
Samples for cell culture were cut to 6 mm in diameter and 3 mm height. Human 
chondrocytes were seeded at 400000 cells/scaffold with standard culture media and 
cultured 21 days in normoxia. 
As can be seen on figure 4-2, cell number is generally seen to increase with culture 
time; lower cell numbers are observed in PCL+HA hybrids at 7 and 14 days than in 
uncoated PCL scaffolds. In case of PCL+HA2s, some cells appear shrunk and may 
be suffering apoptosis (See figure 4-2 at 7 days). The cells generally showed a 
fibroblastic shape with elongated cytoskeleton and filopodia, characteristic of 
dedifferentiated chondrocytes[192]. Only in a few occasions (see for example 
picture for PCL+HA1s at 14 days), rounded chondrocytes were found within the 
structure, mostly in PCL+HA1s and occasionally in PCL and PCL+HA2s samples.  
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Figure 4-2. SEM images of PCL, PCL+HA1s and PCL+HA2s scaffolds seeded 
with human chondrocytes cells after 7, 14, and 21 days of culture. 
(magnification/scale bar = X1000/60μm). 
 
In figure 4-3 and figure 4-4, light microscopy pictures of the construct slices 
(100µm) have been combined with the immunofluorescent pictures from confocal 
laser scanning microscope to permit the simultaneous visualization of the cells and 
the construct structure. Scaffold material appears as black, pore space as gray; in 
PCL+HA1s samples, the hyaluronic acid phase appears as translucid fibres that 
cross the pore space. In figure 4-3A constructs are marked for collagen type I and II, 
in figure 4-3B for aggrecan and actin cytoskeleton and in figure 4-4 for CD44. Cell 
distribution is different depending on the material type. Whereas in bare PCL cells 
are very homogenously distributed, in PCL+HA1s (and to a less extent in 
PCL+HA2s) cells tend to form aggregates. In general, in hyaluronic acid containing 
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samples, cells tend to grow in three dimensions, whereas in bare PCL scaffold, 
except in a few cases, cells are spread on the pore walls, and grow in volume only 
after locally reaching confluence. In PCL+HA1s, cell distribution varies from one 
sample region to another one, whereas in control samples and PCL+HA2s the 
behaviour is more homogenous.  
The presence of collagen type I and II can be visualized in all samples. For instance, 
in bare PCL collagen type I and II are localized in the same parts of the construct 
and appear mostly intracellularly (figure 4-3A). In HA-coated samples there are 
domains with predominance of either one collagen type or the other, localized in 
different parts; in general, collagen type II is predominant in the areas of high cell 
density and cell aggregates, whereas collagen type I is predominant in the cells that 
are directly spread on the pore walls (figure 4-3A). The only exception to this 
behaviour is seen in PCL+HA2s at 21 days, where collagen type I and II appear in a 
homogenous manner within the pore space. Most collagen is intracellular, except for 
PCL+HA1s where some collagen deposition outside the cell is observed. Developed 
actin cytoskeleton is seen for an overwhelming majority of cells in PCL and 
PCL+HA2s construct; cells are generally spread on the pore surface or crossing the 
pore space; in contrast, in PCL+HA1s, nearby the spread cells on pore walls (likely 
where there was no or little HA), one can observe that in the cell clusters some cells 
lack the actin stress fibres network and their presence is only revealed by DAPI 
nucleus staining (see for example the two cells at the center of the picture at day 
7).As can be seen in figure 4-3B, there is nearly no presence of aggrecan in the PCL 
construct. Aggrecan is most marked in PCL+HA1s samples, consistently with the 
data from quantitative GAGs analysis; in these samples, it appears mainly in the cell 
aggregates although not every cell cluster is marked for GAGs as can be seen for 
day 14 (right side of the picture). Here again, only in these samples aggrecan is 
found extracellularly, while in PCL+HA2s, it is mostly stained within the cell bodies 
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or close to the nucleus. In some cases, the repartition of the aggrecan as a sphere 
surrounding the cell is proper of a neoformed pericellular matrix (same cells as 
mentioned before, day 7). In the case of the clusters unfortunately the cell density 
leads to a very high signal intensity, making interpretation difficult. As can be seen 
on figure 4-4, staining for CD44 has very low intensity in PCL samples after 21 
days, with many cells showing very little expression or no expression of CD44. On 
the other hand, there is staining for CD44 in PCL+HA1s and PCL+HA2s samples in 
most cells of the constructs. This shows a higher CD44 expression in cells that were 
cultured in the presence of hyaluronic acid. 
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Figure 4-3. Composition of light microscopy and immunofluorescent staining 
for collagen type I (green) and II (red) and nuclei (blue) (A) and 
immunofluorescent staining for aggrecan (red) and actin (green) and nuclei 
(blue) (B) (magnification/scale bar= X40/100μm). The black areas of the 
pictures correspond to the scaffold. 
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Figure 4-4. Composition of light microscopy and immunofluorescent staining 
for CD44 receptors (green) and nuclei (blue). The black areas of the pictures 
correspond to the scaffold. (magnification/scale bar= X40/100 μm). 
 
4.2.4. Quantitative biochemical assays 
Total DNA was always higher in bare PCL samples than in hyaluronic acid 
modified samples regardless of the modification type (figure 4-5). To simplify the 
presentation of results, significant differences are only pointed out between different 
materials at the same time or between day 21 and day 7. Cell seeding efficiency was 
determined comparing the theoretical number of seeded cells with the number of 
cells attached to the scaffold 3h after seeding. Cell number was calculated 
measuring total DNA and dividing the result by 11.2pg DNA/cell that is the 
theoretical DNA content by human chondrocyte[193]. Values obtained varied highly 
from one material to other, showing PCL+HA1s the worst value. In the case of PCL 
and PCL+HA1s, cell number grows with time, whereas in PCL+HA2s at 14 days 
there is a decrease in cell number and then cell number increases again at day 21 and 
becomes higher than in PCL+HA1s. All samples can be described as biocompatible 
and supporting cell adhesion and cell growth; no cytotoxicity due to DVS is 
observed. The proliferation ratio between day 21 and day 7 is the highest for 
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PCL+HA2s (2.4±0.5), followed by PCL+HA1s (1.9±1.7) (increase in cell number is 
not significant due to high dispersion); the minor ratio is observed for PCL 
(1.7±0.6). 
 
Figure 4-5. Total DNA of chondrocytes cell seeded in PCL, PCL+HA1s and 
PCL+HA2s. Results are averaged from n=3 experiments. Error bars represent 
standard deviation. Significance (p<0.05) compared to same group at day 7 is 
signalled as (*) and (P) for cultured samples compared to PCL samples at same 
time. 
 
Sulfated glycosaminoglycan content in the constructs is presented in figure 4-6. To 
simplify the presentation of results, significant differences are only noticed between 
different materials at the same time or between day 21 and day 7. As can be seen, 
GAGs absolute content is higher in PCL control samples than in other samples, 
(statistically significant at day 14 with p < 0.05). Significant differences are found 
between day 21 and day 7 for both PCL and PCL+HA2s samples (p < 0.05). Based 
on the observation that GAGs content follows roughly the tendency of DNA content 
in the samples, it was decided to compare the ratio of GAGs to DNA as a 
qualification of the glycosaminoglycans production per cell. Results are shown in 
figure 4-6. As can be seen, at all times the glycosaminoglycan production per cell is 
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significantly higher (p < 0.05) in PCL+HA1s than in bare PCL; GAGs content 
normalized to cell number is not statistically different at day 21 when compared to 
day 7 in none of the samples, although an increasing trend is seen in PCL+HA1s and 
decreasing trend in other samples. PCL+HA2s shows a similar trend to PCL, with 
no significant difference unless at day 14 where the GAGs content is significantly 
lower than in PCL. At day 21 the most glycosaminoglycans per cell is found in 
PCL+HA 1step samples, with significant differences regarding PCL and PCL+HA2s 
(p < 0.05); this difference is not due to decreasing cell number in PCL+HA1s 
sample, as mean DNA content in PCL+HA1s samples increases with time as seen in 
figure 4-5. 
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Figure 4-6. Total glycosaminoglycans (GAGs) (A) and glycosaminoglycans 
normalized to total DNA of chondrocytes at day 7, 14 and 21 in PCL, 
PCL+HA1s and PCL+HA2s. Results are averaged from n=3 experiments. 
Error bars represent standard deviation. Significance (p<0.05) compared to 
similar group is signalled as: (P) PCL, (1) PCL+HA1s and (2) PCL+HA2s 
samples for each group at the same time and compared to same sample group 
at day 7 is signalled is (*). 
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4.2.5. Discussion 
In this section we tested the hypothesis that modifying PCL scaffolds with 
hyaluronan could improve cell redifferentiation and verify if this technique was 
effective to develop an in vitro construct for cartilage tissue engineering. The effect 
of hyaluronic acid on chondrocyte behaviour was tested in unfavorable conditions 
where dedifferentiation is likely to occur due to the use of FBS[188](which is 
employed to favour cell adhesion due to protein adsorption and to boost cell growth 
due to the presence of growth factors)[194]
 
and to the low cell densities used due to 
the use of human primary cell line. 
As described in the results section above, although both HA-modified samples 
contains similar amounts of HA, the incorporated hyaluronic acid shows a different 
microstructure depending on the methodology used, with homogenous crosslinking 
leading to a gel phase that fills the pores, whereas crosslinking of hyaluronic acid in 
two steps (PCL HA2s) leads to a thin coating on the scaffolds’ pore walls. Both 
samples are more hydrophilic than bare PCL sample due to the presence of 
hyaluronic acid. When the hydrophobic PCL scaffold was immersed in liquid water, 
the swelling ratio was only around 1.4 (table 4-2) as high hydrophobicity and 
surface tension impedes water penetration inside the scaffold, which can be a 
drawback when implanted in vivo. Hyaluronic acid coating improves wettability and 
allows water penetration inside the pore structure, regardless of the coating strategy 
used. Nevertheless, as seen by Cryo-scanning electron microscopy, 
microenvironment inside the hydrated scaffold is different, with presence of a gel 
phase in PCL+HA1s but a thin coating on the pore walls in PCL+HA2s. Lower 
swelling degree was observed in thin films made using the same two-step procedure 
(table 4-2) what explains that the hyaluronic acid coating in PCL+HA2s does not 
fill the pores when swollen. 
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Mechanical properties of the scaffolds tested were similar. There were initially some 
concerns about the effect of treatment because of the usage of sodium hydroxide 
(which can cause a cleavage of the ester bonds). As can be seen in table 4-2, there is 
no statistically significant difference in the moduli neither in dry nor in wet state; the 
effect of the treatment on PCL scaffolds mechanical properties is minimal and 
should not compromise the further use of the scaffold as a chondral implant. In the 
wet state, modulus decreases as described by other groups even when testing 
polycaprolactone based materials.[195, 196] Despite the high hydrophobicity, water 
diffusion inside the amorphous and crystalline part of PCL is very fast,[197] and 
may lower stiffness by decreasing interchain and intrachain interaction due to 
electrostatic interaction between water dipoles and carbonyl groups of PCL. 
The elastic compressive moduli shown are in the range of moduli described for 
human articular cartilage by Athanasiou et al. [198] (0.5–1.82 MPa) although other 
groups have obtained higher values of 8–13.5 MPa[199] depending on the joint 
observed, when measuring with higher loading rate, described as ‘‘instantaneous 
modulus’’. In a previous work, our group implanted macroporous PCL scaffolds 
(with similar elastic modulus) in a rabbit knee model[48]; after 3 months, scaffolds 
seeded with allogenic chondrocytes were invaded by neoformed tissue; indentation 
measurements showed that the elastic modulus of the tissue–scaffold construct was 
the same than that of native cartilage controls (and significantly higher than pellet 
control). The values of the moduli measured here are similar those in that study and 
should grant adequate mechanical properties in vivo if the pore structure is 
successfully invaded by tissue. Higher initial modulus could be easily reached by 
varying the PCL content in the solution during the scaffold preparation (equilibrium 
modulus up to 4–5 MPa). Sample stiffness is an important factor in articular 
cartilage tissue engineering as articular cartilage is subjected to high dynamic 
compression loading in vivo. It has been shown that cartilage cells change their 
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secretion profile[102] when exposed to an excessive load: catabolic activity 
becomes faster than anabolic activity, which provokes a loss of proteoglycans,[103] 
matrix degradation and consequently a further decrease in mechanical properties. 
This usually leads to a repair tissue with inferior biochemical and biomechanical 
properties.[53] Matching rigidity of cartilage tissue using only a hydrogel is very 
difficult, and moreover the high chain density and network crosslinking necessary to 
obtain such rigidities using hydrogels has been shown to inhibit extracellular matrix 
production.[104] This type of structure (particularly PCL+HA1s) is thus interesting, 
as the polyester scaffolding guarantees adequate macroscopic mechanical behaviour, 
yielding a rigidity similar to cartilage while the microenvironment as sensed by the 
cells is a kind of diluted jelly, thus favouring cell migration, ECM production and 
diffusion. 
Cells adhered to the material and proliferated in all three-dimensional supports. 
Seeding efficiency was lower in PCL+HA1s, what could be related to the presence 
of the gel phase inside the pores as seen in figure 4-1. This explains also the low 
densities found at day 7 in confocal microscopy; heterogeneous cell distribution may 
be due to limited diffusion throughout the gel. Hyaluronic acid may also be 
responsible for the reduced initial adhesion and seeding efficiency due to its 
hydrophilic character that does not permit non-specific adsorption of proteins.[64] 
As shown in the confocal microscopy images, the first and obvious differences in 
chondrocyte behaviour is the cell arrangement within the scaffold. Whereas in PCL 
scaffolds the cells tend to grow spread over the pore walls, in presence of hyaluronic 
acid cells are seen filling the pore space. Cell distribution in PCL–HA2s is quite 
uniform while in the case of PCL–HA1s it is less homogeneous appearing some cell 
clustering. It has been described in the literature that scaffolding materials, although 
presenting a 3D structure, do not necessarily encourage 3D growth in vitro, and that 
the behaviour of the cells seeded into macroporous scaffolds may be very similar to 
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that of 2D cultures if at the cell’s scale, the pore wall appears as a flat surface.[200] 
This fact has motivated the use of a cell carrier together with the scaffolds,[201] or 
secondary gel phases inside the pores,[202] to get a three-dimensional tissue growth 
as occurs in vivo mainly due to the formation of a fibrin clot inside the implant. Here 
it appears that the modification of PCL with a hydrogel, in this case HA, can change 
this behaviour, although it is not clear why. Lower modulus of hyaluronic acid may 
allow for greater mobility of cells; it is known that in materials with rigidity 
gradients, cells tend to accumulate on the stiffer parts,[203] and that focal adhesions 
are strengthened by the increased rigidity.[204] As a matter of fact, formation of 
marked stress fibres in the actin cytoskeleton, which is associated with 
dedifferentiated phenotype,[188,192] is more prominent in PCL control than in other 
samples. This difference in growth mode may account for some of the effects 
observed in the immunofluorescent marking for collagen type I, II and aggrecan. 
Another clue feature may be the activation of intracellular pathways due to the 
binding of cells to hyaluronic acid through CD44; in fact CD44 expression at the 
end of culture time is higher in samples that contain HA, regardless of the structure 
of hyaluronic acid in the samples (figure 4-4). High levels of CD44 expression have 
been described as a clue for increased chondrogenic capacity in chondrocytes 
subpopulations and high expression of CD44 and integrin α3 was associated with 
more glycosaminoglycans production per cell and more mRNA of collagen type 
II.[205]  
The formation of a pericellular matrix like surrounding the cells composed by 
aggrecan was observed occasionally in PCL+HA1s samples and may be triggered by 
the interaction of hyaluronic acid with CD44 and to the better retention of small 
proteoglycans due to constructive interaction with exogenous hyaluronic acid at 
specific binding sites.[206] Both in PCL+HA1s and PCL+HA2s, molecular weights 
between crosslinks are far higher than the number of hyaluronic acid saccharides 
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necessary for CD44 binding (observed already with hexasaccharides).[207] 
Nevertheless intracellular cascades that depend on CD44 may react in a different 
way upon binding; for instance clustering of CD44 with other membrane 
components may be hampered if CD 44 receptor is anchored to hyaluronic acid 
chain with very low mobility and high stiffness, as may be the case in PCL+HA2s. 
This may explain why scarce quantitative differences are observed between 
PCL+HA2s samples and PCL controls despite the qualitative differences observed 
by immunofluorescent staining. Another mechanism implied in the different 
response in PCL+HA1s and PCL+HA2s could be the influence of molecular 
crowding and of hyaluronic acid chain mobility on the ECM synthesis.[208] It is 
also likely that albeit due to restricted diffusion through the gel phase or due to an 
enhancement in the specific interaction between aggrecan and hyaluronic acid 
binding sites due to chain mobility glycosaminoglycans retention inside the 
construct is easier in PCL+HA1s. Higher normalized GAGs content could be due to 
better retention or to higher synthesis of GAGs; combination of quantitative analysis 
of gene expression and analysis of GAGs secreted in the medium will be necessary 
to clarify this point. 
 
4.2.6 Conclusions 
Primary articular chondrocytes were cultured in dedifferentiating conditions and the 
effect of two types of hyaluronic acid coating on cell proliferation, cell morphology, 
GAGs synthesis, ECM and cell markers was studied. Cells in PCL controls show 
signs of dedifferentiation such as reduced biosynthetic capacity, low staining for 
collagen type II and aggrecan and increased staining for collagen type I. In control 
samples the cells grow stuck on the pores walls, cells show a fibroblastic shape, and 
their behaviour can be assimilated to 2D behaviour. In samples modified with HA, 
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cell distribution is more heterogeneous and different cell sub-populations are found 
in the construct, with the formation of cell clusters that depending on localization or 
cell organization show either positive markers for collagen type I or collagen type II 
and aggrecan. In some zones the behaviour is similar to that observed in PCL 
control (cells spread on pore wall), while in other zones formation of cell clusters 
and three dimensional growth is observed; in these zones there is more presence of 
cartilage specific ECM like collagen type II and aggrecan. In both HA containing 
samples, markers for CD44 are detected on most cells whereas in pure PCL samples 
there is hardly any presence of CD44. ECM production per cell is higher in PCL-
HA1s than in both PCL and PCL-HA2s samples. 
All the mentioned results point towards a better phenotypic conservation in PCL-HA 
samples, with promising results when using PCL-HA1s. Enhanced hydrophilicity of 
the constructs and increased CD44 expression of chondrocytes in presence of HA 
shows that the strategy followed could be useful for cartilage tissue engineering in a 
cell-free approach if the increased hydrophilicity favours cell invasion and the 
presence of HA permits to home CD44 positive cells, which will be the subject of 
future works.  
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4.3. Characterization of hypoxia as culture condition to develop an in vitro 
construct.  
Autologous cell implantation requires a huge number of cells, and bone marrow 
mesenchymal stem cells is generally considered as a suitable source.[53, 112] 
Nevertheless, as commented in the introduction, the technology for successful MSC-
based cartilage tissue engineering is still lacking. The objective of this part of the 
work and the following sections was to test the influence of different culture 
conditions on chondrogenic differentiation of MSC cultured within the pores of our 
PCL+HA scaffolds. The results obtained in these scaffolds will be compared with 
those of pure PCL scaffolds and scaffolds made of a composite of PCL with 5% by 
weight of bioactive glass nanoparticles (PCL-5BG). This task was developed on 
Trinity Centre for Bioengineering (TCBE) under the supervision of Dr. Daniel J. 
Kelly and Dr. Yurong Liu. Present section is focused on the use of hypoxia during 
culture of mesenchymal stem cells in chondrogenic medium. The quality of the 
tissue produced by the cells in vitro was evaluated by testing its mechanical 
properties and measuring cell and extracellular matrix levels and distribution. 
Hyaluronic acid coating protocol selected was the one step but in order to improve 
cell seeding efficiency it was slightly modified, these samples will be called 
hereafter PCL+HA1s-m. The modified protocol sought to produce a thin layer of 
hyaluronic acid on the pore walls leaving more free space in the macropore during 
cell seeding than in PCL+HA1s samples. Protocol modification, described in the 
materials and methods section, was to dry the sample along the crosslink reaction to 
produce a hyaluronic acid coating with less swelling capacity when cell suspension 
is injected into the scaffold. On the other hand Bioglass
®
 was introduced into PCL 
scaffolds to increase the scaffold hydrophilicity improving cell invasion and cell 
seeding efficiency. In vitro construct characterization was performed with porcine 
bone marrow mesenchymal stem cells under hypoxia conditions. 
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Table 4-3. Table with tested samples.  
 
Scaffolds of 5mm diameter and 3 mm height were seeded with porcine MSC at 
500000 cells/scaffold and cultured with chondrogenic media under hypoxia 
conditions (5% CO2 - 5% O2) for 35 days. Control PCL, PCL+HA1s-m and PCL-
5BG samples were cultured under normoxia conditions (5% CO2 - 20% O2) for 35 
days. 
 
Table 4-4. Table with cultured samples ID for present section, tested samples 
and scaffold culture conditions. 
 
The influence of scaffold over cell response to hypoxia was performed evaluating 
the ECM using histological stain and immunostains to determine ECM distribution 
as well biochemical and mechanical evaluation of ECM.  
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4.3.1. Mechanical properties 
Equilibrium elastic modulus (measured in a stress-strain compression ramp) and 
dynamic mechanical modulus (measured under dynamic compression loading) are 
depicted in figure 4-7. Contribution of the growing tissue over dynamic modulus 
increases with culture time in both conditions for all the materials. For PCL (NO and 
HY) and BG (NO and HY), increment was scarce in the first two weeks and 
increased between day 17 and day 35, while in HA (NO and HY) samples the 
increase was steady over the whole culture time. Oxygen tension in the culture did 
not have any significant effect over the mechanical properties in none of the 
samples. No significant trend was observed in the values of the equilibrium 
modulus, presented in figure 4-7. 
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Figure 4-7: Mechanical results. Equilibrium modulus (A) and dynamic 
modulus (B) at day 1, 17 and 35 under normoxia (NO) and hypoxia (HY). 
Results are averaged from n=4 experiments. Error bars represent standard 
deviation. Significance (p<0.05) compared to similar group for normalized 
scaffolds is signalled as: (P) PCL, (B) BG and (H) HA samples for each group 
at the same time and culture condition.  
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4.3.2. Cell behaviour and differentiation 
The evolution of DNA content in the constructs is shown in figure 4-8. Initial cell 
number at day 1 (a standard curve of mesenchymal stem cells numbers vs. DNA 
content was determined for this purpose) showed that seeding efficiency in BG 
(79.63 ± 12.26) and PCL (78.27% ± 8.02) scaffolds were similar, whereas seeding 
efficiency in HA (48.75% ± 11.71) constructs was lower. In all constructs cells 
proliferated up to day 17, showing that materials support mid-term survival of 
mesenchymal cells. Proliferation was slower in hypoxic conditions than in normoxic 
ones up to day 17, except for HA NO and HA HY samples, where proliferation was 
equal in both conditions. From day 17 to day 35, DNA content remained nearly 
constant for all samples in hypoxic conditions and for PCL NO. However, there was 
a strong decrease in DNA content in BG NO and HA NO samples during the same 
time. 
MSC chondrogenic differentiation was studied by assessing the production of ECM 
components, such as glycosaminoglycans and collagen, by the cells. 
Glycosaminoglycans content normalized to total DNA is shown in figure 4-9. 
Glycosaminoglycans secretion increased with time for all samples. In normoxic 
conditions, glycosaminoglycans secretion was limited; hypoxia led to significant 
enhancement for most conditions (PCL HY at all times, HA HY at 35 days and BG 
HY at 17 days). Glycosaminoglycans secretion per cell was comparable for hypoxic 
cultures in all materials. In normoxic conditions, GAGs secretion remained low 
(increase seen in BG NO sample is mainly because the decrement in DNA levels at 
35 days). Results for collagen secretion are shown in figure 4-9. collagen secretion 
per cell also increased over time, being superior at day 35 for all samples. At day 17, 
both HA (NO and HY) and BG (NO and HY) scaffolds showed inferior collagen 
secretion than PCL scaffolds both in normoxic and hypoxic conditions, whereas at 
day 35 only HA (NO and HY) showed inferior collagen level. Hypoxia did not show 
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a positive effect on collagen content per cell. The only two conditions where there 
was a significant difference was for PCL HY and BG HY at day 17, where normoxic 
samples showed increased collagen content with respect to the hypoxic ones. 
 
 
Figure 4-8. Total DNA of porcine mesenchymal stem cells after seeding at day 
1, 17 and 35 in scaffolds under normoxia (NO) and hypoxia (HY). Results are 
averaged from n=4 experiments. Error bars represent standard deviation. 
Significance (p<0.05) compared to similar group for normalized scaffolds is 
signalled as: (P) PCL, (B) BG and (H) HA samples for each group at the same 
time and culture condition and (#) statically cultured sample from the same 
type at the same time. 
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Figure 4-9. Glycosaminoglycans (GAGs) (A) and collagen (B) levels normalized 
to total DNA at day 17 and 35 under normoxia (NO) and hypoxia (HY). Results 
are averaged from n=4 experiments. Error bars represent standard deviation. 
Significance (p<0.05) compared to similar group for normalized scaffolds is 
signalled as: (P) PCL, (B) BG and (H) HA samples for each group at the same 
time and culture condition and (#) statically cultured sample from the same 
type at the same time. 
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A qualitative observation of extracellular matrix secretion at 35 days is provided in 
figure 4-10, figure 4-11 and figure 4-12. Accumulation of glycosaminoglycans 
over culture time is shown in figure 4-10. In normoxic conditions, staining of 
mucopolysaccharides (shown in blue in figure 4-10) is limited, with a smooth blue 
staining filling the pores (PCL NO and BG NO) whereas in HA NO sample the 
secretion was limited to isolated cell clusters. In hypoxic conditions, in all materials 
there were significant amounts of matrix filling the scaffolds pores and in some 
zones of intense blue color, cells were embedded in lacunae within a 
glycosaminoglycans-rich matrix. Collagen deposition shown in red in figure 4-11; 
consistent with the findings of the biochemical analysis, collagen deposition is 
higher in PCL and BG samples, while in HA samples less intense stain is observed. 
Stained parts show either a rough and fibrous texture (such as in BG (NO and HY) 
samples or PCL NO sample) or a non textured pink background such as in PCL HY 
and HA HY samples. 
Secretion of cartilage specific collagen was assessed using immunochemical stain 
against collagen type I (figure 4-12) and collagen type II (figure 4-12). In all 
samples both types of collagen are present; hypoxic culture mode leads to a 
reduction in collagen type I specific staining, whereas collagen type II staining was 
slightly more pronounced. In HA NO sample there was not much matrix stain either 
of collagen type I or collagen type II, but in HA HY sample there was a pronounced 
staining for collagen type II. 
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Figure 4-10. Alcian Blue staining for glycosaminoglycans at day 17 and 35 
under normoxia (NO) and hypoxia (HY). Glycosaminoglycans appear in blue 
and cells in pink. (magnification/scale bar = X1.25/1mm and X10/100 μm).  
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Figure 4-11. Picro-Sirius Red staining for collagen at day 17 and 35 under 
normoxia (NO) and hypoxia (HY). Collagen appears in red and cells in purple. 
(magnification/scale bar = X1.25/1mm and X10/100 μm). 
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Figure 4-12: Microscopic views of anti- collagen type I (A) and anti-collagen 
type II (B) immunohistochemical staining of scaffolds cultured with 
mesenchymal stem cells at day 35 under normoxia (NO) and hypoxia (HY). 
Scaffold appears gray and collagen is brown. (magnification/Scale bar = 
X10/100μm).  
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4.3.3. Discussion 
The hypothesis of this study was that hypoxia improves viability and 
chondrogenesis in in vitro culture in our scaffolds. Cartilage is constitutively 
hypoxic with oxygen levels between 1% to 7% depending on the depth inside the 
tissue[120]. Hypoxia has been seen to regulate chondrogenic induction of MSCs, 
partly through the activation of hypoxia inducible factors, mainly HIF-1α which 
accumulates inside the nucleus in hypoxic conditions and modulates DNA binding 
affinity of various gene promoters[209]. Not only  OX9 promoter’s affinity for 
DNA is upregulated by HIF-1α, but also Cbfa/RUNX2 promoter affinity for DNA is 
downregulated in presence of HIF-1α, and the balance between  OX9 and RUNX2 
has been shown to be critical in the switch between adult mature chondrocytes and 
hypertrophic chondrocytes[123]. Hypoxia may thus be an easy way to avoid 
terminal differentiation, as well as to improve the quality of the formed tissue; 
several enzymes implicated in matrix synthesis, including hydroxylases, are more 
stable in hypoxic conditions, contributing to enhance ECM quality[124,209]. 
In our work, agarose mould was used to improve cell seeding and in fact it was 
successful, obtaining a cell seeding efficiency higher than 50%. On the other hand. 
normoxic culture of chondroinduced MSCs during up to 35 days in synthetic 
scaffolds resulted in a decrease in DNA content in both HA NO and BG NO groups 
with respect to 17 days, whereas a slight decrease was seen in PCL NO group. 
Chondrogenic differentiation that follows into a terminal differentiation provokes 
apoptosis in MSCs[210], and hypoxia has been shown to inhibit apoptosis of 
chondrocytes and chondroinduced MSCs via both the HIF-1α and the PI3K/Akt 
pathway[211]. This could explain why hypoxia was necessary in order to maintain 
constant DNA content over a large culture period when cultivating MSCs along the 
chondrogenic pathway in our materials. Supplementing with TGF3, in our model, 
was not sufficient to maintain cell viability in high oxygen conditions over a large 
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period. 
Hypoxia increased glycosaminoglycans/cell synthesis in PCL HY and HA HY 
materials, whereas no significant difference was seen in BG HY materials. 
Consistent with findings from the literature, total collagen content per cell in 
normoxic culture in PCL NO and BG HY was higher at 17 days than in their 
hypoxic counterparts, whereas in all other conditions no significant differences 
between normoxia and hypoxia were found. 
Due to the lack of a general theoretical framework about the mechanisms of ECM 
deposition enhancement in hypoxic conditions and to the variety of the experimental 
setups (levels of oxygen employed:1, 2, 4, 5, 10%; timing of hypoxia; culture mode: 
scaffold, pellet/ aggregate, hydrogel; cell source: bone marrow, adult chondrocyte, 
synovium derived stem cells, infrapatellar fat stem cell) findings from literature 
often look contradictory and fuzzy. These findings can mean that the cells under 
hypoxia regulate the secretory profile from a non-specific one to a more hyaline 
cartilage profile. It has been reported that in hyaline cartilage the content of collagen 
is 15% and that of proteoglycans 9% percent of total cartilage wet weight[6] , thus 
the ratio collagen/proteoglycans is 1.67. In the present study we found that PCL NO 
and HA NO showed aberrant ratios of 6 while the ratio was 3 in BG NO. On the 
other hand in the same sample compositions (bare PCL, Bioglass
®
 composite and 
PCL coated with hyaluronic acid) under hypoxia a ratio around 1.5 was determined. 
Our results suggest that ECM evaluation in base to increments or decrements of 
biochemical components levels is not enough. Collagen/proteoglycans ratio provides 
direct measurement about tissue quality. In our work hypoxia showed a powerful 
positive effect over cell differentiation more important than cell substrate. On the 
other hand Bioglass® composite showed a surprisingly positive effect over 
collagen/proteoglycans pointing that bioactive glasses can have a positive use on 
cartilage tissue engineering but need further studies to check if differentiation leads 
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to hypertrophic cartilage. 
Increased GAGs synthesis as a result of hypoxic culture was observed in 
many[212,213] but not all published works [214,215] in literature. Increased 
collagen secretion by cells is not a common finding (in some cases even inferior 
values are found in hypoxic conditions[124]) although more specific staining for 
collagen type II and less staining for collagen type I is generally described [213]. In 
our work, both collagen type I and collagen type II were observed, although 
collagen type I deposition was limited and collagen type II increased under hypoxia; 
culture of the cells on a rigid substrate that appears as two-dimensional for cells due 
to the pore size may be related to the presence of collagen type I, which is very 
limited in hydrogel cultures [213]. One reason for this may be the regulation of cell 
fate through cell cytoskeleton and cytoskeletal tension. Whereas hydrogel culture 
promotes cell rounding and limits cytoskeletal pre-stress due to the presence of actin 
in a cortical form, adhesion to rigid materials and spreading is associated with 
developed actin fibres and cytoskeletal tension, which is known to favour the 
production of fibrous tissue[216]. This is concordant with the observation of marked 
fibrous texture observed in picrosirius stain in normoxic cultures. Interestingly, a 
great qualitative difference was observed under hypoxia, where a diffuse staining 
was observed whereas cells appeared more prone to cluster formation. Around these 
clusters that seem to mimic the condensation stage, glycosaminoglycans deposition 
was increased. Hyaline cartilage ECM is mainly formed of glycosaminoglycans, 
which provide compression resistance through osmotic retention of water in their 
negatively charged chains, and fibrillar collagen type II, which provides tensile 
resistance. Promotion of GAGs secretion through hypoxia promotes the balance 
between collagen and glycosaminoglycans content in the formed tissue, leading to a 
cartilage-like appearance of the formed tissue in all three materials. At the contrary, 
lack of glycosaminoglycans in the secreted ECM (which in our model is not 
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mimicked by the presence of an hydrogel phase, as when chondrocytes are cultured 
in alginate or agarose gels) leads to the formation of highly fibrous extracellular 
matrix that likely promotes excess cytoskeletal tension, which may lead to further 
phenotypic mismatch and production of collagen type I instead of collagen type II. 
Moreover, traditional models (hydrogel or pellet) enhance the retention of 
ECM[217]; in the case of pellet or aggregates, the dimension of the construct is 
determinant in restricting the diffusion of secreted macromolecules into the culture 
medium [218]. Despite of these pitfalls of our system with respect to in vitro culture 
(as they can be seen as positive for in vivo applications where the constraints are 
different), significant amounts of ECM were observed in all materials excepted HA 
NO. Hypoxia proved a more decisive influence than the material modification with 
respect to chondrogenesis, although hyaluronic acid modification in the present form 
did not show a positive response as expected. Modification with Bioglass
® 
seemed 
to lead to some increase in glycosaminoglycans production and collagen type II 
staining in normoxic conditions, (although total collagen per cell was significantly 
lower than PCL control at 17 days in both hypoxic and normoxic conditions) but had 
no significant effect in hypoxic conditions. Release of phosphate ions may have 
contributed to cell apoptosis in these samples,[219] explaining the decrease in DNA 
content observed between day 17 and 35. 
 
4.3.4. Conclusions 
Our data suggests that in our scaffolds TGFβ3 induced chondrogenesis but let’s to 
cell apoptosis in normoxic conditions as observed through the DNA values; thus, in 
our model, hypoxia conditions were necessary to maintain viability up to 35 days in 
culture. Additionally hypoxia regulated ECM synthesis. GAG/cell ratio was 
increased under hypoxic conditions in PCL and HA scaffolds. On the other hand the 
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collagen level was similar in normoxia and hypoxia conditions but staining for 
collagen type II was more prominent under hypoxia. Hypoxia induces a 
collagen/GAGs ratio closer to that of healthy cartilage the differences in this respect 
with normoxia culture conditions increases with culture time. An unexpected result 
was that BG reinforced scaffold showed the lower ratios in normoxia (2.7) 
compared to PCL and HA coated scaffold (6.4 and 5.7 respectively). Hypoxic 
conditions had more influence on biological response than substrate composition.
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4.4. Characterization of mechanical stimulation to improve hypoxia effect. 
The objective of this part of the work was to check if mechanical stimulation could 
improve the positive response obtained under hypoxic conditions. This task was 
developed in the Trinity Centre for Bioengineering (TCBE) and hydrostatic pressure 
was used as mechanical input to improve the previous results. The materials tested 
were PCL+HA1s-m, PCL-5BG and PCL. Samples were cultured in free swelling 
conditions up to 14 days before sealing the samples inside sterile plastic bags and 
starting to apply hydrostatic pressure during 3 weeks). Samples from the hydrostatic 
pressure group were placed inside the custom made bioreactor described in the 
materials and methods section while free swelling control samples were placed in an 
open water bath, both inside a 37ºC incubator. Porcine MSC were cultured with 
CDM+ media under hypoxia conditions (5% CO2 - 5% O2) for 35 days. This work 
has entitled “Compositional changes of synthetic biodegradable scaffolds modulate 
the influence of hydrostatic pressure on chondrogenesis of mesenchymal stem 
cells”[220] been recently submitted for publication. 
 
Table 4-5. Table with tested samples.  
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Scaffolds were seeded with porcine MSC at 500000 cells/scaffold and cultured with 
chondrogenic media under hypoxia conditions (5% CO2 - 5% O2) for 35 days 
sealed inside sterile plastic bags from day 14 to 35. 
 
Table 4-6. Table with cultured samples ID for present section, tested samples 
and scaffold culture conditions. 
 
The effect of substrate over MSC differentiation response to hydrostatic pressure 
was evaluated using a dynamic mechanical test to study the ECM contribution to 
construct mechanical properties as well biochemical and histological study was 
performed to evaluate the quality of obtained cell-scaffold construct. 
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4.4.1. Mechanical properties 
Equilibrium and dynamic modulus shown in figure 4-13 were normalized 
considering that scaffold and ingrowing tissue contribution to total modulus is 
additive, as in a parallel model (common strain, additive stress). The mechanical 
properties of polycaprolactone and polycaprolactone/hyaluronic acid scaffolds did 
not change significantly with time. In contrast, the equilibrium modulus of the PCL-
5BG scaffolds increased with time in culture. The dynamic modulus of both 
hyaluronic acid and BG scaffolds significantly increased with time. The application 
of cyclic hydrostatic pressure did not significantly affect the equilibrium or the 
dynamic modulus of any of the three mesenchymal stem cells seeded scaffolds. 
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Figure 4-13: Mechanical results. Equilibrium modulus (A) and dynamic 
modulus (B) of whole construct (soft grey) and normalized (subtracting the 
value of the corresponding acellular scaffolds) (dark grey), at day 1 and at day 
35 under free swelling (FS) and hydrostatic pressure (HP). Results are 
averaged from n=4 experiments. Significance (p<0.05) compared to similar 
group for normalized scaffolds is signalled as: (P) PCL, (B) BG and (H) HA 
samples for each group at the same time and culture condition; and (*) sample 
from the same type at day 1.   
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4.4.2. Cell behaviour and differentiation 
The total DNA content of the scaffolds at day 1 was used as a measure of the cell 
seeding efficiency of the scaffolds (figure 4-14). Cell seeding efficiency was 
calculated as in the previous section; in HA scaffolds (27.5% ± 15.66) it was 
significantly lower compared with PCL (63.56% ± 11.21) and BG (88.08% ± 24.43) 
scaffolds which were not significantly different to each other. DNA content 
increased with time for all three scaffold types, demonstrating that they supported 
mesenchymal stem cells proliferation (ratios of proliferation between 1.5 and 4). 
Proliferation was highest in the HA scaffolds, its values at 35 days were similar to 
BG and PCL samples. Hydrostatic pressure did not significantly affect mesenchymal 
stem cells proliferation within the scaffolds. 
On the other hand as seen from glycosaminoglycans and collagen levels normalized 
to total DNA at day 35 (figure 4-15), MSCs cultured inside PCL HP and BG HP 
scaffolds responded positively to the application of hydrostatic pressure, showing 
both significantly higher production of glycosaminoglycans and collagen than their 
respective free swelling control. In contrast, HA HP scaffolds loading had no 
significant effect on GAGs production, and moreover it had a significant and 
negative impact on normalized collagen levels. On the other hand collagen/GAG 
ratio results for all tested samples (in HP and FS conditions) was close to 1.67 the 
value reported for hyaline cartilage[6], but was more close in samples of HP group 
pointing that mechanical stimulation tends to approach slightly this ratio to in vivo 
data. 
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Figure 4-14. Total DNA of porcine mesenchymal stem cells after seeding at day 
1 and 35 in scaffolds under free swelling (FS) and hydrostatic pressure (HP). 
Results are averaged from n=4 experiments. Significance (p<0.05) compared to 
similar group for normalized scaffolds is signalled as: (P) PCL, (B) BG and (H) 
HA samples for each group at the same time and culture condition. 
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Figure 4-15. Glycosaminoglycans (GAGs) (A) and collagen (B) levels 
normalized to total DNA at day 35 under free swelling (FS) and hydrostatic 
pressure (HP) conditions in scaffolds. Results are averaged from n=4 
experiments. Significance (p<0.05) compared to similar group is signalled as: 
(P) PCL, (B) BG and (H) HA samples for each group at the same time and 
culture condition and (#) statically cultured sample from the same type at the 
same time.  
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The Picro-Sirius Red and Alcian Blue staining, figure 4-16, show the distribution of 
the cells and secreted extracellular matrix in the different mesenchymal stem cells 
seeded scaffolds after 35 days in culture. In all the samples, the polymer matrix 
appears grey, whereas the pore space appears with the background color (if void) or 
coloured if it contains cells or extracellular matrix.  
Collagen staining in all samples is more marked at the scaffold edge and around cell 
aggregates (figure 4-16 A). In free swelling conditions cells seem to aggregate into 
large clusters, mainly at or just under the surface of the scaffold. The pores of the 
PCL FS scaffolds appeared to be homogenously filled with a collagenous matrix. On 
the other hand in HA FS scaffolds, most of the collagen is deposited on the outside 
of the construct, whereas BG FS situation is intermediary, with most collagen on the 
surface but with some deposition within the bulk of the construct. Loading seems to 
improve the distribution of cells and the collagen repartition inside the samples. 
Mesenchymal stem cells cultured under hydrostatic pressure showed small cell 
aggregates distributed throughout the scaffold and similar collagen staining pattern 
filling the pores. Alcian blue staining (figure 4-16 B), which stains negatively 
charged proteoglycans and glycosaminoglycans, showed a different pattern. 
Generally staining for glycosaminoglycans was more prominent at the center of the 
samples whereas the edges were poorly stained. (In HA samples, scaffold colour 
changes from grey to blue-grey due to the staining of the pore walls by Alcian Blue; 
nevertheless, as hyaluronic acid is deposited as a very thin layer on the pore walls 
and inside the scaffold struts’ microporosity, staining within the pores is not due to 
the presence of HA). Relatively homogenous Alcian blue staining was observed 
within HA scaffolds, whereas PCL and BG showed more localized staining. 
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Figure 4-16: (A) Picro-Sirius Red staining for collagen and (B) Alcian Blue 
staining for glycosaminoglycans at day 35 under free swelling (FS) and 
hydrostatic pressure (HP). A: Collagen appears in red and cells in purple. B: 
glycosaminoglycans appear in blue and cells in pink. (magnification/scale bar = 
X1.25/1mm and X10/100 μm).  
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Modulation of cell differentiation through the interplay of scaffolding material and 
culture conditions was studied by examining collagen type I and II deposition using 
immunohistochemical staining. Immunochemical staining for collagen type I 
presented in figure 4-17 follows the staining pattern for picro-sirius red. The 
macroscopic distribution was quite homogenous, only in HA samples some areas 
without extracellular matrix were observed, mainly in the bottom part of the 
scaffold. The common pattern of all samples for collagen type I was a darker 
staining at the scaffold’s edge, either on top or bottom of the construct; moreover, 
there was heterogeneity at microscopic scale, with zones showing strong staining 
and zones with almost no stain inside the same pore. In the zones where staining was 
strong, a fibrillar collagen structure and organization of cells along the fibres were 
visible. Differences in the staining of collagen type I between adhesive materials 
(PCL FS and BG FS) and HA FS in free swelling conditions were observed. PCL FS 
and BG FS show a prominent collagen type I staining compared to HA FS samples 
that do not show the appearance of strong fibres as in the other samples. Loading 
conditions affect collagen type I staining profile, and this effect seems to be 
modulated by the material: whereas staining is more pronounced in free swelling 
condition for PCL HP and especially for BG HP in the three different zones 
observed, in the case of HA HP hydrostatic pressure did not show a dramatic effect 
on collagen type I deposition. The immunohistochemical staining for collagen type 
II, presented in figure 4-18 follows the staining pattern for glycosaminoglycans. The 
macroscopic distribution was not homogenous, with greater type II collagen 
deposition observed in the center of the scaffolds and the upper surface as seen in 
the Alcian blue staining. Fibrillar appearance of collagen type II was much less 
marked than in the case of collagen type I for all samples. In some samples, the 
typical structure of chondrocytes in their lacunae can be observed, for example in 
PCL HP in or in HA FS samples. Here again, the effect of hydrostatic pressure was 
not observable.  
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Figure 4-17: Microscopic views of anti- collagen type I immunohistochemical 
staining of scaffolds cultured with mesenchymal stem cells at day 35 under free 
swelling (FS) and hydrostatic pressure (HP). Scaffold appears gray and 
collagen is brown. (magnification/Scale bar = X10/100μm).  
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Figure 4-18: Microscopic views of anti- collagen type II immunohistochemical 
staining of scaffolds cultured with mesenchymal stem cells at day 35 under free 
swelling (FS) and hydrostatic pressure (HP. Scaffold appears gray and collagen 
is brown. (magnification/Scale bar = X10/100μm).  
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4.4.3. Discussion 
Initial hypothesis was that hydrostatic pressure enhances the effect of hypoxia on 
chondrogenesis but this effect could be substrate dependent. In order to verify the 
hypothesis that simple material modifications may lead to a modulation of cell 
response to culture conditions, in the present work PCL scaffolds modified with 
hyaluronan or Bioglass® were used to study chondrogenic differentiation of MSCs 
under hydrostatic pressure, which is known to be a potent chondrogenic 
stimulus[107, 132]. 
Mechanical reinforcement of the scaffolds due to matrix deposition has been 
described in other works. The high rigidity of void scaffolds (in comparison with the 
formed tissue) may mask the effect of ECM deposition within the scaffolds, what 
may explain why no significant increases in the mechanical properties of the 
construct were observed with the application of hydrostatic pressure despite clear 
increases in extracellular matrix deposition. Mechanical properties should increase 
with time because the scaffold’s pores are filled as a consequence of ECM 
deposition, increasing the resistance to fluid flow during mechanical tests due to the 
scaffold’s permeability reduction. Normalized equilibrium and dynamic moduli 
were in the order of magnitude of the modulus observed in cartilage superficial 
region from porcine femoral condyle[221]. 
Scaffolds show a macroporous interconnected structure that allow for easy cell 
seeding and proliferation. The high hydrophobicity of PCL scaffold can represent a 
drawback to cell penetration and even distribution inside the scaffold; hyaluronic 
acid and Bioglass
®
 were introduced inside the composites to lower the 
hydrophobicity. Bioglass
®
 introduction increases the cell seeding efficiency 
compared with PCL or HA samples. Bioactive glass particles inclusion in polymer 
scaffolds has been reported to modify the surface hydrophilicity and protein 
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adsorption.[76,77] These characteristics of the modified scaffolds can explain the 
increased cell adhesion in BG samples. On the other hand, HA samples showed a 
significantly lower cell seeding efficiency compared to BG and PCL samples as 
already observed in previous section despite the use of an agarose mould. Lower cell 
seeding efficiency is thought to be due to the lower protein absorption over the 
hydrogel.[95] Nevertheless the cell proliferation inside HA samples was two -fold 
higher than the others groups. This may be due to an increased TGF production 
induced by CD44 interaction to hyaluronic acid or the modulation of pathways 
through the adhesion to hyaluronic acid.[98] Cell distribution was heterogeneous in 
all samples, but gained homogeneity when hydrostatic pressure was applied. As 
hydrostatic pressure has been previously shown to modulate cell migration[222] it is 
likely responsible for the more homogenous distribution of both cells and 
extracellular matrix. As a matter of fact, under hydrostatic pressure, small cell 
aggregates grew inside the ECM while under free swelling conditions cells grew in 
bigger aggregates. Moreover cell growth was affected by the substrate used; whereas 
PCL and BG induced cell attachment to the pores wall, growth of cell aggregates 
was observed inside the pores of PCL+HA1s-m samples. 
These differences in cell distribution, growth and localization correlated with ECM 
histological staining. Hydrostatic pressure generally favoured a more marked 
extracellular matrix deposition and led to a more homogeneous staining, without the 
intense staining at the edges generally observed in the experiments performed in 
section 3.2. Hydrostatic pressure loading is known to increase the expression of 
proteoglycans and collagen:[133] in our study, cells’ extracellular matrix synthesis 
was significantly affected by the mechanical stimulation, validating hydrostatic 
pressure as a promising culture stimulus to develop cell constructs in vitro. 
Enhanced deposition of matrix was seen in histological cuts stained with either 
Picro-Sirius Red or Alcian Blue. Sustained deposition of collagen was observed 
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possibly due to the hypoxic conditions,[223] as previous experiments with long 
cultures of mesenchymal stem cells in normoxic conditions in such scaffolds 
showed poor results (see section 4.3.). Collagen type II presented the same staining 
pattern as glycosaminoglycans and appeared generally where there was less collagen 
type I. Most of this collagen type II appeared in the center of the scaffolds whereas 
collagen type I deposition was generally favoured on the surface. This may be 
related with further central hypoxia that mediates expression of HIF-1α and 
increases lysylhydroxylation of collagen type II.[224] 
On the other hand, most interestingly, the substrates modulated the cell response to 
hydrostatic pressure, whereas all substrates led to similar quantitative ECM 
synthesis levels under free swelling conditions; only the PCL HP and BG HP 
scaffolds showed a positive response to loading. In contrast hydrostatic pressure 
appeared to have little impact on ECM accumulation with HA HP scaffolds. This is 
likely related to the mechanism and strength of the cell adhesion to the different 
substrates. Whereas cells interact with BG and PCL scaffolds through adsorbed 
proteins and integrin signalling, in the case of HA samples protein adsorption is 
greatly reduced and interaction may occur through CD44 binding.[95,96] As 
observed in the results section, collagen type I deposition pattern was very different 
between adhesive (PCL and BG) and less adhesive (HA) samples. Strong fibres with 
intense stain, consistent with the application of significant cell contractility, were 
observed in PCL FS and BG FS samples, and lessened under hydrostatic pressure, 
whereas this was not observed to the same extent in hyaluronic acid samples. As 
force is applied by integrin binding, (in chondrocytes mechanical stress transmission 
and adhesion strength has been shown to be mainly due to β1 integrin[225,226]), one 
could infer that hyaluronic acid limits integrin binding while PCL and BG promote 
it. Cell matrix interactions through integrin binding has been shown to inhibit MSCs 
chondrogenesis,[106, 107] and whereas agarose gels (that promote cell rounding) 
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were able to support chondrogenesis, fibrin gels (that induce cell spreading) showed 
less glycosaminoglycans expression.[107] On the other hand, in the same study, 
only fibrin gels showed a positive response to hydrostatic pressure whereas agarose 
samples did not; moreover mechanically induced enhancement of chondrogenesis in 
PEG hydrogels was shown to be integrin dependent[127]. Thus, different integrin 
implication in PCL and BG vs. HA scaffolds could explain why hydrostatic pressure 
showed a positive effect on ECM production in PCL HP and BH HP scaffolds but 
not in HA HP scaffolds, in which hydrostatic pressure had little or no effect. 
Immunofluorescence studies for different integrins was performed afterwards 
(results not shown), but at late times no significant differences were found in the 
studied cell surface receptors (αv, α5, β1, CD44) most probably due to the abundance 
of ECM at this time and the predominance of cell-extracellular matrix interaction 
over cell-material interaction. 
 
4.4.4.- Conclusions 
Culture of MSCs on synthetic rigid scaffolds can lead to positive results when 
cultured using chondrogenic factors such as TGF-β3, hypoxia and intermittent 
hydrostatic pressure. Such scaffolds, once cultured, show modulus values in the 
range of normal cartilage tissue and should thus be biomechanically apt for 
implantation. Small composition changes in the scaffolding materials lead to 
different MSC response to intermittent hydrostatic pressure. As a result, a typical 
response (increase of ECM production; less prominent staining for collagen type I) 
is observed in bare PCL and Bioglass
®
 containing scaffolds. Distribution and 
morphology of the deposited ECM was also greatly changed by HA coating. Such 
changes are thought to be related with differential expression and use of cell surface 
receptors and their associated pathways. 
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4.5. Characterization of coculture of MSCs and chondrocytes as culture 
condition to develop an in vitro construct. 
Mesenchymal stem cell differentiation in vitro is a necessary step to develop 
effective cell-scaffold construct because the environment found in cartilage defect 
site could not be able to drive a correct in vivo differentiation.[62] MSC 
differentiation in vitro is performed using typical culture conditions such as growth 
factors supply, hypoxia and mechanical stimulation that were studied in previous 
sections. The use of such culture conditions showed to be able to induce MSC 
chondrogenesis but it has been pointed out that it does not prevent hypertrophy[52]. 
Co-culture is another approach used in order to obtain a satisfactory chondrogenesis 
and prevent hypertrophy. Co-culture is based on the premise that different cell types 
can generate a paracrine or cell-cell effect during in vitro culture that can direct cell 
fate to the desired phenotype.[52,137] The objective of this part of the thesis was to 
determine if indirect co-culture of mesenchymal stem cells with hyaline 
chondrocytes could improve chondrogenic differentiation of MSCs. Cell interaction 
was studied with a new indirect co-culture system that was developed trying to 
mimic the in vivo situation when a cell-scaffold construct is implanted in a cartilage 
defect and interact with the chondrocytes of host cartilage and also with subchondral 
bone cells only through secreted factors. With this system we wanted to study the 
influence of MSC and chondrocytes on each other, trying to determine on one hand 
if the presence of chondrocytes permits to stabilize the phenotype of differentiated 
MSCs and on the other hand if MSC signalling stimulates ECM production and 
chondrocytes redifferentiation. 
To ensure the isolation of both cell types in our co-culture system they were seeded 
isolated in two different constructs. MSCs were cultured on two different substrates, 
one adhesive (fibronectin) and another non adhesive (hyaluronic acid). In previous 
parts of the thesis, hyaluronic acid coating was used but there were concerns about 
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the seeding efficiency and the effective interaction between cells and hydrogel. In 
the present work MSCs were dispersed in chemically modified hyaluronic acid 
solution before being injected into PCL scaffold, where the suspension was 
enzymatically crosslinked; in this way mesenchymal stem cells could be 
encapsulated in hyaluronic acid gel in order to limit interaction of MSCs with PCL 
scaffold, enhancing HA-cell interaction. Moreover, in previous sections PCL 
scaffolds were coated with FBS that is not defined protein solution but rather 
contains a wide range of adhesive proteins. In the present section the bare PCL 
control scaffolds were coated with fibronectin in order to obtain a homogenous cell 
attachment to the scaffold through integrin attachment to fibronectin adhesion 
domains. We expected that in these different and more controlled environments (HA 
vs. FN), MSC would express different adhesion protein patterns, which may 
modulate the way MSCs respond to co-culture stimulus; some findings in this line in 
the case of chondrocytes were reported in reference[128]. On the other hand 
chondrocytes were encapsulated in alginate gel that is a well known biomaterial in 
cartilage tissue engineering able to retain spherical morphology and chondrocyte 
phenotype while being inert and offering no specific biological cues to encapsulated 
chondrocytes.  
Alginate mould fabrication process, sizes and scaffold assembling are described in 
section 2.2.3.4. Samples (table 4-8) were divided in three groups: Co-culture, MSC 
monoculture control and chondrocyte monoculture control. Samples mounting 
sketch is shown in figure 2-9. Co-culture was PCL+FN and PCL+HAts samples 
seeded with MSC cultured inserted in an alginate mould containing chondrocytes. 
MSC monoculture control was defined as PCL+FN and PCL+HAts seeded with 
MSC inserted in an acellular alginate mould without chondrocytes.   
  
 
 
Figure 4-19. Coculture sketch (A) samples were divided in coculture constructs conformed by scaffolds seeded 
with MSC and an alginate mould seeded with chondrocytes. Control samples were monoculture of MSC without 
chondrocytes in alginate mould and chondrocyte monoculture seeded into the alginate mould with a scaffold 
without cells. Picture of assembled alginate-scaffold construct(B).  
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Table 4-7. Table with tested samples.  
 
Finally chondrocyte monoculture control was defined as an alginate mould seeded 
with chondrocytes (CHOmControl) with a PCL scaffold inserted. As a result the two 
types of cell were expected to grow separately and to interact only through soluble 
signals. Porcine MSCs were seeded in the scaffold and chondrocytes in alginate gel 
in a proportion of 1:4 and were cultured with chondrogenic media under normoxia 
conditions for 35 days. Samples were removed at day 1, 17 and 35 and prepared for 
mechanical, biochemical and histological analysis. Samples for mechanical and 
biochemical tests were removed from the culture plate, washed with DPBS and the 
scaffold was separated from the alginate mould. Alginate samples were stored at -
80ºC while scaffolds were used to perform non-destructive mechanical assays, after 
which they were washed and stored at -80ºC until biochemical analysis was 
performed. On the other hand for histological analysis whole constructs (alginate + 
scaffold) were fixed and included in polyester wax. 
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Table 4-8. Table with cultured samples ID for present section, tested samples 
and scaffold coculture combination.  
 
The influence of material on initial adhesion was performed using 
immunofluorescent staining of day 1 scaffolds for integrins β1, αv, α5, and surface 
receptor CD44.  
The influence of MSC on chondrocyte ECM production was assessed using 
histological stains for collagen and glycosaminoglycans as well as biochemical 
quantitative analysis of collagen content and GAG content. Collagen type II was 
quantified by ELISA.  
The influence of chondrocyte on MSC behaviour and phenotypic stability was 
studied both by assessing the content and quality of produced ECM (histological 
stain/ biochemical quantitative assay) as well as the expression of hypertrophic 
markers such as collagen type X by ELISA and ALP by enzymatic assay. 
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4.5.1. Characterization of materials. 
PCL scaffolds showed the same structure (figure 4-20) and similar porosity and 
mechanical properties (table 4-9) as obtained in previous sections. Samples with 
hyaluronic acid were obtained by filling PCL scaffolds with an injectable in situ 
crosslinkable tyramine-substituted hyaluronic acid. In Cryo-scanning electron 
microscopy pictures (figure 4-20) swollen PCL HAts samples’ macropores were 
completely filled with a porous hydrogel. Figure 4-21 shows Alcian blue staining 
picture corroborating that hyaluronic acid filled the whole scaffold. On the other 
hand Alcian blue staining showed a hole in the middle of the structure that probably 
was made by the needle insertion used to inject the hyaluronic acid. Scaffold 
porosity or mechanical properties (table 4-6) did not show significant differences 
compared to bare PCL scaffolds. On the other hand swollen PCL+HAts showed a 
decrement of elastic modulus in compression probably related with the hole made in 
the scaffold with the needle (showed on figure 4-21 at HAts sample center), thus in 
further works another kind of mechanism would be needed in order to inject the 
viscous solution without damaging the scaffold. 
 
 
Table 4-9. Total porosity of and mechanical analysis of scaffolds. 
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Figure 4-20. Scanning electron microscopy picture of PCL scaffold (A) and 
Scanning electron microscopy (dry samples) and Cryo-scanning electron 
microscopy (swollen samples) micrographs of PCL+HAts (B). 
(magnification/Scale bar = X100/600 μm and X1000/60 μm).  
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4.5.2. Initial adhesion of MSC to HA or FN-modified PCL scaffolds 
In this work porcine MSCs were seeded at 3x10
5
 cells/scaffold and bovine 
chondrocytes at 1.2x20
6
 cells/alginate gel (sample ID showed in table 4-8). Cell 
seeding was determined as the number of cells present on cell-scaffold construct at 
day 1. Cell seeding efficiency was determined for mesenchymal stem cells with a 
MSC number vs. DNA standard curve determined for this purpose. Chondrocyte cell 
numbers were calculated on the basis of 7.7 pg DNA/cell[227]. MSCmFN and 
MSCcFN samples showed a cell seeding efficiency average of 35 ± 4%, not 
significantly different of the average efficiency for MSCmHA and MSCcHA (32 ± 
9%). On the other hand alginate mould seeding efficiency was 59 ± 16% which 
combined with the results of scaffolds means that actual MSC: chondrocyte ratio 
was close to 1:7 for both scaffold types rather than the initially intended 1:4 ratio. To 
determine if cell seeding distribution was homogeneous through the scaffold and 
which cell receptors were involved in initial adhesion samples at day 1 were fixed 
and stained with haematoxylin staining or immunostaining as shown on figure 4-21 
and figure 4-22 respectively. At day one cells seeded on MSCmFN and MSCcFN 
samples (figure 4-21) showed homogeneous cell dispersion through the scaffold 
pores, with cells showing an expanded morphology. On the other hand MSCmHA 
and MSCcHA at day one (figure 4-21) were completely filled with hyaluronic acid 
as observed on figure 4-21, with the cells showing a spherical shape as expected, 
and embedded homogeneously in the hydrogel phase. Immunostaining (figure 4-22) 
of MSC seeded in fibronectin coated samples showed an adhesion profile 
characterized by abundant β1 integrin staining, less prominent α5 and αv staining and 
no staining for CD44. In contrast, MSC seeded in samples with hyaluronic acid 
expressed CD44 at day 1, as shown in figure 4-22. On the other hand integrin 
staining of α5 was visible while β1 and αv staining was weak and only observed in 
some cells. 
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Figure 4-21. Hematoxylin staining for nucleus and Alcian Blue staining for 
glycosaminoglycans at day 1 in PCL+FN (FN) and PCL+HAts (HA) scaffolds. 
A: Cells appears in purple and glycosaminoglycans appear in blue. 
(magnification/Scale bar = X1.6/1mm).  
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Figure 4-22. Microscopic views of anti-α5, αv, β1 and CD-44 
immunohistochemical staining mesenchymal stem cells at day 1 in PCL+FN 
(FN) and PCL+HAts (HA) scaffolds. Cell nucleus appears blue and adhesion 
protein is green. (magnification/Scale bar = X20/100 μm).  
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4.5.3. DNA and proliferation 
Cell population was studied at day 1, 17 and 35. DNA content (in figure 4-23) 
showed that MSCs proliferated with time in fibronectin coated samples while in 
hyaluronic acid filled samples cell number decreased with time. Coculture 
conditions improved cell proliferation significantly in MSCcFN compared to 
monoculture. On the other hand in hyaluronic acid filled samples coculture led to a 
stable cell number but there was no proliferation during the whole time of culture. 
Chondrocytes proliferated in alginate hydrogel in all tested samples in coculture and 
monoculture conditions as shown in figure 4-23. In coculture, there was a 
decrement of DNA content with respect to monoculture control, showing that the 
behaviour of chondrocytes seeded into alginate gels was also affected by the 
presence of MSCs. This reduction of DNA content (figure 4-23) was statistically 
significant in CHOcFN samples where proliferation seemed to stop at day 35 while 
CHOcHA only showed a slightly lower DNA content than CHOmControl. 
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Figure 4-23. Total DNA of porcine mesenchymal stem cells after seeding at day 
1, 17 and 35 in scaffolds (A) under monoculture (m) and coculture (c) and 
bovine chondrocytes (B) seeded in alginate in monoculture or coculture. Results 
are averaged from n=4 experiments. Significance (p<0.05) compared to similar 
group for normalized scaffolds is signalled as: (F) MSC_FN, (H) MSC_HA, 
(Fc) CHO_FN and (Hc) CHO_HA samples for each group at the same time and 
(#) cocultured sample from the same type at the same time.  
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4.5.4. Extracellular matrix synthesis 
Extracellular matrix synthesis was evaluated as collagen and glycosaminoglycans 
content normalized to DNA content as shown in figure 4-24 and figure 4-25. 
Regarding the central part of the construct where MSCs were seeded, normalized 
glycosaminoglycans and collagen content (figure 4-24 and figure 4-25) increased 
with time in both scaffold types. Normalized collagen (figure 4-24) content was 
severely lowered by chondrocytes coculture with values several times lower than 
monoculture controls in both scaffold types without remarkable differences between 
them. On the other hand normalized glycosaminoglycans (figure 4-25) response to 
coculture was affected by the substrate. In FN coated samples, GAG content was 
higher in coculture conditions (MSCcFN>MSCmFN), while in HA filled samples, 
GAG content was higher in monoculture conditions (MSCmHA>MSCcHA). As a 
result GAG content was slightly higher in MSCcFN samples than in MSCcHA, 
while GAG content was significantly higher in MSCmHA than in MSCmFN. 
Chondrocyte normalized ECM deposition, presented in figure 4-24 and figure 4-25 
showed an increment with time for all tested samples. Extracellular matrix synthesis 
was affected by the coculture with MSC. Coculture improved glycosaminoglycans 
and collagen deposition in CHOcFN and CHOcHA compared to CHOmControl, but 
this difference was only significant for CHOcFN. On the other hand, CHOcFN had 
significantly higher normalized collagen and GAG content at day 35 than CHOcHA, 
showing that the material used to culture the MSCs influences their interaction with 
chondrocytes. 
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Figure 4-24: Collagen levels normalized to total DNA at day 17 and 35 in 
scaffolds (A) under monoculture (m) and coculture (c) and bovine chondrocytes 
seeded in alginate (B) in monoculture or coculture. Results are averaged from 
n=4 experiments. Significance (p<0.05) compared to similar group for 
normalized scaffolds is signalled as: (F) MSC_FN, (H) MSC_HA, (Fc) 
CHO_FN and (Hc) CHO_HA samples for each group at the same time and (#) 
cocultured sample from the same type at the same time.  
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Figure 4-25: Glycosaminoglycans (GAGs) levels normalized to total DNA at 
day 17 and 35 in scaffolds (A) under monoculture (m) and coculture (c) and 
bovine chondrocytes seeded in alginate (B) in monoculture or coculture. Results 
are averaged from n=4 experiments. Significance (p<0.05) compared to similar 
group for normalized scaffolds is signalled as: (F) MSC_FN, (H) MSC_HA, 
(Fc) CHO_FN and (Hc) CHO_HA samples for each group at the same time and 
(#) cocultured sample from the same type at the same time. 
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4.5.5. Histological stains 
Obtained constructs alginate/scaffold structure is shown in figure 4-26 at day 35 
with PCL+FN samples stained with Picrosirius red and PCL+HAts stained with 
Alcian blue to stain the HA inside the pores.  
 
Figure 4-26. Picro-Sirius Red staining for collagen at day 35 in FNmo and FNco 
samples (A). Collagen appears in red and cells in purple. Alcian Blue staining 
for glycosaminoglycans at day 35 in HAmo and HAco samples (B). 
Glycosaminoglycans appears in blue and cells in purple. (magnification/scale 
bar = 1.6X/1mm). 
 
Extracellular matrix distribution was evaluated by means of collagen and 
glycosaminoglycans staining (figure 4-27 and figure 4-28) at day 17 and 35. Cell 
and ECM distribution varied depending of culture condition and the scaffold 
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composition. Monoculture of MSC seeded in MSCmFN and MSCmHA samples 
seems to induce fibroblastic cell shape, fibrous matrix distribution and high collagen 
deposition. Important differences between monoculture and coculture conditions 
were found in MSC cultured in fibronectin coated scaffolds. Collagen deposition is 
higher in monoculture as shown in figure 4-27 with a marked staining pattern. MSC 
showed a fibroblastic shape and were distributed along the scaffold volume. In 
addition in monoculture the extracellular matrix showed a fibrous staining pattern. 
On the other hand MSC seeded in MSCcFN samples showed a cell distribution 
limited to scaffold top part with a less fibrous and softer ECM staining. 
Glycosaminoglycans (figure 4-28) showed a staining pattern similar to collagen but 
the staining was more intense in coculture conditions than in monoculture. 
Extracellular matrix distribution in hyaluronic acid filled samples (figure 4-27 and 
figure 4-28) was different from MSCmFN and MSCcFN. The main difference was 
that cells adopted a spherical shape in hyaluronic acid filled samples. Coculture 
allowed retaining the spherical morphology of all mesenchymal stem cells cultured 
in MSCcHA scaffolds at day 35 (figure 4-27) while MSCmHA showed a collagen 
staining pattern similar to MSCmFN. In MSCcHA samples Picro Sirius red staining 
was found weakly in the thin cell layer on the surface of the scaffold and in the 
inside area where round cells were found. On the other hand Alcian blue staining 
(figure 4-28) showed that hyaluronic acid filled the pores homogeneously and 
remained intact during the 35 days of cell culture but hydrogel background did not 
allow studying the GAG distribution in MSCcHA.  
Collagen and glycosaminoglycans distribution in chondrocyte seeded alginate 
moulds was studied (figure 4-29) and was localized as a weak staining ring 
surrounding cells but no significant differences were found between samples or 
culture conditions.  
  
 
 
 
Figure 4-27. Picro-Sirius Red staining for collagen at day 17 and 35 under  monoculture (m) and coculture (c) of 
MSC cultured in scaffolds. Collagen appears in red and cells in purple. (magnification/scale bar= 10X/200µm). 
  
  
 
 
 
Figure 4-28. Alcian Blue staining for glycosaminoglycans at day 17 and 35 under monoculture (m) and coculture 
(c) of MSC cultured in scaffolds. Glycosaminoglycans appears in blue and cells in purple. (magnification/scale 
bar= 10X/200µm). 
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Figure 4-29. Picro-Sirius Red staining for collagen (A) and Alcian blue staining 
(B) at day 17 and 35 under monoculture (m) and coculture (c) of chondrocytes 
in alginate mould. Collagen appears in red, glycosaminoglycans appears in blue 
and cells in purple. (magnification/scale bar= 10X/200µm). 
 
4.5.6. Expression of collagen type II 
MSC differentiation to hyaline chondrocyte was studied measuring collagen type II 
compared to total collagen content. As can be observed in figure 4-30 collagen type 
II content normalized to total collagen content showed significant differences 
between the different culture conditions: MSCcFN samples showed 16 times more 
normalized collagen type II deposition than MSCmFN. Normalized collagen type II 
deposition in MSCcHA samples (figure 4-30) showed the same response to culture 
conditions studied as MSCcFN but with values slightly lower.  
Chondrocyte seeded samples showed an unexpected result because collagen type II 
levels (figure 4-30) were lower than 2%, extremely low compared with the 20% of 
MSCcFN or MSCcHA samples. On the other hand coculture showed a positive but 
not significant effect on collagen type II deposition. 
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Figure 4-30. Collagen type II (collagen II) normalized to total collagen content 
at day 35 in scaffolds (A) and alginate mould (B). Results are averaged from 
n=4 experiments. Significance (p<0.05) compared to cocultured sample from 
the same type at the same time.  
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4.5.7. Expression of hypertrophic markers 
Hypertrophic chondrocyte phenotype was evaluated for cultured MSC (figure 4-31) 
by means of ALP levels and collagen type X compared to total collagen content. 
Hypertrophic markers showed different patterns (figure 4-31). Normalized collagen 
type X (figure 4-31) showed a significantly higher percentage in coculture 
conditions than in monoculture but no sample presented values higher than 0.004% 
of collagen type X normalized to total collagen content. Nevertheless, Alkaline 
phosphatase release (figure 4-31) was several times higher in mesenchymal stem 
cells in monoculture compared to samples cultured under coculture conditions. On 
the other hand no significant differences between the different tested materials were 
found with respect to the response to coculture, but hyaluronic acid filled samples  
showed values higher than fibronectin coated samples for collagen type X and ALP. 
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Figure 4-31. Collagen type X (collagen X) normalized to total collagen content 
(A) and alkaline phosphatase (ALP) released to culture media normalized to 
construct total DNA (B) at day 35 in scaffolds. Results are averaged from n=4 
experiments. Significance (p<0.05) compared to similar group for normalized 
scaffolds is signalled as: (F) MSC_FN and (H) MSC_HA samples for each 
group at the same time and (#) cocultured sample from the same type at the 
same time.   
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4.5.8. Discussion 
Different therapies used in clinics to resolve defects in articular cartilage shows that 
new formed tissue lacks the properties of hyaline cartilage and even if initially 
regenerated tissue histology presents some characteristics of native tissue, it soon 
degenerates towards fibrocartilage. Thus it seems that the environment found by the 
cells invading the defect (MSCs coming from subchondral bone) or transplanted 
(expanded chondrocytes or autologous MSCs) does not promote the in vivo 
acquisition of a hyaline chondrocyte phenotype.[13,62] This encourages the 
development of tissue engineered implants containing well characterized, previously 
in vitro differentiated chondrocytes that can be directly implanted in the site of the 
cartilage defect. In addition to the optimization of biophysical culture conditions 
(growth factors supply, hypoxia, mechanical stimulation) coculture of different cell 
types can generate a paracrine effect during in vitro culture that may direct cell fate 
towards the desired phenotype.[52] On the other hand, it is known that scaffolding 
material properties have a great deal of influence on the differentiation of stem cells 
and ECM deposition. In this work, we wanted to study the influence of the 
scaffolding material used to culture the mesenchymal stem cells on their response to 
a coculture with mature hyaline chondrocytes. Due to the separation of both cell 
types in our culture model, we would also be able to check whether the material 
where MSCs were seeded also would have an influence on chondrocyte behaviour 
despite of the fact that chondrocyte microenvironment would not change (alginate 
was used in every case). Obtained scaffolds (with or without hyaluronic acid) that 
showed a 80% of porosity and an elastic modulus in range with articular 
cartilage[22] were seeded with MSC for 35 days with chondrogenic culture media in 
coculture or monoculture. In the present work we use the alginate mould in which 
chondrocytes are seeded playing at the same time the role of the agarose moulds 
used in previous sections. However, cell seeding efficiency with alginate mould was 
around a half of that obtained in previous sections pointing that new mould did not 
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match perfectly with the scaffold size. Cell adhesion at 24 hours is shown in figure 
4-22 where it can be seen that MSC seeded in fibronectin coated scaffolds were 
attached to the surface through β1 integrin mainly and α5 and αv integrin. M Cs 
adhesion protein profile observed in MSCmFN and MSCcFN was expected because 
the α5β1 integrin mediates cell adhesion to fibronectin.[228] On the other hand 
MSC seeded in MSCmHA and MSCcHA showed CD44 attachment as expected. In 
figure 4-22 α5 integrin staining is shown although cells were cultured in serum-free 
conditions pointing that cells seeded probably start secreting their own ECM 
proteins like fibronectin already in the first 24 hours. 
Coculture has a positive effect on cell proliferation in MSCcFN and MSCcHA in 
contrast with the findings of other works were indirect coculture in transwell model 
or with two scaffolds in the same well did not show MSC proliferation improvement 
compared to monoculture control[140,146]. There was no proliferation in hyaluronic 
acid filled samples with a constant decrement in DNA content with time. One 
possible explanation to the observed differences is that α5β1 integrin adhesion to 
fibronectin, necessary for chondrocyte proliferation[228],was present in MSCmFN 
and MSCcFN but not in MSCmHA and MSCcHA samples. On the other hand 
coculture showed an important effect over ECM deposition, distribution and 
composition. Normalized collagen deposition in MSCmFN and MSCmHA was 
around 9 times lower compared to MSCcFN and MSCcHA. Obtained results are 
similar to results in static conditions obtained by Levorson et al.[146] In that work 
indirect coculture was performed with MSC and chondrocytes seeded separately in 
two scaffolds and cultured in the same well separated by a vertical piece of 
propylene mesh. Normalized glycosaminoglycans and collagen values deposited by 
MSCs in monoculture were higher than in coculture,[146] but normalized content 
differences between culture conditions were small and showed a great variability. 
On the other hand cartilage tissue typically shows a wet weight percentage of 
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proteoglycans (9%) and collagen (15%) [6] that can be defined as 
collagen/proteoglycans ratio of 1.67. In present study MSCmFN ratio of non-
normalized collagen/ glycosaminoglycan was 9.8 whereas in MSCmHA it was 7.8. 
Ratio for both samples was far of theoretical 1.67 but the ratios of cocultured 
samples were around 1.1 for MSCcFN and MSCcHA much closer to the healthy 
tissue. These results suggest that coculture has a normalizing effect on ECM 
composition and that high collagen levels found in monoculture may be an 
anomalous secretion. Extracellular matrix was examined using Picrosirius red and 
Alcian blue staining to determine collagen and glycosaminoglycans distribution. The 
most important feature of monoculture staining was the intense collagen staining 
(consistent with the higher total collagen content found in monoculture) distributed 
along the scaffold with a visible fibrous staining. Such a pattern was already 
described previously in PCL scaffolds cultured in normoxia conditions (section 4.3. 
and section 4.4.). On the other hand MSC seeded in MSCcFN samples showed a 
less fibrous matrix deposition. These results are in good agreement with our 
previous hypothesis that monoculture induces a secretory profile that does not match 
that of hyaline cartilage. On the other hand cell distribution was affected by cell 
culture conditions. MSC seeded in MSCcHA were able to retain a spherical shape 
35 days in contrast with MSCmHA suggesting that substrate alone was not enough 
to retain spherical shape. MSC cultured in MSCcFN were limited to the top part. 
This different cell distribution can be a consequence of deficient oxygen or/and 
nutrient distribution from outside to MSC seeded inside the scaffold. The mass 
transport could be affected because the chondrocytes that surrounded the scaffold 
consumed the main part of oxygen and nutrients and MSC migrate to the top part 
with a higher nutrient supply. Construct mechanical properties were studied at day 1, 
17 and 35 but no significant differences (that could be related to huge differences of 
ECM components deposition or ECM distribution) were found. Results obtained are 
in contrast with the work of Bian et al.[145] with cells seeded on methacrylated 
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hyaluronic acid. Cells showed an ECM deposition increment in direct coculture 
compared to MSC control that was translated in a significant mechanical modulus 
increment.[145] If cell-scaffold construct mechanical elastic modulus can be roughly 
speaking a sum of the contributions of the scaffold modulus plus the extracellular 
matrix modulus (as in a parallel model for a two phase construct). Our results mean 
that ECM secreted by the cells has a small effect over the construct mechanical 
response as shown in previous sections. Vikingsson et al.[229] showed that the 
scaffold/hydrogel construct stiffness depends of hydrogel crosslinking degree 
because for low crosslink degree the scaffold’s higher stiffness hides the 
contribution of the gel filling retaining water. On the other hand in cartilage tissue 
proteoglycans are entrapped in a collagen matrix mesh, which combination is 
responsible of cartilage unique properties.[6] This can explain why no differences in 
the mechanical properties were found at the end of culture between the studied 
culture conditions. In our samples collagen and proteoglycans probably are 
deposited randomly without a defined organization with a low crosslink degree 
between collagen and proteoglycans explaining the huge differences between culture 
conditions. Finally the eventual development of a hypertrophic phenotype was 
evaluated . MSCcFN and HAcFN showed the highest normalized collagen type II 
values that combined with collagen/GAGs shows that coculture improved ECM 
quality compared to monoculture, the later inducing a more fibroblastic phenotype. 
The effect of the coculture with mature chondrocytes seems thus to have a positive 
effect on MSCs since they showed a higher synthesis of collagen type II and reduced 
expression of ALP as is described in other works[138,141,147]. Nevertheless 
cocultured samples showed an overexpression of collagen type X compared with 
monocultures in contrast with other works [138,141]. It is worth note that anyway 
hypertrophic marker values obtained (figure 4-31) for collagen type X and ALP for 
all samples were extremely low what combined with absence of calcium deposits in 
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alizarin red staining points that hypertrophy was quite low regardless of the culture 
condition. 
Chondrocyte redifferentiation usually was observed in direct coculture studies but 
literature suggests that non contact coculture had less effect on chondrocyte 
redifferentiation.[52] In the present work a paracrine effect of mesenchymal stem 
cells over chondrocytes was observed. Paracrine effect resulted in a decrement of 
cell proliferation and an increment of collagen and glycosaminoglycans synthesis. 
The effect of the presence of MSCs on chondrocytes evolution in coculture is clear 
independently of the type of support in which MSCs were seeded. 
Finally obtained results showed a strong interaction between mature chondrocytes 
and MSCs in indirect coculture, so supporting previous findings in the same sense 
[138,141,147] but in contrast with other studies that points that only direct coculture 
works[140,145]. On the other hand differences with literature can be explained as 
coculture system is a highly modifiable study platform where different cell types, 
passage numbers, cell density and coculture system are used. All these parameters 
can strongly affect the results hampering direct comparison with the literature.[137] 
 
4.5.9. Conclusions 
Indirect coculture condition showed a high positive effect over MSC 
chondrogenesis. Coculture corrected the anomalous collagen/ glycosaminoglycan 
ratio and fibrillar extracellular matrix deposition observed on MSC cultured in 
monoculture. In addition coculture improved collagen type II synthesis and reduced 
ALP release. On the other hand coculture improved the effect of hyaluronic acid 
over cell morphology retaining the spherical morphology up to 35 days in culture. 
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Differences between tested materials were few: fibronectin coating improved MSC 
proliferation and hyaluronic acid improved slightly chondrogenic differentiation. 
Commented differences between substrates can be related with differential 
expression and interaction of cell surface receptors. 
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4.6. Chapter discussion 
This chapter focuses on developing a cell-scaffold construct in vitro suitable for 
cartilage tissue engineering. The aim was to obtain a construct containing in vitro 
differentiated chondrocytes. We addressed the research in two directions: (a) 
developing scaffolds with different coatings and (b) differentiating in vitro MSCs 
seeded into the scaffolds by culturing under different chondrogenic conditions.  
First developed prototype samples were based on PCL scaffolds coated with 
hyaluronic acid. PCL scaffold protect cells from excessive loading and hyaluronic 
acid provides a correct biological environment. Hyaluronic acid coating was 
crosslinked in two different ways (1 step and 2 steps). Samples had similar values of 
hyaluronic acid weight but in PCL+HA1s samples hydrogel partially fills the pore 
meanwhile on PCL HA2s only coats the pore’s walls. Developed samples improved 
hydrophilicity of PCL samples and showed an elastic modulus in range with 
cartilage[22]. Cell culture showed that coating allowed cell growth inside the pore 
using the hydrogel filler as substrate compared with PCL where cells grew stuck to 
the walls. On the other hand coating was not perfect, the PCL surfaces appears in 
some parts of the pore walls and cells attached to these zones showed a behaviour 
similar to cells in naked PCL scaffolds. Finally the main function of hyaluronic acid 
coating that was to improve chondrogenic phenotype through hyaluronic acid-CD44 
interaction was successful: A high number of the cells seeded on PCL+HA samples 
showed positive CD44 staining. The obtained results were used to correct certain 
characteristics of the developed PCL+HA samples. PCL+HA1s showed the best cell 
response but had the worst cell seeding efficiency probably because the hyaluronic 
acid filled the pore. Modified scaffold PCL+HA1s-m showed a similar hyaluronic 
acid coating but did not fill the pore. On the other hand PCL+HA2s samples showed 
the highest cell seeding efficiency compared to PCL samples probably because it 
was more hydrophilic than PCL. To improve cell seeding on PCL samples PCL was 
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combined with Bioglass
®
 providing the scaffold with higher hydrophilicity and 
increased initial cell adhesion[77]. Bioglass
® 
is a bioactive glass widely used in bone 
tissue engineering but not in cartilage tissue engineering[9,77] New developed 
scaffolds were able to support cell proliferation and differentiation at similar levels 
to PCL control but showed worse results than PCL scaffolds in normoxia conditions. 
In addition PCL-5BG reduced their mechanical properties to the half in 35 days in 
acellular culture pointing that polymer degradation is probably too fast for cartilage 
tissue engineering. Finally cells were encapsulated inside a crosslinkable hyaluronic 
acid to obtain a support able to isolate them in a hydrogel environment. That new 
scaffold was able promote chondrogenesis. In spite that it showed a negative effect 
over cell proliferation it was able to retain round shape with the addition of extrinsic 
factors pointing that an external chondrogenic stimulus was still required. 
The second part of the study was to analyze culture conditions in order to improve 
chondrogenesis. In a first study scaffold samples were tested with chondrocytes 
without chondrogenic media to determine if hyaluronic acid coating can rescue the 
phenotype in adverse conditions. Culture media used in the first chapter section 
contained FBS that is a probed dedifferentiating factor that represent an adverse 
culture condition.[188,191] The obtained results suggested that chondrocyte 
interaction with hyaluronic acid could improve chondrogenic phenotype expression. 
In the next studies a serum free culture medium was used containing chondrogenic 
factors such as transforming growth factor β3 or dexamethasone that promote 
chondrogenic ECM secretion.[125] On the other hand in vivo is a complex 
environment with different oxygen level tension, complex mechanical signals and 
cell interactions through paracrine signals or cell-cell contacts. In this work we used 
different culture conditions such as hypoxia, hydrostatic pressure or coculture to 
reproduce chondrogenic stimulus in vitro. Cartilage tissue in vivo is subjected to 
hypoxia that affect the cells through hypoxia inducible factors inducing 
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chondrogenic differentiation of mesenchymal stem cells.[209] Our results showed 
that hypoxia was a more decisive chondrogenic factor than the characteristics of the 
material substrate. PCL-5BG and PCL+HA1s-m failed in normoxia conditions to 
develop chondrogenic markers while results clearly improved under hypoxia. These 
results point that hypoxia is a key factor to obtain well functional constructs. 
Secondly hypoxia was improved with the application of hydrostatic pressure that is 
another chondrogenic stimulus[132]. In our work hydrostatic pressure improved in 
vitro construct allowing a better production of ECM components and better cell 
distribution. Hypoxia showed to be a key factor on MSC chondrogenesis and 
obtained results with the bioreactor showed that hydrostatic pressure was able to 
improve hypoxia effect. Finally coculture is a new platform to induce mesenchymal 
stem cell chondrogenesis and chondrocytes redifferentiation.[52] Indirect coculture 
was chosen as culture method to separate paracrine effect from cell-cell contact 
interaction trying to mimic cartilage cell interaction in vivo. It has been described in 
the literature that chondrocytes release to the culture media paracrine factors able to 
induce cell differentiation and inhibit hypertrophy.[137,138,141] In our work 
coculture improved chondrogenesis of MSCs and reduced the expression of ALP; in 
our system no significant production of hypertrophic collagen type X was found. In 
addition chondrocyte redifferentiation improvement was found in our coculture with 
MSCs. The main drawback in our coculture system was the deficient cell 
distribution along the scaffold at day 35. Our hypothesis is that the huge number of 
chondrocytes surrounding scaffold impair oxygen and nutrient diffusion as 
consequence of cell metabolism. We expect that reducing the alginate mould 
diameter and cell number or the use of a bioreactor to force nutrient diffusion can 
solve lack cell distribution.  
Finally we use the collagen/proteoglycans ratio to establish a direct relationship 
between the obtained results and the effect of each extrinsic chondrogenic factor 
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studied. Healthy cartilage has a defined ratio of collagen and proteoglycans that has 
been reported to be 1.67[6]. In the first study about normoxia versus hypoxia culture 
conditions we observed that normoxia conditions showed aberrant ratios from 3 to 
6.4 while hypoxia reduce the ratio to normal values around 1.5. When hydrostatic 
pressure was applied to improve the hypoxia results we obtained similar values 
between samples cultured hypoxia in free conditions or with mechanical loading. 
Values under hydrostatic pressure were more similar to the expected 1.67 ratio. 
Final study compared coculture with monoculture in normoxia conditions. Cells 
seeded in monoculture showed anomalous rates of 7.8 to 9.8 compared with 
cocultures that showed values of 1.1. As a conclusion, the obtained results point that 
suitable in vitro construct can be obtained with our hybrid scaffolds using a 
combination of different chondrogenic biophysical stimulus. 
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5. Conclusions 
1) Freeze extraction and particle leaching mixed technique allow 
fabricating a macroporous scaffold with a bimodal porosity composed by 
micropores (few microns) and macropores (around 200 µm) suitable for 
cartilage and bone tissue engineering. The scaffolds obtained showed a 
porosity over 85%. Macropores allow cell colonization and tissue invasion 
meanwhile the micropores contribute to the diffusion of nutrients and 
residues. On the other hand scaffolds could be produced polylactide-
polycaprolactone blends with the same technique and showed similar 
morphology than polycaprolactone scaffolds but with higher mechanical 
properties. Polymer blend scaffolds showed small spherical structures over 
scaffold surface due to polymer phase separation between polycaprolactone 
and polylactic acid. 
2) Composite polymer scaffolds reinforced with mineral particles 
were obtained analogously. Morphology and porosity was similar to bare 
polymer scaffolds furthermore, mineral particles appear at the surfaces of the 
pore walls. The mechanical properties of the scaffold improves even for low 
mineral content. Besides hybrid scaffolds whose internal surfaces were 
coated with a layer biomimetic hydroxyapatite were obtained by immersion 
in simulated body fluid. Tested samples showed hydroxyapatite crystals with 
cauliflower like morphology. 
3) Polymer blend scaffolds and composites showed different 
degradation response depending on the major polymer phase composition and 
the presence of hydroxyapatite. The degradation rate of polylactic acid phase 
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in the blends was faster than that polycaprolactone allowing modulating 
degradation kinetics of the scaffold blends. On the other hand hydroxyapatite 
introduction decreased polycaprolactone degradation rate in both, 
polycaprolactone and polylactic acid rich blends. 
 4) Developed composite scaffolds did not show cell cytotoxicity. 
On the other hand scaffolds with 5% of mineral reinforcement did not 
provoke any improvement in cell differentiation but enhanced the cell 
adhesion compared to pure polycaprolactone samples. In vivo study showed 
that studied scaffolds are able to promote bone regeneration in a rabbit 
critical size defect. Bone regenerated showed mechanical properties quite 
similar to health bone. The mechanical behaviour and biological response of 
developed biomaterials was similar to reference material used as control. 
5) Coating of the pore walls with hyaluronic acid was performed 
with different protocols. This coatings did not affect scaffold mechanical 
properties but increased its hydrophilicity improving cell invasion. 
Hyaluronic acid morphology was different for each coating protocol 
employed. Filling pores and cross-linking in one step coating fills the pores 
with hyaluronic acid hindering cell seeding meanwhile one step modified to 
dry the coating simultaneously to cross-link and two step protocol in which a 
HA dry layer is first deposited and dried before crosslinking allows obtaining 
a functional coating leaving the macropores open for cell seeding. 
Polycaprolactone scaffolds coated with hyaluronic acid showed enhanced 
chondrogenic redifferentiation of adult human chondrocytes compared with 
non coated scaffolds. Cells in polycaprolactone scaffolds grown with 
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fibroblastic shape stuck to the surface and with reduced biosynthetic capacity 
showing high staining of collagen type I but reduced collagen type II and 
aggrecan. On the other hand binding of chondrocytes with HA chains in HA 
coated scaffold by CD44 receptor was proved. Chondrocytes in this 
environment showed higher ECM production and enhanced expression of 
chondrogenic markers compared to PCL scaffolds. PCL+HA scaffolds 
showed some nude PCL zones due to imperfect coating. In that zones cell 
attached and behave as in bare PCL scaffold. On the other hand hyaluronic 
acid substitution with tyramine was effective and crosslinked in presence of 
HRP and H2O2. Hydrogel repartition inside the scaffold was homogeneous 
filling all the pores but even in this case the mechanical properties of the 
scaffold were not affected. 
6) Hypoxia positively affected chondrogenesis in any of the 
substrates considered. While under normoxic conditions expression of 
chondrogenic markers and production of ECM was deficient even with the 
addition of TGF-3, hypoxia conditions maintained viability and regulated 
ECM synthesis enhancing collagen type II staining and reducing collagen 
type I. Collagen production levels were similar under normoxia or hypoxia 
but interestingly GAGs/cell ratio was improved under hypoxia conditions in 
hyaluronic acid coated and polycaprolactone scaffolds. On the other hand 
small composition changes in the scaffolding materials lead to different 
mesenchymal stem cells response to intermittent hydrostatic pressure. 
Polycaprolactone and PCL-5BG scaffolds showed an ECM production 
increment and a reduction of collagen type I staining meanwhile distribution 
and morphology of the deposited ECM was also greatly changed in presence 
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of hyaluronic acid coating. Finally MSCs cultured on synthetic rigid scaffolds 
proliferate and secrete ECM showing modulus values in the range of normal 
cartilage tissue and should thus be biomechanically apt for implantation.  
7) In indirect coculture, interactions between chondrocytes and 
MSCs is mediated by soluble factors secreted by each of them. The presence 
of mature chondrocytes close but without direct contact with MSCs produce 
several significant changes in MSCs fate, thus as is observed on normalized 
collagen type II content and collagen/GAGs ratio. Samples in coculture 
showed a significant increment in normalized collagen type II and a 
collagen/GAGs ratio more close to healthy cartilage than monocultured 
samples. On the other hand effect of substrates over MSC only was observed 
in histological staining were cells shape and ECM distribution was different 
if cells were isolated in HA hydrogel or not. On the other hand the presence 
of MSCs affect redifferentiation of mature chondrocytes seeded in alginate 
gels. In particular normalized collagen, glycosaminoglycans and collagen 
type II content was improved in presence of MSC. 
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Glossary 
ALP   Alkaline phosphatase 
ARNT   Aryl hydrogen receptor nuclear translocator 
BG   Bioglass®45S5 
BSA   Bovine serum albumin 
DMEM   Dulbecco’s modified Eagle’s medium 
DPBS   Dulbecco’s phosphate buffered saline 
DPBSG  Dulbecco’s phosphate buffered saline with 2g/l glucose 
DSC   Differential scanning calorimetry 
DVS   Divinyl sulfone 
ECM   Extracellular matrix 
EDX   Energy dispersive X-ray 
FBS   Foetal bovine serum 
FN   Fibronectin 
FS   Free swelling 
GAG   Glycosaminoglycan 
HA   Hyaluronic acid 
HAp   Hydroxyapatite 
HIF-1α   Hypoxia inducible factor-1α 
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HP   Hydrostatic pressure 
HRP   Horseradish peroxidase 
HY   Hypoxia 
MSC   Mesenchymal stem cell 
NO   Normoxia 
OC   Osteocalcin  
PCL   Polycaprolactone 
PEMA   Polyethylmethacrylate 
PHD   Prolyl-4 hydroxylase 
PLLA   Poly(L-lactic acid) 
SEM   Scanning electron microscopy 
TGA   Thermogravimetric analysis 
VHL   E3 ubiquitin ligase Von Hippel-Lindau 
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cells the alginate mold or scaffold and co-culture defined as scaffold and alginate 
mold seeded with cells. (page 77) 
 
Figure 3-1. Micrographs of developed scaffolds (A). Micrographs of developed 
scaffolds (B). (magnification/scale bar = X100/500 μm; X200/300 μm and 
X1000/60 μm). (page 100) 
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Figure 3-2. Micrographs and energy-dispersive X-ray spectroscopy spectra of 
scaffolds. (magnification/scale bar = X1000/50μm). (page 101) 
Figure 3-3. Micrographs of different scaffolds. Beside micrographs the 
corresponding EDX spectra for the sample surfaces are shown. (magnification/scale 
bar= X1000/50 μm).  (page 103) 
Figure 3-4. Differential scanning calorimetry graphs of developed scaffolds. (page 
104) 
Figure 3-5. Microstructure of polyester scaffolds at week 0 and 78. Detail views of 
blend scaffolds in the upper right corner of each micrograph. (magnification/scale 
bar = 200X/300 μm and 1000X/60 μm). (page 116) 
Figure 3-6. Representative TGA curve at day one for bare PCL/PLLA blends and 
composite. Weight loss of a particular phase was determined as the weight (blue 
curve) loss between the temperatures limited by the onset and offset of weight loss 
derivate peaks(red curve). (page 118) 
Figure 3-7. Evolution of sample weight and composition with time as determined by 
weighing and thermogravimetry. PCL (Blue), PLLA (green) and inorganic content 
(red). Error bars represent standard deviation. Significance (p<0.05) compared to 
same material phase at day 0 is signalled as: (A) PLLA, (B) PCL and (C) mineral 
particles. (page 119) 
Figure 3-8. Mechanical compressive properties of the scaffolds. Evolution of the 
elastic modulus with time (A) evolution of the yield strength with time (B) and 
evolution of the densification modulus with time (C). Error bars represent standard 
deviation. Significance (p<0.05) compared to same scaffold at day 0 is signalled as: 
(a) PCL/PLLA(80/20), (b) PCL/PLLA(20/80), (A) PCL/PLLA(80/20)-20HAP and 
(B) PCL/PLLA(20/80)-20HAP. (page 120) 
 
Figure 4-1. Scanning electron microscopy picture of PCL scaffold (A) and Cryo-
scanning electron microscopy (swollen samples) micrographs of PCL+HA1s and 
PCL+HA2s (B). Detail views of hyaluronic acid coated scaffolds in the upper right 
corner of each micrograph. (page 136) 
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Figure 4-2. SEM images of PCL, PCL+HA1s and PCL+HA2s scaffolds seeded with 
human chondrocytes cells after 7, 14, and 21 days of culture. (magnification/scale 
bar = X1000/60μm). (page 139) 
Figure 4-3. Composition of light microscopy and immunofluorescent staining for 
collagen type I (green) and II (red) and nuclei (blue) (A) and immunofluorescent 
staining for aggrecan (red) and actin (green) and nuclei (blue) (B) 
(magnification/scale bar= X40/100μm). The black areas of the pictures correspond 
to the scaffold. (page 142) 
Figure 4-4. Composition of light microscopy and immunofluorescent staining for 
CD44 receptors (green) and nuclei (blue). The black areas of the pictures correspond 
to the scaffold. (magnification/scale bar= X40/100 μm). (page 143) 
Figure 4-5. Total DNA of chondrocytes cell seeded in PCL, PCL+HA1s and 
PCL+HA2s. Results are averaged from n=3 experiments. Error bars represent 
standard deviation. Significance (p<0.05) compared to same group at day 7 is 
signalled as (*) and (P) for cultured samples compared to PCL samples at same time. 
(page 144) 
Figure 4-6. Total glycosaminoglycans (GAGs) (A) and glycosaminoglycans 
normalized to total DNA of chondrocytes at day 7, 14 and 21 in PCL, PCL+HA1s 
and PCL+HA2s. Results are averaged from n=3 experiments. Error bars represent 
standard deviation. Significance (p<0.05) compared to similar group is signalled as: 
(P) PCL, (1) PCL+HA1s and (2) PCL+HA2s samples for each group at the same 
time and compared to same sample group at day 7 is signalled is (*). (page 146) 
Figure 4-7: Mechanical results. Equilibrium modulus (A) and dynamic modulus (B) 
at day 1, 17 and 35 under normoxia (NO) and hypoxia (HY). Results are averaged 
from n=4 experiments. Error bars represent standard deviation. Significance 
(p<0.05) compared to similar group for normalized scaffolds is signalled as: (P) 
PCL, (B) BG and (H) HA samples for each group at the same time and culture 
condition. (page 156) 
Figure 4-8. Total DNA of porcine mesenchymal stem cells after seeding at day 1, 17 
and 35 in scaffolds under normoxia (NO) and hypoxia (HY). Results are averaged 
from n=4 experiments. Error bars represent standard deviation. Significance 
(p<0.05) compared to similar group for normalized scaffolds is signalled as: (P) 
PCL, (B) BG and (H) HA samples for each group at the same time and culture 
condition and (#) statically cultured sample from the same type at the same time. 
(page 158) 
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Figure 4-9. Glycosaminoglycans (GAGs) (A) and collagen (B) levels normalized to 
total DNA at day 17 and 35 under normoxia (NO) and hypoxia (HY). Results are 
averaged from n=4 experiments. Error bars represent standard deviation. 
Significance (p<0.05) compared to similar group for normalized scaffolds is 
signalled as: (P) PCL, (B) BG and (H) HA samples for each group at the same time 
and culture condition and (#) statically cultured sample from the same type at the 
same time. (page 159) 
Figure 4-10. Alcian Blue staining for glycosaminoglycans at day 17 and 35 under 
normoxia (NO) and hypoxia (HY). Glycosaminoglycans appear in blue and cells in 
pink. (magnification/scale bar = X1.25/1mm and X10/100 μm). (page 161) 
Figure 4-11. Picro-Sirius Red staining for collagen at day 17 and 35 under normoxia 
(NO) and hypoxia (HY). Collagen appears in red and cells in purple. 
(magnification/scale bar = X1.25/1mm and X10/100 μm). (page 162) 
Figure 4-12: Microscopic views of anti- collagen type I (A) and anti-collagen type II 
(B) immunohistochemical staining of scaffolds cultured with mesenchymal stem 
cells at day 35 under normoxia (NO) and hypoxia (HY). Scaffold appears gray and 
collagen is brown. (magnification/ cale bar = X10/100μm). (page 163) 
Figure 4-13: Mechanical results. Equilibrium modulus (A) and dynamic modulus 
(B) of whole construct (soft grey) and normalized (subtracting the value of the 
corresponding acellular scaffolds) (dark grey), at day 1 and at day 35 under free 
swelling (FS) and hydrostatic pressure (HP). Results are averaged from n=4 
experiments. Significance (p<0.05) compared to similar group for normalized 
scaffolds is signalled as: (P) PCL, (B) BG and (H) HA samples for each group at the 
same time and culture condition; and (*) sample from the same type at day 1. (page 
172) 
Figure 4-14. Total DNA of porcine mesenchymal stem cells after seeding at day 1 
and 35 in scaffolds under free swelling (FS) and hydrostatic pressure (HP). Results 
are averaged from n=4 experiments. Significance (p<0.05) compared to similar 
group for normalized scaffolds is signalled as: (P) PCL, (B) BG and (H) HA samples 
for each group at the same time and culture condition. (page 174) 
Figure 4-15. Glycosaminoglycans (GAGs) (A) and collagen (B) levels normalized to 
total DNA at day 35 under free swelling (FS) and hydrostatic pressure (HP) 
conditions in scaffolds. Results are averaged from n=4 experiments. Significance 
(p<0.05) compared to similar group is signalled as: (P) PCL, (B) BG and (H) HA 
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samples for each group at the same time and culture condition and (#) statically 
cultured sample from the same type at the same time. (page 175) 
Figure 4-16: (A) Picro-Sirius Red staining for collagen and (B) Alcian Blue staining 
for glycosaminoglycans at day 35 under free swelling (FS) and hydrostatic pressure 
(HP). A: Collagen appears in red and cells in purple. B: glycosaminoglycans appear 
in blue and cells in pink. . (magnification/scale bar = X1.25/1mm and X10/100 μm). 
(page 177) 
Figure 4-17: Microscopic views of anti- collagen type I immunohistochemical 
staining of scaffolds cultured with mesenchymal stem cells at day 35 under free 
swelling (FS) and hydrostatic pressure (HP). Scaffold appears gray and collagen is 
brown. (magnification/Scale bar = X10/100μm). (page 179) 
Figure 4-18: Microscopic views of anti- collagen type II immunohistochemical 
staining of scaffolds cultured with mesenchymal stem cells at day 35 under free 
swelling (FS) and hydrostatic pressure (HP. Scaffold appears gray and collagen is 
brown. (magnification/ cale bar = X10/100μm). (page 180) 
Figure 4-19. Coculture sketch (A) samples were divided in coculture constructs 
conformed by scaffolds seeded with MSC and an alginate mould seeded with 
chondrocytes. Control samples were monoculture of MSC without chondrocytes in 
alginate mould and chondrocyte monoculture seeded into the alginate mould with a 
scaffold without cells. Picture of assembled alginate-scaffold construct(B). (page 
187) 
Figure 4-20. Scanning electron microscopy picture of PCL scaffold (A) and 
Scanning electron microscopy (dry samples) and Cryo-scanning electron 
microscopy (swollen samples) micrographs of PCL+HAts (B). (magnification/Scale 
bar = X100/600 μm and X1000/60 μm). (page 191) 
Figure 4-21. Hematoxylin staining for nucleus and Alcian Blue staining for 
glycosaminoglycans at day 1 in PCL+FN (FN) and PCL+HAts (HA) scaffolds. A: 
Cells appears in purple and glycosaminoglycans appear in blue. 
(magnification/Scale bar = X1.6/1mm). (page 193) 
Figure 4-22. Microscopic views of anti-α5, αv, β1 and CD-44 immunohistochemical 
staining mesenchymal stem cells at day 1 in PCL+FN (FN) and PCL+HAts (HA) 
scaffolds. Cell nucleus appears blue and adhesion protein is green. 
(magnification/ cale bar = X20/100 μm). (page 194) 
 233 
Figure 4-23. Total DNA of porcine mesenchymal stem cells after seeding at day 1, 
17 and 35 in scaffolds (A) under monoculture (m) and coculture (c) and bovine 
chondrocytes (B) seeded in alginate in monoculture or coculture. Results are 
averaged from n=4 experiments. Significance (p<0.05) compared to similar group 
for normalized scaffolds is signalled as: (F) MSC_FN, (H) MSC_HA, (Fc) 
CHO_FN and (Hc) CHO_HA samples for each group at the same time and (#) 
cocultured sample from the same type at the same time. (page 196) 
Figure 4-24: Collagen levels normalized to total DNA at day 17 and 35 in scaffolds 
(A) under monoculture (m) and coculture (c) and bovine chondrocytes seeded in 
alginate (B) in monoculture or coculture. Results are averaged from n=4 
experiments. Significance (p<0.05) compared to similar group for normalized 
scaffolds is signalled as: (F) MSC_FN, (H) MSC_HA, (Fc) CHO_FN and (Hc) 
CHO_HA samples for each group at the same time and (#) cocultured sample from 
the same type at the same time. (page 198) 
Figure 4-25: Glycosaminoglycans (GAGs) levels normalized to total DNA at day 17 
and 35 in scaffolds (A) under monoculture (m) and coculture (c) and bovine 
chondrocytes seeded in alginate (B) in monoculture or coculture. Results are 
averaged from n=4 experiments. Significance (p<0.05) compared to similar group 
for normalized scaffolds is signalled as: (F) MSC_FN, (H) MSC_HA, (Fc) 
CHO_FN and (Hc) CHO_HA samples for each group at the same time and (#) 
cocultured sample from the same type at the same time. (page 199) 
Figure 4-26. Picro-Sirius Red staining for collagen at day 35 in FNmo and FNco 
samples (A). Collagen appears in red and cells in purple. Alcian Blue staining for 
glycosaminoglycans at day 35 in HAmo and HAco samples (B). 
Glycosaminoglycans appears in blue and cells in purple. (magnification/scale bar = 
1.6X/1mm). (page 200) 
Figure 4-27. Picro-Sirius Red staining for collagen at day 17 and 35 under  
monoculture (m) and coculture (c) of MSC cultured in scaffolds. Collagen appears 
in red and cells in purple. (magnification/scale bar= 10X/200µm). (page 202) 
Figure 4-28. Alcian Blue staining for glycosaminoglycans at day 17 and 35 under 
monoculture (m) and coculture (c) of MSC cultured in scaffolds. 
Glycosaminoglycans appears in blue and cells in purple. (magnification/scale bar= 
10X/200µm). (page 203) 
Figure 4-29. Picro-Sirius Red staining for collagen (A) and Alcian blue staining (B) 
at day 17 and 35 under  monoculture (m) and coculture (c) of chondrocytes in 
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alginate mould. Collagen appears in red, glycosaminoglycans appears in blue and 
cells in purple. (magnification/scale bar= 10X/200µm). (page 204) 
Figure 4-30. Collagen type II (collagen II) normalized to total collagen content at 
day 35 in scaffolds (A) and alginate mould (B). Results are averaged from n=4 
experiments. Significance (p<0.05) compared to cocultured sample from the same 
type at the same time. (page 205) 
Figure 4-31. Collagen type X (collagen X) normalized to total collagen content (A) 
and alkaline phosphatase (ALP) released to culture media normalized to construct 
total DNA (B) at day 35 in scaffolds. Results are averaged from n=4 experiments. 
Significance (p<0.05) compared to similar group for normalized scaffolds is 
signalled as: (F) MSC_FN and (H) MSC_HA samples for each group at the same 
time and (#) cocultured sample from the same type at the same time. (page 207) 
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Table index 
Table 2-1. Table with culture medium composition for cell expansion and culture in 
scaffolds of each cell type. (page 53) 
 
Table 3-1. Table with tested samples composition. (page 95) 
Table 3-2. Total porosity, solid residue analysis, crystallinity and mechanical 
analysis of the different scaffolds. The Diff. (%) means the difference in the amount 
of microparticles detected in the composites and the nominal value. Samples that 
show significant differences (p<0.05) with composition 1 sample are pointed with 
(*) and (**) for samples compared to composition 9. (page 106) 
Table 3-3. Table with tested samples composition. (page 112) 
Table 3-4. Total porosity of composite scaffolds series, solid residue analysis of 
composite scaffolds series, mechanical analysis of scaffolds, crystallinity analysis of 
scaffolds series and relative weight loss at 78 weeks. The Diff. (%) means the 
difference in the amount of microparticles detected and the nominal value. Samples 
that show significant differences (p<0.05) with PCL/PLLA(20/80) sample are 
pointed with (*), (**) for PCL/PLLA(80/20) and (***) for samples compared to 
PCL/PLLA(20/80)-20HAP. (page 114) 
 
Table 4-1. Table with tested samples composition. (page 134) 
Table 4-2. Total porosity of hybrid scaffolds series, Hyaluronic acid content analysis 
of hybrid scaffolds series and mechanical analysis of scaffolds. Significance 
(p<0.05) between samples is signalled as (*). (page 137) 
Table 4-3. Table with tested samples. (page 154) 
Table 4-4. Table with cultured samples ID for present section, tested samples and 
scaffold culture conditions. (page 154) 
Table 4-5. Table with tested samples. (page 169) 
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Table 4-6. Table with cultured samples ID for present section, tested samples and 
scaffold culture conditions. (page 170) 
Table 4-7. Table with tested samples. (page 188) 
Table 4-8. Table with cultured samples ID for present section, tested samples and 
scaffold coculture combination. (page 189) 
Table 4-9. Total porosity of and mechanical analysis of scaffolds. (page 190) 
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